what incivo is incivo works by inhibiting the activity of the virus that causes hepatitis c infection . it is used in adults , adolescents and children aged 18 years and older who are already taking peginterferon alfa , ribavirin and telaprevir , medicines known as ns3 - 4a protease inhibitors . the ns3 , 4a enzyme inhibitor stops hepatitis c virus from multiplying and blocking its action . it works by blocking the action of two other proteins called peginerferon alpha and ribavir . what incivo looks like and contents of the pack incivo belongs to a group
do not take incivo - if you are allergic to telaprevir or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking incivo : if you have previously taken peginterferon alfa or ribavirin . if your doctor has told you that incivo is not suitable for you , tell your doctor or pharmacist before taking it . if you take more incivo than you should if you accidentally take too many of the following medicines , you may experience severe side effects : 56 the medicine alfuzosin may
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose regimen is one tablet once a day . your doctor will tell you how many tablets of incivo to take at the same time each day . you should take the tablet with the appropriate dose regimen . if you take more incivo than you should if you accidentally take too many tablets , contact your doctor immediately . if possible , your doctor may prescribe a higher dose of 3 tablets once daily ( 2 to 8 tablets per day ), depending on the severity of both hepatitis c
like all medicines , this medicine can cause side effects , although not everybody gets them . rash : if you get an itchy skin rash , stop taking incivo and tell your doctor straight away . the rash is usually mild to moderate . other symptoms of the rash may include : - a severe skin reaction . - a skin rash that spreads around the body . if your rash spreads to other areas of the body , contact your doctor immediately . - swelling of lymph glands , a wide - spread rash , peeling skin , fever , flu - like symptoms , painful skin blisters , blisters in the mouth , eyes , and /
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the bottle after exp . this medicinal product does not require any special storage conditions . incivo tablets must be kept in the bottle in order to protect from light . keep the bottle tightly closed , so that it can be easily removed from the bottle .
what incivo contains - the active substance is telaprevir . each tablet of incivocontains 375 mg of teleprevir in one tablet . - the other ingredients are tablet core hypromellose acetate succinate , calcium hydrogen phosphate ( anhydrous ), microcrystalline cellulose ( e460 ), silica colloidal anhydrated , sodium lauryl sulphate , croscarmellose sodium , sodium stearyl fumarate . film - coat polyvinyl alcohol , macrogol , talc , titanium dioxide ( e171 ), iron oxide yellow ( e172 ). what
the active substance of zinbryta is daclizumab beta , which is a monoclonal antibody . what it is used for it is a type of protein that belongs to a group of proteins called cytokines . how zinbaryta works in multiple sclerosis , therapy is started as two ms treatment followed by other treatments . inflammation destroys the protective sheath that protects the nerves in the central nervous system ( the brain and spinal cord ). this loss of myelin ( demyelination ) can lead to relapsing ms ( repeated attacks ( relapses ). symptoms include difficulty with walking , vision
do not take zinbryta : - if you have previously had a serious allergic reaction to daclizumab or any of the other ingredients of this medicine ( listed in section 6 . possible signs of liver problems ). warnings and precautions talk to your doctor , pharmacist or nurse before taking zin bryta if : - you have or have had any other autoimmune disorders . - you are taking any other medicines , including herbal supplements . your doctor will tell you whether you should take any medicines or supplements that may increase the risk of liver side effects . these medicines should be taken with or without food . warnings and
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose of zinbryta is 150 mg once a day . your doctor will do a blood test to check how well your liver is working . the recommended starting dose for your doctor , pharmacist or nurse is 40 mg twice a day ( two tablets in the morning and one tablet in the evening ). your doctor may change your dose depending on the results of this blood test . if you have any further questions on the use of this medicine , ask your doctor . how
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with zinbryta : tell your doctor straight away if you notice any of the following serious side effects : liver problems very common ( may affect more than 1 in 10 people ): unexplained nausea ( feeling sick ) vomiting ( being sick ) stomach pain increased tiredness loss of appetite ( anorexia ) changes in the colour of your skin or your eyes turn yellow dark ( tea - coloured ) urine 41 uncommon ( might affect up to 1 in 100 people ): severe inflammation of the liver which may lead to death
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the syringe / pen label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the zinbryta pre - filled syringe in the original package in order to protect from light . you may need to use it if you have not used it before . if you are not sure , talk to your pharmacist or nurse before using it . if the solution is clear , colourless or slightly yellow , it should be used immediately .
what zinbryta contains the active substance is daclizumab beta . each pre - filled syringe contains 150 micrograms of the active ingredient in this medicine . one vial contains 1 ml of solution for injection ( for example , one pen with a syringe with a 150 mg dose in the morning and one pen containing a 75 mg dose of the other ingredient in the evening ). each pre- filled pen contains 150 mg of the same ingredient in each vial , as well as one 50 mg dose . the other ingredients are sodium succinate , succinic acid , sodium chloride , polysorbate
wilzin belongs to a group of medicines called metabolism products . wilson ' s disease is due to a rare inherited defect in copper excretion from the liver to the eyes and brain . this defect leads to liver damage and neurological disorders . wilzin works by slowing down the accumulation of copper in the intestine , enabling its further accumulation in the body . this is important in the treatment of wilson '. if you have any further questions on the use of this treatment , ask your doctor .
do not take wilzin - if you are allergic ( hypersensitive ) to zinc or any of the other ingredients of wilzin ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking wilzin wilzin is for initial therapy only . signs and symptoms of wilson ' s disease are currently being treated with another anti - copper agent called penicillamine . before wilzin starts the initial treatment , your doctor will discuss with you whether you should be treated with other anti - copper agents such as penicillinamine . the duration of the treatment will depend on the condition of blood
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the different dose regimens are as follows : the usual starting dose is 25 mg once a day . the usual dose is 50 mg once in the morning . this dose will be gradually increased by 1 mg each day . wilzin 50 mg twice a day is 1 to 6 mg . your doctor will tell you how many tablets of wilzin to take . the daily dose may vary from 25 mg to 1 mg , depending on how you respond to the medicine . if you take more wilzin than you should
like all medicines , wilzin can cause side effects , although not everybody gets them . the following side effects have been reported with wilzin : very common ( affects more than 1 user in 10 ): very common : may affect up to 1 in 10 people 100 uncommon : affects 1 to 10 users in 1 , 000 people very rare : affects less than 1 per 10 , 000 users not known ( frequency cannot be estimated from the available data ): very rare ( affects 1 in 100 people ): not known : cannot affect the amount of wilzin in the blood ; gastric irritation after treatment ; changes in blood tests ; an increase in some
keep out of the sight and reach of children . do not use wilzin after the expiry date which is stated on the carton and on the label after exp . store below 25 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what wilzin contains the active substance is zinc . each 25 mg hard capsule contains zinc equivalent to 83 . 92 micrograms of zinc ( equivalent to zinc acetate dihydrate ) in 50 mg hard capsules . the other ingredients are : capsule content : capsule contents : capsule shell : capsule size : 167 . 84 mm ( 0 . 9 mm in diameter ) capsule shell - printing ink : gelatin , titanium dioxide ( e171 ), brilliant blue fcf ( e132 ). what wilzin looks like and contents of the pack wilzin 25 mg capsules are white to off - white , capsule shaped , imprinted with " wilzin
biktarvy contains the active substance bictegravir . it is an antiretroviral medicine known as an integrase strand transfer inhibitor ( emtricitabine ). it is also a nucleoside reverse transcriptase inhibitor ( nrti ) tenofovir alafenamide . this belongs to a group of anti - hiv medicines known as a nucleotide reverse transcriptionase inhibitors ( trti ). biktarv is used for the treatment of human immunodeficiency virus ( hiv ). hiv is a type of infection that spreads rapidly around the world .
do not take biktarvy if : you are allergic to bictegravir , emtricitabine , tenofovir alafenamide or any of the other ingredients of this medicine ( listed in section 6 ). you are taking the following medicines : rifampicin ( used to treat some bacterial infections ) - tuberculosis - st . john ' s wort ( hypericum perforatum ) - a herbal remedy for depression and anxiety . warnings and precautions talk to your doctor , pharmacist or nurse before taking biktorvy : if you have liver problems . liver disease is a
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . your doctor may prescribe antacids to help prevent stomach ulcers , heartburn and acid reflux . the other ingredients are aluminium and magnesium hydroxide mineral supplements , vitamins , magnesium and iron ( see section 2 " important information about these medicines "). biktarvy may be taken with or without dialysis . if you take more of these medicines than you should if you accidentally take too many of them , contact your doctor straight away . bik
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following : inflammation ( signs of infection ) in patients with advanced hiv infection : opportunistic infections ( infections caused by a weak immune system ). symptoms of inflammation may occur after previous infections have been treated with hiv treatment . these symptoms are caused by changes in the body ' s immune response that help fight infections . there are no obvious symptoms of autoimmune disorders . immune system attacks the body tissue that makes it hard for medicines to work properly . these can be a sign that you may have hiv
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the label after " exp ". this medicine does not require any special storage conditions . keep the bottle tightly closed in order to protect from moisture . after the seal has been opened , biktarvy should be used immediately .
what biktarvy contains - the active substances are bictegravir , emtricitabine and tenofovir alafenamide . each biktravir sodium equivalent to 50 mg / m2 of the active substance in each tablet . each tablet of bictecitabir contains 200 mg of the other ingredient in the tablet core microcrystalline cellulose , croscarmellose sodium and magnesium stearate . - the other ingredients are film - coating polyvinyl alcohol , titanium dioxide ( e171 ), macrogol , talc , iron oxide red (
novonorm is an oral antidiabetic medicine that contains repaglinide . it works by helping your pancreas make better insulin to control your blood sugar ( glucose ). type 2 diabetes is a disease in which your body does not make enough insulin when it makes too much insulin . this lowers the sugar in your blood and increases the amount of glucose in your body . this helps to control the level of sugar in the blood . novonorm can be used alone or in combination with metformin . if you have diabetes , your doctor will tell you how long you should continue treatment . diet and exercise and weight reduction
do not take novonorm : - if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). if you have type 1 diabetes . your doctor will check the acid level in your blood regularly . warnings and precautions diabetic ketoacidosis ( a severe liver disease ) has been reported in patients taking gemfibrozil ( a medicine used to lower increased fat levels in the blood ). 47 if you suffer from liver problems . no vonorm should not be used in patients with moderate liver disease . if any of these apply to you , tell your doctor before taking
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 0 . 5 mg tablet once a day . swallow the tablet whole with a glass of water . you can take novonorm with or without food . the usual starting dose is 30 mg twice a day for up to 4 weeks . your doctor may increase your dose to 30 mg two times a day ( up to 16 weeks ). this will help control your blood sugar . if you have a hypo , you should contact your doctor . if your diabetes does not respond to your treatment
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia is the most common side effect of novonorm ( may affect up to 1 in 10 people ). if you have a hypo in section 2 , you should contact your doctor immediately if you experience any of the following symptoms : swelling , difficulty in breathing , rapid heartbeat , feeling dizzy or sweating ( anaphylactic reaction ). other side effects may include : very common ( affects more than 1 user in 10 ): stomach pain diarrhoea uncommon ( affects 1 to 1 users in 1 , 000 ): acute coronary syndrome (
what novonorm contains - the active substance is repaglinide . - the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate anhydrous , maize starch , polacrilin potassium , povidone ( polyvidone ), glycerol , magnesium stearate , meglumine , poloxamer , iron oxide yellow ( e172 ), 1 mg / ml ( e433 ) and iron oxide red ( e322 ) ( see section 2 " no vonorm contains sodium "). what novonorg looks like and contents of the pack novonrom tablets are white to off -
pumarix is a vaccine for use in adults , adolescents and children aged 18 years and older . pandemic flu ( influenza ) is a type of influenza that occurs every few decades . it is very common ( may affect more than 1 in 10 people ). pandemic influenza is similar to ordinary flu . the vaccine works by preventing the spread of the disease . none of the ingredients in the vaccine can cause flu . as with all vaccines , pumarix may not fully protect all persons who are vaccinated .
do not use pumarix : if you have had a sudden life - threatening allergic reaction to any of the ingredients of this vaccine ( listed in section 6 ). if you are allergic to chicken protein , ovalbumin , formaldehyde or sodium deoxycholate . if you experience signs of an allergic reaction such as itchy skin rash , shortness of breath , swelling of the face or tongue . if any of these apply to you , tell your doctor before you receive the vaccine . medical treatment may be needed if you develop signs of any allergic reaction . do not give this vaccine to children less than 33 years of age .
pumarix is for use in adults 18 years of age and older . pumarix contains a similar h5n1 as03 to those of the other ingredients in this vaccine ( listed in section 6 ). the recommended dose is one injection into a muscle in the upper arm . if you have any further questions on the use of this vaccine , ask your doctor or pharmacist .
like all medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions allergic reactions may lead to dangerously low blood pressure , shock and emergency treatment . the following side effects have been reported with pumarix : very common ( may affect more than 1 in 10 people pain at the site of the injection headache tired aching muscles joint pain common ( likely to affect up to 1 in 100 people ) redness or swelling at the injection fever sweating shivering diarrhoea feeling sick uncommon ( possible to affect less than 1 per 100 people ). after the injection , bruising , a hard lump , itching , warmth swollen
keep this vaccine out of the sight and reach of children . do not use this vaccine after the expiry date which is stated on the carton and on the suspension after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the suspension in the outer carton in order to protect from light . once the vaccine has been prepared , it should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 30 .
what pumarix contains the active substance is split influenza virus ( 5 / 2005 ) ( pr8 - ibcdc - rg2 ). each vial contains 0 . 5 mg haemagglutinin , which is used to prevent the pandemic . the vaccine contains an ' adjuvant ' as03 . this adjuvanted contains salqualene , dl - α - tocopherol , polysorbate 80 and adjuvants . the other ingredients in the vaccine are sodium chloride , disodium hydrogen phosphate , potassium dihydrogen phosphate , water and water for injections . what is pumar
somakit t is a radiopharmaceutical product that contains the active substance edotreotide . the powder contains a radioactive substance called gallium ( 68ga ) chloride . the other ingredient in this product ( excipients ) are gallium , 68ga , and eosinophiline . this procedure allows the amount of gallium in the blood to be reduced . the solution for injection is given into a vein or other part of the body areas as a medical imaging procedure called positron emission tomography ( positrt ) ( pet scan ). this medical procedure allows images to be taken of the abnormal cells
do not take somakittoc - if you are allergic to edotreotide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if you have experienced an allergic reaction ( see section 4 " warnings , precautions and precautions "). if you think you may have kidney or liver problems . if you suffer from renal or hepatic disease . children and adolescents do not give this medicine to children below 18 years of age because of the risk of allergic reaction . the examination will be repeated every 28 days . there are others
there are strict laws on the use of radiopharmaceutical products . somakittoc must not be used in children and adolescents below the age of 29 years . the nuclear medicine doctor supervising the procedure will determine the correct dose of somackittoc . the recommended dose of the product is 100 mg / m2 . the dose may be increased up to 200 mg megabecquerel per kg of body weight . the administration of the medicine will depend on the results of the procedure and on the quality of radiolabelling . the usual dose is one single intravenous injection , followed by a single injection .
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are allergic reactions ( hypersensitivity ). somakittoc may cause symptoms such as warm flush , redness of the skin , swelling , itching , nausea and difficulty breathing . allergic reactions may include stinging at the injection site and ionising radiation ( a type of radiation that can cause cancer and hereditary abnormalities ). reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . this medicine does not require any special storage conditions . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials and radiolabelling . the following information is intended for the specialist only : storage of somakittoc in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . storage at room temperature ( up to room temperature ) for up to 4
what somakit t contains - the active substance is edotreotide . each vial of powder contains 40 mg edotereotide ( as 10 - phenanthroline ). - the other ingredients are gentisic acid , mannitol , formic acid ( e421 ), sodium hydroxide , water for injections , sodium and radiolabelling . - the solvent for the solution is hydrochloric acid . - radiopharmaceutical preparation is provided in a glass vial with black flip - off cap . - a white powder is supplied as a clear and colourless solution . the radioactive substance is
afinitor is an anticancer medicine that contains the active substance erolimus . everolimus stops the growth of cancer cells . afinitor works by blocking a hormone receptor ( hormone receptor ) that is involved in the development of positive advanced breast cancer ( postmenopausal ). it belongs to a group of non - steroidal aromatase inhibitors . this helps to keep the disease under control . it is also used in combination with a medicine called exemestane , which is a steroid inhibitor . hormonal anticancer therapy is used to treat advanced tumours ( neuroendocrine tumours ) in the stomach , bow
always take afinitor exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . your doctor will tell you how many tablets to take . cancer treatment tell your doctor if you think you may be allergic to any of the following : everolimus , sirolimus , or temsirolamus . if any of these apply to you ( or you are unsure ), talk to your doctor before taking this medicine . you must not be allergic . if you have any problems with your liver , or any disease affecting your liver .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended starting dose is one 10 mg tablet once a day . if you take more afinitor than you should if you have liver problems , your doctor may prescribe a lower dose of afinit ( 5 mg ) or 5 mg or 7 . 5 mg twice a day , depending on the severity of certain side effects . your doctor will tell you how long you should continue to take the tablet . you should not stop taking afininitor unless your doctor tells you to . if treatment with af
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking afinitor and tell your doctor straight away if you experience an allergic reaction such as : difficulty breathing or swallowing swelling of the face , lips , tongue or throat severe itching of the skin with a red rash or raised bumps if you notice any of the following side effects while you are taking the medicine : very common ( may affect more than 1 in 10 people ): increased temperature ( chills ( signs of infection ) fever , coughing , difficulty breathing and wheezing if you have inflammation of the lung ( pneumonitis 46 common (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the tablet in the outer carton in order to protect from light . after first opening the blister , remove the tablets from the refrigerator and discard the tablet . this medicine does not require any special storage conditions . if you notice any visible signs of tampering , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use
what afinitor contains - the active substance is everolimus . each tablet contains either 2 . 5 mg or 2 . 75 mg of either of the two active substances . - the other ingredients are : - tablet core : everolimide . - tablet coating : vermis ( e460 ). - tablet coat : vertex ( e464 ). - vermis , e460b . - afinnitor 5 mg / 5 mg tablets : the other ingredient is butylhydroxytoluene , magnesium stearate , lactose monohydrate , hypromellose , crospovidone and lactose
what laventair ellipta is and what it contains the active substance is umeclidinium bromide ( also called vilanterol ). this belongs to a group of medicines called bronchodilators . what it is used for and how it works it is important to tell your doctor if you have or have ever had chronic obstructive pulmonary disease ( copd ). copd is a long - term condition that causes breathing difficulties . copd works by tightening the muscles around the airways in the lungs , making it easier for air to get in and out of the lungs . this helps to relieve your
do not use laventair ellipta 31 - if you are allergic to umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . if you have asthma , tell your doctor straight away . if any of these apply to you ( or you are not sure ), talk to a doctor or pharmacist before you are given this medicine : - asthma . if your doctor thinks that your asthma is getting worse . - heart problems . - high blood pressure . - an eye problem called
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one inhalation once a day . this medicine should be used within 24 hours of your last dose of laventair ellipta . do not stop using this medicine without talking to your doctor first . if you have any further questions on the use of this medicine , ask your doctor . how to use the inhaler tell your doctor straight away if you think you may have a sudden attack of breathlessness or wheezing . to prevent this attack , your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions tell your doctor immediately if you experience any of the following symptoms while taking laventair ellipta : very common side effects ( may affect more than 1 in 100 people ): skin rash ( hives ) redness rare side effects : may affect up to 1 in 1 , 000 people : swelling mainly of the face or mouth ( angioedema ), feeling very wheezy , coughing , difficulty in breathing , feeling weak , light headed , collapse or loss of consciousness . immediate breathing difficulties : if you have immediate breathing problems while taking
what laventair ellipta contains - the active substances are umeclidinium bromide and vilanterol . each inhaler contains 55 mg umclidinicium , equivalent to 65 mg of the active substance . - the other ingredients are : - the excipients are : capsule content : omeclinium 135bromide 22 capsule shell : e464vilterol , trifenatate , lactose monohydrate ( see end of section 2 ' how to use '). - the solvent in the inhaler is lactose ' and magnesium stearate . what
the active substance of tremfya is guselkumab , which is a monoclonal antibody . this medicine works by attaching itself to a protein called il - 23 which is involved in the development of psoriasis . it is used for the treatment of patients with moderate to severe " plaque psORiasis " which is an inflammatory condition that affects the skin and nails . it helps to improve the condition by reducing symptoms such as scaling , shedding , flaking , itching , pain and burning .
do not use tremfya if you are allergic to guselkumab or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before using trefya . if you have an active infection or active tuberculosis warnings , precautions , and precautions before you are given tremfa , tell your doctor or pharmacist if you : - have an infection or an infection with tuberculosis 36 - have ever had an infection , or symptoms of an infection that could be signs of infections . - have
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of tremfya is 100 micrograms ( 1 pre - filled syringe ) injected under the skin ( subcutaneous injection ) every 4 to 8 weeks . your doctor will tell you how long you should continue to use tremfingya . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects : serious allergic reaction , including difficulty breathing or swallowing , swelling of the face , lips , tongue or throat , severe itching of the skin , a red rash and raised bumps other side effects you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects some side effects may be serious : very common ( may affect more than 1 in 10 people ): upper respiratory infections ( common ) side effects that may affect up to 1
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the pre - filled syringe label after " exp ". this medicine does not require any special storage conditions . if you notice that the solution is cloudy or contains large particles , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what tremfya contains - the active substance is guselkumab . each pre - filled syringe contains 100 mg of gusel kumab in 1 ml solution . - the other ingredients are histidine , histidine monohydrochloride monohydrate , polysorbate 80 , sucrose and water for injections . what tremfa looks like and contents of the pack solution for injection in a vial is a clear , colourless to pale yellow solution . tremfaya is supplied in a carton pack containing one single - dose glass syringe and a multipack containing 2 , 1 or 2 single -
the active substance of trepulmix , treprostinil , is a substance that belongs to a group of medicines called prostacyclins . it is a hormone produced by the body that helps to control blood pressure . by relaxing blood vessels that are clogged with prostaceclins , it prevents blood from clotting . trepulsmix is used to treat inoperable chronic thromboembolic pulmonary hypertension ( cteph ). persistent or recurrentcteph is a condition in which surgical treatment and exercise capacity are not sufficient to control symptoms of the disease . the most common symptoms of chronic trombo
do not take trepulmix if you are allergic to treprostinil or any of the other ingredients of this medicine ( listed in section 6 ). if you have a disease called " pulmonary veno - occlusive disease ". this is a disease that causes blood vessels in the lungs to become swollen , leading to a higher pressure in the blood vessels between the heart and the lungs . if you suffer from severe liver disease . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if you : have a heart problem , such as a heart attack ( myocardial infarction
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . trepulmix is given as a continuous subcutaneous infusion under the skin into a small tube ( cannula ) in the upper abdomen ( thigh ). your doctor will show you how to use it . you will be carefully trained by your doctor on how to prepare and inject it . the recommended dose is one tablet once a day . it is given by a portable pump containing your treprostinil . the pump is connected to the infusion line so that you can avoid accidental overdose . the
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): widening of blood vessels pain due to the infusion site reaction . bruising at the infusionsite bleeding . headaches , nausea , diarrhoea jaw pain . common : dizziness , light - headedness , fainting . low blood pressure skin rashes , muscle pain ( myalgia ), joint pain ( arthralgia ), swelling of feet , ankles , legs , fluid retention , hot flush pain in arms and / or legs 36 uncommon : may affect up to 1 in 100 people
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . trepulmix vial may be kept at room temperature ( up to 30 ) for continuous subcutaneous infusion ( i . e . a single infusion ( syringe ) of unrefrigerated trepulmix ) for up to 72 hours . this medicine is not to be used if you notice any visible signs of damage such as discolouration or
what trepulmix contains the active substances are treprostinil and sodium salt . each vial ( 1 ml ) contains 1 mg of treprosticinil ( as sodium salt ). each 10 ml vial contains 10 mg of the active substance in treprosteinil . the other ingredients are sodium salt and trepiplmix 2 . 5 mg / ml . each 20 ml ampoule ( 10 ml ) vial has 25 mg or 50 mg of aldosterone ( e . g . treprostail ). the other ingredient ( excipients ) are water for injections . what trep
the active substance of thorinane is enoxaparin sodium . it is a low molecular weight heparin ( lmwh ). the recommended dose of thorinicane is 1 milligram per kilogram of body weight to prevent existing blood clots from forming ( see section 2 , " thorinsane contains sodium "). the recommended dosage is 2 milligrams per kg body weight . the other recommended dose is 1 mg / kilogram body weight per kg of bodyweight ( mwh ). your doctor will check your blood regularly during and after your operation . if you have an acute illness called unstable angina (
do not take thorinane : if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine ( listed in section 6 ). if you have had an allergic reaction ( such as rash , swallowing , breathing problems or swelling of your lips , face , throat or tongue ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you : have ever had or might now have a reaction to other low molecular weight heparins ( e . g . nadroparin , tinzaparin , dalteparin ). you have experienced a reaction called heparin
like other similar medicines ( medicines to prevent blood clotting ), thorinane is used to prevent bleeding . the bleeding should be stopped immediately . if you experience any bleeding event that does not involve excessive bleeding , exceptional weakness , tiredness , paleness , dizziness , headache or unexplained swelling , stop taking your medicine and contact your doctor immediately . talk to your doctor or pharmacist if you have any of the following : - a severe allergic reaction ( difficulty breathing , swelling of the lips , mouth , throat or eyes ) - blockage of a blood vessel ( a blood clot ) - cramping pain , redness , warmth or
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the syringe label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . after dilution the solution should be used within 8 hours . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user . the thorinane pre - filled syringes should be discarded .
what thorinane contains - the active substance is enoxaparin sodium . each pre - filled syringe contains 100 mg of enoxapearin sodium in 0 . 2 ml solution for injection . each 2 , 000 ml syringe delivers 2 mg / ml ( 0 . 5 ml ) of enxaparinodium in solution for injections . the recommended dose for injection is one vial of 0 .2 ml solution . what thorinicane looks like and contents of the pack the product is a clear , colourless type i neutral glass syringe barrel with fixed needle and needle shield , chlorobutyl rubber stopper
senstend contains the active substances lidocaine and prilocaine . both belong to a group of local anaesthetics . senstend is used to prevent lifelong premature ejaculation in the head of your penis . it is used when ejaculation is not possible .
do not use senstend : if you are allergic to lidocaine , prilocaine or any of the other ingredients of this medicine ( listed in section 6 ). if you have a history of allergy or sensitivity to local anaesthetics ( amide - type local analgeshetics ) if you suffer from a genetic disease or other condition that affects your red blood cells such as glucose or phosphate deficiency ( anaemia or methaemoglobinaemia ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . the following conditions may affect your ability to use it : medicine sensitivities ( sensitivity
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use the recommended dose of senstend is 3 mg twice a day . the first 3 times a day use 1 ml of solution for injection in the head of your penis . the second time a maximum of 3 ml should be used 24 hours after the first dose . the recommended starting dose is 4 mg once a day using the spray container . use the pump technique to remove the valve from the penis . contact with eyes , nose , mouth and ears should be avoided
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with senstend : very common ( may affect more than 1 in 10 people ): inability to develop or maintain an erection in the penis feeling of burning in the area where the penis is inserted uncommon ( might affect up to 1 in 100 people ): headache local irritation of the throat , irritation in the skin redness due to failure to ejaculate during sexual intercourse abnormal orgasm tingling of the penis pain or discomfort when the penis itching is not due to a high temperature . other side effects that may occur with sen
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the container in the outer carton in order to protect from light . after first opening , the product may be stored at room temperature ( up to 25 ) for a period of up to 12 months . once the metal container has been opened , it should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user
what senstend contains - the active substances are lidocaine and prilocaine . each ml of solution contains 150 micrograms ( 0 . 5 ml ) lidocain and 50 microlitres ( 1 ml ). each spray container contains 7 . 5 microliters ( 2 . 5 mg ) of prlocaine in each spray . each spraycontainer contains 6 . 5 to 20 ml . - the other ingredients are water for injections ( e . g . solvent ) and light yellow cutaneous spray in an aluminium spray container with metering valve . each carton contains 1 , 6 , 5 or 5 spr
opdivo is a medicine used to treat advanced melanoma ( a type of skin cancer ). in adults melanoma is usually treated with complete resection in adults ( treatment with surgery ) or adjuvant therapy . in advanced non - small cell lung cancer ( advanced renal cell carcinoma ) advanced kidney cancer in adults classical hodgkin lymphoma has been previously treated with previous therapies , including an autologous stem - cell transplant ( a transplant ) advanced cancer of the head and neck in adults advanced urothelial carcinoma ( bladder and urinary tract cancer ) opdivo contains a substance called nivolum
do not take opdivo : - if you are allergic to nivolumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before you are given this medicine : if you have problems with your heart , such as a change in the rhythm of the heartbeat or an abnormal heart rhythm . - if your lungs have breathing difficulties such as cough or inflammation of the lungs ( pneumonitis or interstitial lung disease ). if you experience diarrhoea , watery , loose or soft stools or any symptoms of inflammation of any intestines ( col
always take opdivo exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is one 240 mg tablet once a day ( 2 tablets of 480 mg ) for the first 4 weeks of treatment . your doctor may increase the dose of ipilimumab depending on how you respond to the treatment . if you have skin cancer , your doctor will give you one 1 mg tablet of nivolumab per kilogram of your body weight every 4 weeks . if your doctor thinks that the effect of the treatment is too strong or too weak ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and the vial label after " exp ". this medicine does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . opdivo may be kept at room temperature ( up to 25 ) for up to 48 hours after preparation . the infusion solution should be used immediately . any unused medicine or waste material should be disposed of in accordance with local requirements .
what opdivo contains - the active substance is nivolumab . each ml of concentrate for solution for infusion contains 10 mg of niviolumab in 40 ml solution . each 4 ml vial contains 100 mg of 10 mg ( corresponding to 240 mg / ml ) solution for injection . - the other ingredients are sodium citrate dihydrate , sodium chloride ( see section 2 " opdiolo contains sodium "), mannitol ( e421 ), pentetic acid , polysorbate 80 , sodium hydroxide , hydrochloric acid and water for injections . what opDivo looks like
clopidogrel tad contains the active substance clopidiogrel . it belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood that clump together during blood clotting . by preventing this clumping , anti platelet medicinalproducts reduce the chances of blood clots forming ( a process called thrombosis ). by blocking this thrombi ) from forming in hardened blood vessels ( arteries ), the product is used to prevent atherothrombotic events ( such as stroke , heart attack , or death ). when taken in combination with clopid
do not take clopidogrel tad : if you are more than 30 years of age . if you think you may be allergic to clopidineogrel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer , bleeding within the brain or severe liver disease . if any of these apply to you , tell your doctor or pharmacist . warnings and precautions talk to your doctor , pharmacist or nurse before you are given the tablet : if any or all of the above applies to you ( or you are not
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ) is one 75 mg tablet of clopidogrel to be taken orally once a day . if you have severe chest pain ( unstable angina or heart attack ), your doctor may prescribe a lower dose ( 300 mg / m2 ). your doctor will tell you how long you should continue to take the tablet . you may need to take it at intervals of up to 75 minutes before or at intervals
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin or the whites of the eyes ( jaundice ). - bleeding that appears under the skin as red pinpoint dots and / or confusion ( see section 2 " warnings and precautions "). - swelling in the mouth . - skin disorders such as rashes , itching and blisters of theskin . these could be signs of an allergic
what clopidogrel tad contains - the active substance is clopidiogrel . each film - coated tablet contains 75 mg of clopidoogrel ( as hydrochloride ). - the other ingredients are : tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone , macrogol 6000 and hydrogenated castor oil . tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , talc and microgol 3000 ( e1520 ). what clopridogrel tet
tacforius contains the active substance tacrolimus , which is an immunosuppressant . tacforius works by preventing your organ transplant from coming back to your liver or kidney . this will improve your body ' s immune system and reduce the risk of rejection caused by your transplanted organ . it is also used to prevent rejection of transplanted organs by your liver , kidney , heart or any previous treatment after your transplantation .
do not take tacforius if you are allergic to tacrolimus or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to sirolimus , any macrolide , antibiotic ( e . g . erythromycin , clarithromycin or josamycin ), or any other ingredients present in tacrulimus immediate release capsules . tac forius prolonged - release capsules should be swallowed whole with a sufficient amount of water . tacrolamus prolonged -release capsules should not be taken with or without food or drink . if you take tac
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of this medicine is one tablet a day . transplant patients should take the same tacrolimus medicine as transplant patients . however , if you have been told that you have received or might receive any other medicine , talk to your doctor . if you think that you may have been given a different tacrolamus medicine , ask your doctor for advice before taking this medicine . taking tacforius always take the right medicine to prevent the rejection of your transplanted organ by your body weight .
like all medicines , this medicine can cause side effects , although not everybody gets them . infections stop taking tacforius and tell your doctor straight away if you notice any of the following serious or severe effects : - allergic and anaphylactic reactions ( benign or malignant tumours ) that have been reported in patients treated with tac forius treatment : pure red cell aplasia ( a very severe reduction in red blood cell counts ). - agranulocytosis ( a severely lowered number of white blood cells ). - haemolytic anaemia ( decreased number of red blood cells due to abnormal breakdown ). - fe
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . keep all the prolonged - release hard capsules in the outer carton in order to protect from light . after first opening the aluminium wrapping , tacforius should be used immediately .
what tacforius contains - the active substance is tacrolimus . each hard capsule contains 0 . 5 mg / ml of solution for injection . - the other ingredients are capsule content hypromellose 2910 , ethylcellulose , lactose , magnesium stearate . - capsule shell tacfortius is available in packs containing 1 , 3 or 5 hard capsules of tacrolamus ( as monohydrate ). - the following hard capsules are available in multipacks containing 1 hard capsule of tacromelose ( 2910 ), lactose ( e420 ) and magnesium starchate ( e470b ). -
clopidogrel zentiva is a medicine that belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood that clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( thrombosis ). clopidiogrelzentiva reduces the risk of blood blots ( also known as thrombi ) forming in hardened blood vessels ( arteries ), which can lead to atherothrombotic events ( such as stroke , heart attack , or death ). when clopid
do not take clopidogrel zentiva : - if you are allergic ( hypersensitive ) to any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if you have a medical condition that is currently causing bleeding such as a stomach ulcer , bleeding within the brain or severe liver disease . if you think any of these apply to you , tell your doctor or pharmacist . before you start taking clopridogrelzentiva , take special care with the following precautions : - before you take any of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if you have a condition called ' atrial fibrillation ' ( an irregular heartbeat ), your doctor may prescribe a lower dose of 75 mg of clopidogrel zentiva to help control severe chest pain ( unstable angina or heart attack ). the recommended starting dose is 300 mg taken once a day . your doctor will tell you how many tablets to take . the recommended daily dose is one 300 mg tablet once daily for 4 weeks . the maximum recommended dose is two 75 mg tablets once daily
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ). - bleeding that appears under the skin as red pinpoint dots or confusion ( see section 2 " warnings and precautions "). - swelling in the mouth . - skin disorders such as rashes , itching and blisters of theskin . these could be signs of an allergic reaction . the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . clopidogrel zentiva must be used immediately after preparation . aluminium blisters should be kept in the original package in order to protect from light and moisture . once thawed , the product should be used within 30 . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would not normally be longer than 30 .
what clopidogrel zentiva contains the active substance is clopidiogrel . each tablet contains 75 mg of clopidoogrel ( as hydrogen sulphate ). see section 2 for further information . the other ingredients in the tablet core are : tablet core : lactose ' ( see section 4 for lactose ', ' clopidineogrel zinc contains hydrogenated castor oil ') tablet coating : mannitol ( e421 ) hydrogenated Castor oil ) tablet coat : microcrystalline cellulose , macrogol 6000 , low - substituted hydroxypropylcellulose , lact
yttriga is a radioactive medicine that must not be mixed with another medicine . tiny radiation doses are used for the treatment of radiolabelled medicinal product . do not throw away any medicines via wastewater . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
you must not be given yttriga - if you are allergic ( hypersensitive ) to chloride or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be pregnant or breast - feeding , ask your doctor or pharmacist for advice before you are given this medicine . warnings and precautions talk to your doctor , pharmacist or nurse before being given ytriga : if you have been given a radioactive medicine or another medicinal product containing radiopharmaceuticals , please tell your doctor . if you were given more than the recommended dose , your doctor may need to adjust your dose .
yttriga will be administered under the supervision of a doctor experienced in the treatment of radiolabelling of medicinal products for specific diseases . the treatment will be supervised by a qualified healthcare professional . the doctor will decide on the appropriate treatment for you .
like all medicines , yttriga can cause side effects , although not everybody gets them . reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
yttriga must be kept out of the sight and reach of children . local regulations on radioactive substances and waste material should be followed .
what yttriga contains - the active substance is chloride . each ml contains 1 ml sterile solution . - the other ingredients are hydrochloric acid ( see section 3 ) and water for injections . what ytriga looks like and contents of the pack the solution is a clear , colourless type i glass vial with a flat bottom and a silicon stopper with an aluminium seal .
ciambra is a medicine used to treat cancer . ciambra contains the active substance cisplatin , which is another anti - cancer medicine . it is used for treatment of malignant pleural mesothelioma ( a type of cancer that affects the lining of the lung ) in adults who have not received prior chemotherapy . cimbra is used in adult patients whose disease has responded to treatment with initial chemotherapy . if you have lung cancer , your doctor may decide to give you another type of treatment , called initial chemotherapy ( i . e . initial treatment ). if you are a patient with advanced stage of lung cancer
do not use ciambra : - if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before breast - feeding . before starting treatment with the first dose , you should tell your doctor if : - you are receiving or have recently received a vaccine against yellow fever . your doctor may decide to stop your treatment if you have any of these conditions . - you have or have had problems with your kidneys . before you are given cimbra , your doctor will check your blood cell counts
the recommended dose of ciambra is 500 micrograms per kilogram of your body ' s surface area . this means that your height and weight are evenly distributed across the body . your doctor will work out the right dose for you based on this body surface area for you . the duration of treatment will depend on your blood cell counts and on your response to treatment . the doctor has mixed the ciamra powder in 9 ml of water for 9 minutes . the other ingredients are sodium chloride solution and water for injections ( see section 2 ). the doctor will decide on the dose you need to receive . the infusion will be given
like all medicines , this medicine can cause side effects , although not everybody gets them . 52 tell your doctor straight away if you experience fever or signs of infection , such as a temperature or sweating . infection may affect more white blood cells than normal , which may increase the risk of infection ( sepsis ), which may lead to death . chest pain with a fast heart rate , pain , redness , swelling or sores in your mouth . signs of allergic reaction may include skin rash , burning or prickling sensation , fever . skin reactions may be life - threatening and may result in death . a severe rash , itching or blister
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the vial label after exp . this medicine does not require any special storage conditions . the infusion solution of pemetrexed will be stored in a refrigerator ( 2 - 8 ) for up to 15 days at 25 . the reconstituted solution should be used immediately after preparation . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 to 8 and 15
what ciambra contains - the active substance is pemetrexed . each vial contains 100 mg / ml of solution for infusion . - the other ingredients are : one vial containing 100 mg of pemrexed ( as pemetreed disodium hemipentahydrate ). - one pembra 500 mg vial with 500 mg of solutionfor infusion . the other ingredient is : mannitol ( e421 ), hydrochloric acid ( for ph adjustment ) and sodium hydroxide ( to adjust ph adjustment ). see section 2 for further information on the use of this product . what ciam
immunogam belongs to a group of medicines called immunoglobulins ( antibodies ) which help to prevent certain infections from getting into your blood . immunogam is used to prevent increased levels of human hepatitis b immunoglubulins . the active substance in immunogloglobulin g ( gg ) is a substance found in blood plasma of infected people . when you are treated with immunoglogam , your immune system ( the body ' s natural defence system ) will produce its own protection against hepatitis b virus in haemodialysed patients . vaccination with a hepatitis birus carrier leads to an
immunogam should not be used : - if you have an allergic reaction to human immunoglobulins or other blood products , or to any of the other ingredients of immunogam ( listed in section 6 ). if you suffer from an iga deficiency , you should tell your doctor straight away if you experience an allergy reaction to iga containing products . children and adolescents under 18 years of age the safety and efficacy of immunoglubulins have not been established . adverse reactions include chills , headache , fever and vomiting . allergic reactions include nausea ( arthralgia ), joint pain and low blood pressure
always use immunogam exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . vaccination with hepatitis b virus the first vaccine dose is human hepatitis b immunoglobulin . administration prevention the recommended dose for hepatitis b is 500 micrograms per kilogram body surface area ( m2 ) for 24 to 72 hours . if hepatitis b in haemodialysed patients is not adequately protected , the dose may be increased to a maximum of 500 m2 ( m3 ) once every 2 weeks . seroconversion is recommended for vaccination of hepatitis b by a hepatitis birus
like all medicines , immunogam can cause side effects , although not everybody gets them . the following side effects have been reported : very common ( may affect more than 1 in 10 people ): very common : may affect up to 1 in 100 people : very rare : may affects up to one in 10 , 000 people : rare : 1 in 1 , 000 , 000 or less rare : not known : frequency cannot be estimated from the available data from clinical trials . if you experience any of the following undesirable effects during clinical trials , please tell your doctor or pharmacist . the injection site ( the muscle at the site of injection )
keep out of the sight and reach of children . do not use immunogam after the expiry date which is stated on the outer carton and on the label after exp . the store in a refrigerator ( 2 - 8 ). do not freeze . keep the container tightly closed in order to protect from light . immunogaman must not be used if the solution is cloudy or contains deposits . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what immunogam contains - the active substance is human hepatitis b immunoglobulin . one vial of Immunogam 1 ml solution contains 5 mg of human plasma protein , corresponding to a concentration of 96 micrograms / ml . - the other ingredients are polysorbate 80 and water for injections in a glass vial ( see section 2 ).
remicade contains the active substance infliximab . infliximab is a monoclonal antibody a type of protein that recognises and attaches to a specific target in the body called tumour necrosis factor ( tnf ). remicade belongs to a group of medicines called 'tnf blockers '. it is used to treat the following inflammatory diseases : rheumatoid arthritis , psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ), psoriasis . remicades is used in adults 6 years of age and older to treat crohn '
do not take remicade : - if you are allergic to infliximab or any of the other ingredients of the active substance ( listed in section 6 ) - if any of these apply to you ( or you are not sure ), ask your doctor or pharmacist for advice . warnings and precautions talk to your doctor , pharmacist or nurse before you are given the medicine if you : - are allergic ( hypersensitive ) to tb - have tuberculosis ( tb ) - have another serious infection , such as pneumonia or sepsis - have heart failure tell your doctor if you think that you may be taking remic
treatment for rheumatoid arthritis : the recommended dose is 3 mg per kg of body weight . for psoriatic arthritis ( ankylosing spondylitis or bechterew ' s disease ), psoriasis , ulcerative colitis and crohn ' s diseases : the usual dose is 5 mg / kg bodyweight . if you are given more remicade than you should if you have been given too many tablets , talk to your doctor or pharmacist . how to prepare and receive the medicine the doctor or nurse will give you an infusion ( drip ) over 2 hours into one of your veins
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some serious side effects may occur during treatment . if you notice any of the following side effects during your treatment with remicade , tell your doctor straight away : - an allergic reaction ( swelling of your face , lips , mouth or throat , difficulty in swallowing or breathing , skin rash , hives and swelling of the hands , feet or ankles ). these reactions may be signs of an allergy reaction ( see section 2 " warnings and precautions "). allergic side effects in children and adolescents 12 years of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the vial label after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . remicade may be stored at room temperature ( up to 25 ) for up to a single period of time . after infusion , it may be kept in the refrigerator for a maximum of 3 hours ( 2 to 8 ). if not used immediately , in - use storage times and conditions prior to use are the responsibility of
what remicade contains the active substance is infliximab . each vial contains 100 mg of inflixamab in 10 ml solution . the other ingredients are sucrose , polysorbate 80 , monobasic sodium phosphate , dibasicodium phosphate and water for injections . what remicaade looks like and contents of the pack remicades is supplied as a glass vial containing a powder for concentrate for solution for infusion . the powder is white to off - white . each pack contains 1 , 2 , 3 , 4 or 5 vials . not all pack sizes may be marketed .
rasagiline mylan is used to treat parkinson ' s disease in adults . it belongs to a group of medicines called levodopa . it is used in combination with another medicine used in the treatment of parkinson '. parkinson ', a type of disease , causes a loss of cells that produce dopamine in the brain . dopamine is a substance that helps the brain to produce more dopamine , which is important in movement control . rasagilinea mylan works by increasing the amount of dopamine that the brain produces .
do not take rasagiline mylan : - if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). if you have severe liver problems . warnings and precautions talk to your doctor , pharmacist or nurse before taking the following medicines : - rasaline mylan contains monoamine oxidase ( mao ) inhibitors , used to treat depression in patients with parkinson ' s disease . - medicinal or natural products such as st . john ' s wort , pethidine , a strong pain killer . see section 14 for further information on the safety of r
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 tablet once a day by mouth . take rasagiline mylan at about the same time each day . swallow the tablet whole with a glass of water . do not chew or crush the tablet . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with rasagiline mylan : very common side effects ( may affect more than 1 in 10 people ): very common abnormal movements ( dyskinesia ) headache common abdominal pain common 1 , 000 to 1 , 10 , 000 rare cases of fall allergy fever flu ( influenza ) feeling of being unwell neck pain chest pain ( angina pectoris ) low blood pressure with symptoms such as light headedness ( orthostatic hypotension ) decreased appetite constipation dry mouth nausea vomiting flatulence abnormal
what rasagiline mylan contains - the active substance is raspiline . each tablet contains raspigiline tartrate equivalent to 1 mg of raspidine . - the other ingredients are : tablet core : microcrystalline cellulose , tartric acid , maize starch , pregelatinized maize starch and talc , stearic acid ( see section 2 under " raspildine melan contains lactose "), tablet coating : tablet shell : shellac , pvc / biconvex tablets containing 1 tablet . the tablets are available in blister packs containing 7 , 10
do not use hulio if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe infection such as tuberculosis . symptoms of infections may include fever , wounds , feeling tired , dental problems . if you suffer from moderate or severe heart failure . if any of these apply to you , tell your doctor . allergic reaction allergic reactions may include symptoms such as chest tightness , wheezing , dizziness , swelling or a rash . these reactions are usually mild to moderate . infections if you develop an infection ( localised infection ) such as leg ul
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is polyarticular juvenile idiopathic arthritis ( see section 2 ). children and adolescents from 2 years of age and older weighing at least 17 kg the recommended starting dose is 10 mg once a day . your doctor will prescribe the right dose for you . adults from 2 to 17 years old weighing less than 30 kg the usual starting dose for hulio is 40 mg once daily . enthesitis ( arthritis ) patients from 6 to 17 year old weighing 15 kg or more the recommended
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may require urgent medical treatment . tell your doctor straight away if you notice any of the following side effects : very common ( may affect more than 1 in 10 people ) - after the last hulio injection - allergic reaction - heart failure - severe rash , hives swollen face , hands or feet - trouble breathing or swallowing - pale complexion - dizziness - persistent fever , bruising or bleeding - signs and symptoms of infection such as fever , feeling sick , wounds , dental problems , burning
what hulio contains - the active substance is adalimumab . - the other ingredients are monosodium glutumate , sorbitol , methionine , polysorbate 80 , hydrochloric acid and water for injections ( see end of section 2 ). what hulaio looks like and contents of the pack haulio 40 mg is a sterile solution for injection . each vial contains 40 milligrams of the other active substance , in a vial . the solution is clear to slightly opalescent . the vial has a rubber stopper . pack size of 1 , 2 or 1
what yellox is yellox contains the active substance bromfenac . it belongs to a group of medicines called non - steroidal anti - inflammatory drugs ( nsaids ). it works by reducing inflammation . how yellox works yellox reduces eye inflammation following cataract surgery .
do not use yellox if you are allergic to bromfenac or any of the other ingredients of this medicine ( listed in section 6 ). if you have asthma or skin allergy . if you experience intense inflammation in your nose . warnings and precautions talk to your doctor or pharmacist before using this medicine . nsaids may include acetylsalicylic acid , ibuprofen , ketoprofen and diclofenac . this medicine may be used with topical steroids ( such as cortisone ). unwanted side effects such as bleeding problems ( e . g . haemophilia in the past )
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use the recommended dose of yellox is one drop in the eye ( s ) twice a day . the recommended daily dose is 2 drops in the morning and 2 drops on the next day after your cataract surgery . method of administration yellox is for oral use . wash your hands thoroughly with soap and water before using the eye drops . remove the bottle cap from the bottle . hold the bottle tightly closed with your thumb and fingers . tilt your head back
what yellox contains - the active substance is bromfenac . each vial of solution contains : bromenac ( as sodium sesquihydrate ), equivalent to 33 mg of brominac . - the other ingredients are : boric acid , borax , sodium sulphite anhydrous , benzalkonium chloride , tyloxapol , povidone ( k30 ), disodium edetate , sodium hydroxide ( for acidity levels ). what yellox looks like and contents of the pack yellox is a clear yellow liquid ( solution ) supplied in a
dzuveo contains the active substance sufentanil . it belongs to a group of strong painkillers called opioids and is used to treat sudden moderate - to - severe pain .
do not take dzuveo if you are allergic to sufentanil or any of the other ingredients of this medicine ( listed in section 6 ). if you have a serious lung or breathing problem . warnings and precautions talk to your doctor , pharmacist or nurse before taking dzuvoo if : you have any condition that affects your breathing ( e . g . asthma , wheezing or shortness of breath ). your doctor may need to adjust your dose or stop treatment . you have had a head injury or brain tumour . your heart and circulation may not be working properly . slow heart rate or irregular heartbeat
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the single - dose administration device should be used immediately after you have taken this medicine . the recommended dose of dzuveo is one tablet of strong painkillers such as sufentanil 30 mg twice a day . the sublingual tablet should be swallowed whole with a glass of water . use the disposable single -dose applicator . the applicator should be inserted into the tongue . the tablets dissolve in the tongue and allow pain relief to be experienced . the maximum daily dose is 720 mg
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects : - severe breathing problems , such as slow and shallow breathing . stop taking dzuveo and contact your doctor immediately . very common side effects ( may affect more than 1 in 10 people ): - nausea , feeling sick , vomiting , being sick or feeling hot . commonside effects which may affect up to 1 in every 10 people : - inability or difficulty sleeping , feeling anxious , confused , dizziness , headache , drowsiness , feeling sleepy . -
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label after exp . this medicinal product does not require any special temperature storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light and oxygen . dzuveo must not be used if it is discoloured or shows signs of deterioration . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these
what dzuveo contains - the active substance is sufentanil . each tablet contains 30 mg of this medicine . - the other ingredients are : tablet core : citrate , mannitol , dicalcium phosphate , hypromellose , croscarmellose sodium , indigo carmine , stearic acid , magnesium stearate . round edges : 3 mm x 3 mm . the tablet is supplied as a single - dose applicator ( labelled [ sublingual tablet ]). the applicator is provided with one dose of one sufintanil 30 mg tablet . each pack contains
erleada is a cancer medicine that contains the active substance apalutamide . it is used to treat prostate cancer that has spread to other parts of the body and has not responded to surgical treatments . sensitive prostate cancer is a type of cancer that occurs when the body does not respond adequately to surgical treatment . erleada increases the levels of testosterone in the blood , a hormone that is involved in the growth and spread of resistant prostate cancer . by reducing the level of androgens in the body , the cancer grows androgens are removed from the body . by increasing the amount of the two active substances , both of apal
do not take erleada if you are allergic to apalutamide or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be pregnant or are planning to become pregnant , ask your doctor for advice before taking this medicine . pregnancy and breast - feeding your doctor will discuss with you whether you should follow the contraception section of this leaflet . driving and using machines this medicine is unlikely to affect your ability to drive or use machines . this medicine can cause seizures . you should not take any medicines to prevent blood clots ( such as warfarin or acenocoumarol
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 240 mg tablet once a day for up to 60 days . if you take more erleada than you should if you accidentally take too many tablets of this medicine , contact your doctor straight away . take the tablet by mouth with a glass of water . do not chew or crush the tablet . if possible , take it with or without food . you may find it easier to swallow the tablet whole with a drink of water , even if it contains less alcohol than normal . if necessary
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking erleada and tell your doctor straight away if you experience any of the following symptoms : reddish , non - elevated , target - like , circular patches on the trunk , central blisters , skin peeling , ulcers of mouth , throat , nose , genitals and eyes . these serious skin rashes may be accompanied by fever and flu - like symptoms . toxic epidermal necrolysis is a group of serious side effects . the most common side effects are fits ( seizure ) which may affect up to 1 in 100
what erleada contains - the active substance is apalutamide . each film - coated tablet contains 60 mg of appalutamide ( as monohydrate ). - the other ingredients are : tablet core : colloidal anhydrous silica , croscarmellose sodium , hypromellose acetate succinate , magnesium stearate . tablet coating : microcrystalline cellulose ( e460 ), silica ( e470b ), and talc , and titanium dioxide ( e171 ). tablet coat : iron oxide black , iron oxide yellow , macrogol , polyvinyl alcohol ( e1203
what axumin is axumin contains the active ingredient fluciclovine . it is used as a scan ( a pet scan ) in patients who have previously received treatment for prostate cancer . it can be used in combination with other tests for prostate specific antigen ( psa ), a type of protein present in the cancer . an axumin pet scan is used to check whether the cancer has responded to treatment . how axumin works axumin will be given to you by a doctor or nurse who is experienced in the use of this procedure . the radiopharmaceutical will be administered to you to reduce the risk of exposure to radiation
do not use axumin - if you are allergic to fluciclovine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using axumin . if you have kidney problems . you should follow a low sodium diet . axumin is given once a day for a day . the axumin scan will take about 4 hours . the scan may be repeated with your usual medicines for the latest 60 minutes . the dose may be increased if you use more axumin than you should if you forget to use it if you miss a day of the
there are strict laws on the use of radiopharmaceutical products . always use axumin exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of axumin is 370 micrograms megabecquerel per kilogram of body weight . if you use more axumin than you should during the procedure axumin will be injected into a vein by a flush of sodium chloride solution . the procedure will be repeated during the duration of the procedure . the scan will take approximately 5 minutes . do not give the axumin injection if you
like all medicines , this medicine can cause side effects , although not everybody gets them . in clinical studies , the following side effects were reported : very common ( may affect more than 1 in 100 people ) when the medicine was given with axumin . uncommon ( might affect up to 1 in 1 , 000 people ): pain , rash , altered taste in the mouth , altered sense of smell . if any of the side effects gets serious , stop using axumin and talk to your doctor or pharmacist . if you have any further questions on the use of this radiopharmaceutical , ask your doctor , pharmacist or nurse . ion
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial label after exp . this medicine does not require any special storage conditions . radiopharmaceuticals should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of radioactive materials . these measures will help protect the environment .
what axumin contains - the active substance is fluciclovine . axumin 1600 mg : each tablet contains 1600 mg of fluciniclovine ( equivalent to 1600 mg ). each 16000 mg tablet of axumin 3200 mg : one tablet contains 3200mg flucIClovine , equivalent to 32000 mg . - the other ingredients are sodium citrate , concentrated hydrochloric acid , sodium hydroxide ( see section 2 " axumin is for oral use "). what axumin looks like and contents of the pack the 1600 mg tablets are white to off - white , round , biconve
azopt contains brinzolamide which belongs to a group of medicines called carbonic anhydrase inhibitors . it works by reducing pressure within the eye . azopt eye drops help to relieve high pressure in the eye , an illness known as glaucoma . by lowering the pressure in your eye , azopt prevents damage to your sight .
do not take azopt : if you have severe kidney problems . if you are allergic to brinzolamide or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to medicines containing sulphonamides ( medicines used to treat diabetes or infections ). warnings and precautions talk to your doctor , pharmacist or nurse before taking azopt . the same allergy may occur with too much acidity in your blood ( hyperchloraemic acidosis ). if any of these apply to you , tell your doctor or pharmacist before you are given azopt , even if you do not
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . azopt should only be used in the eyes . the recommended dose is 1 drop in the eye each day . if your eyes do not work well enough , your doctor may prescribe azopt as a single drop in each of your eyes ( see section 2 , " azopt is not for you "). how to use the azopt bottle : wash your hands with soap and water . remove the cap from the bottle and put it back on . snap collar : hold the bottle tightly with your thumb or finger
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with azopt : common side effects ( may affect up to 1 in 10 people ): blurred vision , eye irritation , eye pain , eye discharge , itchy eye , dry eye , abnormal eye sensation , redness of the eye . other side effects may include : bad taste . uncommon side effects - effects may affect more than 1 in 100 people ): eye sensitivity to light , inflammation , infection of the conjunctiva , eye swelling , eyelid itching , swelling , deposits in eye , glare , burning sensation ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the bottle after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . to protect from light and infections azopt is available in a pack containing a single bottle .
what azopt contains - the active substance is brinzolamide . each vial contains 10 mg of the substance . - the other ingredients are : benzalkonium chloride , carbomer 974p , edetate disodium , mannitol , purified water , sodium chloride , tyloxapol , hydrochloric acid , sodium hydroxide ( for acidity levels and ph levels ). what azopt looks like and contents of the pack azopt is a milky liquid ( a suspension ) supplied in a 5 ml plastic ( droptainer ) bottle with a screw cap . a pack containing three
the active substance of forxiga is dapagliflozin . it belongs to a group of medicines called medicines that are taken by mouth to treat diabetes . it works by helping control the level of sugar in your blood . it is used in adults , adolescents and children aged 18 years and above . the active substance is foraxiga . diabetes type 1 diabetes is a type of diabetes that occurs when your body does not produce enough insulin to control it . it can also occur when you are overweight or obese . type 2 diabetes occurs when the body makes too much insulin . the insulin that your body makes does not work as
do not take forxiga - if you are allergic to dapagliflozin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking for xiga : if you experience feeling sick or being sick , stomach pain , excessive thirst , fast and deep breathing , confusion , unusual sleepiness or tiredness , a sweet smell to your breath or a sweet or metallic taste in your mouth , a different odour to your urine or sweat , rapid weight loss . if any of these apply to you , tell your doctor . the above symptoms
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of forxiga for adults with type 2 diabetes is between 10 mg and 5 mg once a day . if you have a liver problem , your doctor may prescribe a lower dose . your doctor will tell you how many tablets to take . the usual starting dose for patients with type 1 diabetes is one tablet a day , with or without food . this may be increased to a maximum of one tablet in the morning or two tablets a day in the evening . if your doctor thinks that the effect
like all medicines , this medicine can cause side effects , although not everybody gets them . the most common side effects of forxiga are : angioedema ( may affect up to 1 in 10 , 000 people ). angioedsema may cause swelling of the face , tongue or throat , difficulties swallowing , hives and breathing problems . diabetic ketoacidosis ( type 1 diabetes ) is a rare , but potentially life - threatening , condition that affects more than 1 in 1 , 10 people . type 2 diabetes is rare , affecting up to one in 1, 000 people . if you have been diagnosed with diabetes keto
what forxiga contains - the active substance is dapagliflozin . eachforxiga 5 mg film - coated tablet ( tablet ) contains a single component called ' dpagllozin propanediol monohydrate equivalent to 5 mg of the active ingredient in each tablet . - the other ingredients are : tablet core : microcrystalline cellulose , lactose ( see section 2 under ' for more information on lactose '), crospovidone , silicon dioxide , magnesium stearate . film - coating : polyvinyl alcohol , titanium dioxide ( e171 ), macrogol 3350
mepact contains the active substance mifamurtide . it works by stopping the growth of certain bacteria in the immune system . mepact is used to treat osteosarcoma ( bone cancer ) in adults , adolescents and children aged 2 and 30 years . it is used when surgery is not possible to remove the tumour , and chemotherapy is not able to stop cancer cells growing back .
do not take mepact : - if you are allergic to mifamurtide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking mypact if : - you are taking medicines containing ciclosporin or other calcineurin inhibitors ( non - steroidal - anti - inflammatory drugs ). nsaids can affect your heart or blood vessels . - you have a risk of blood clots ( thrombosis ), bleeding ( haemorrhage ), inflammation of the veins ( vasculitis ).
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of mepact is 2 mg mifamurtide per kilogram body weight every 12 hours for 24 hours . your doctor will tell you how many of your mepact treatments you should take . this will depend on your chemotherapy schedule and on how you respond to your chemotherapy . the recommended daily dose is 36 mg / kg body weight each day . you should continue to take mypact until your doctor tells you otherwise . if you have any further questions on
like all medicines , mepact can cause side effects , although not everybody gets them . tell your doctor immediately if you experience chills , fever or fatigue . some of these effects may be transient . your doctor may prescribe paracetamol to treat fever at the start of treatment . if you have any of the following : stomach problems such as nausea , vomiting or loss of appetite , you should stop chemotherapy immediately and contact your doctor . continuing fever and chills may occur up to 8 weeks after you start taking mepacts . signs of an infection such as rash , any problems breathing , wheezing or any stomach problems
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial in outer carton and on the carton after exp . store in a refrigerator ( 2 - 8 ). store in the original package in order to protect from light . reconstituted suspension contains sodium chloride 9 mg / ml for 9 days . after reconstitution , the product should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would not normally be longer than 9 hours at room temperature ( up
what mepact contains - the active substance is mifamurtide . each vial contains 4 mg of mifamanurtide ( as suspension ). after reconstitution , each ml of suspension contains 0 . 08 mg / ml mifmurtide in each ml . - the other ingredients are : 1 - palmitoyl - 2 - oleoyl sn - glycero - 3 - phosphocholine ( see section 2 under " other ingredients ") 2 - dileoylo - sn - glyco - 5 - phospho - l - serine monosodium salt ( see also
mirvaso contains the active substance brimonidine , which belongs to a group of medicines called alphaagonists . mirvaso is used on the skin and face to reduce redness ( rosacea ) and redness of the face . it is used in adults to treat the following conditions in adults and children aged less than 18 years . rosica is caused by high levels of blood flow in theacial skin that leads to enlargement ( dilution ) of the small blood vessels of the skin , which can lead to redness and swelling of the area around the face and the surrounding area . miraso acts by
do not take mirvaso - if you are allergic to brimonidine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given the medicine . the medicine should not be injected under the skin . certain medicines used to treat depression and parkinson ' s disease : monoamine oxidase ( mao ) inhibitors such as selegiline , moclobemide , tricyclic antidepressants ( such as imipramine ), tetracyclic antidepressant such as maprotiline or mianserin ,
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . mirvaso is given under the skin or on the face . the recommended dose of this medicine is one tablet per body surface area . your doctor will work out the right dose for you based on the size of your body . the dose will be adjusted by your doctor depending on your eyes , mouth , nose or vagina . swallow the tablet whole with a glass of water . do not crush or chew the tablet . if you have any further questions on the use of this product , ask your doctor , pharm
like all medicines , this medicine can cause side effects , although not everybody gets them . uncommon side effects : severe skin irritation , inflammation , skin rash , skin pain , discomfort , dry skin , warm skin sensation , tingling or sensation of pins and needles or swelling . common side effects ( may affect up to 1 in 10 people ): worsening of rosacea after the start of the treatment . symptoms include 2 contact allergy . allergic reaction ( rash ) rare angioedema ( a serious allergic reaction with swelling mainly of the face , mouth and tongue ). if you take more mirvaso than you should contact your doctor immediately
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and tube and pump after exp . this medicinal product does not require any special temperature storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep the container in the outer carton in order to protect from light . after dilution , the product should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would not normally be longer than 24 hours at room temperature ( up to 30 ).
what mirvaso contains - the active substance is brimonidine . each ml of gel contains 3 . 3 mg of bromonidine in 5 ml of solution . - the other ingredients are : - the solvent : brimonidine tartrate , carbomer , methylparahydroxybenzoate , phenoxyethanol , glycerol , titanium dioxide ( e171 ), propylene glycol , sodium hydroxide , purified water ( see section 2 " miraso contains methylparAHydroxy benzoate "). - the printing ink : ethyl glycol ( e1520 ) and propylene
mvasi contains the active substance bevacizumab , which is a humanised monoclonal antibody . it works by interfering with the immune system ( the body ' s natural defences ) to reduce the risk of infection and cancer . by attaching itself to a protein called human vascular endothelial growth factor ( vegf ), it allows the body to increase the number of blood vessels that supply oxygen to the body . by binding to the vegF protein , it allows blood vessels to expand and provide more oxygen . in this way be vacizumsumab increases tumour growth and allows the blood vessels
do not use this medicine : if you are allergic ( hypersensitive ) to bevacizumab or any of the other ingredients of this medicine ( listed in section 6 ) if you ( or your child ) are allergic or hypersensitive to chinese hamster ovary ( cho ) cell products ( see section " warnings and precautions "). if you and your child are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor or pharmacist for advice before using mvasi . driving and using machines do not drive or use machines until you have talked to your doctor
always use mvasi exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage the recommended dose of the medicine is based on your body weight and the type of cancer you have . the usual starting dose is between 5 mg , 7 . 5 mg and 10 mg per kg of body weight . your doctor may increase your dose to a maximum of 15 mg once a day depending on the size of your tumour growing . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse . duration of treatment your doctor will decide how long
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with mvasi : very common side effects ( may affect more than 1 in 10 people ): difficulty in breathing , chest pain , redness or flushing of the skin , a rash , chills , shivering , feeling sick ( nausea ), or being sick ( vomiting ). other side effects include : severe side effects which may affect up to 1 in every 10 people : high blood pressure , numbness or tingling in hands or feet , decreased number of cells in the blood , including white cells .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the vial label after exp . store in a refrigerator ( 2 - 8 ). keep mvasi in theouter carton in order to protect from light . infusion solutions may be stored at room temperature ( up to 24 ) for a single period of 2 to 8 days . the infusion solutions should be used immediately after dilution in a sterile environment . the recommended storage times and conditions are 35 to 2 hours ( at 2 or 8 ) and 48 to 48 hours (
what mvasi contains - the active substance is bevacizumab . each ml contains 25 mg of beviacizumb in 1 . 4 ml of 16 . 5 ml solution for injection . each 4 ml vial contains 100 mg of the other ingredients ( listed in section 6 ). - the other ingredient ( s ) ( s ), which is present in the vial , is : 100 mg / ml ( 0 . 4 %) solution for injections . - the ingredients in the solvent are : trehalose dihydrate , sodium phosphate , polysorbate 20 , water for injections what mvas
tecartus is a gene therapy medicine that is used to treat mantle cell lymphoma in adults . it is used in combination with other medicines to treat refractory mantle cell lipoma , in which your own white blood cells ( called autologous anti - cd19 - transfduced cd3+ cells ) are not fully protected against the growth and spread of the cancer . mantle cell lysisoma is a cancer that affects the immune system ( the body ' s natural defence system ) and affects the number of b - lymphocytes that are involved in the production of the lymph cells . mantlecell lymphoma is caused by
do not use tecartus if you are allergic to any of the ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor or pharmacist for advice . warnings and precautions talk to your doctor , pharmacist or nurse before you are given the medicine if : you have a problem with the number of white blood cells in your blood ( lymphodepleting chemotherapy , see section 3 ). you have problems with the numbers of these types of cells . you have autologous use . tests and checks of your lungs , heart , kidney , blood pressure , infection or inflammation of your
tecartus contains your own white blood cells . your cells will be given to you by a catheter placed into your vein ( a procedure call leukapheresis ). your doctor will decide how much tecartus you should receive . the number of your whiteblood cells in your blood will be calculated by your doctor . the amount of your blood in your vein will depend on your condition . the recommended dose is 3 to 6 micrograms per kilogram of body weight each day . if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse . the usual dose is 2
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you notice any of your side effects . if any of the side effects occur , you may need urgent medical attention . the following side effects have been reported during the tecartus infusion : very common ( may affect more than 1 in 10 people ): fever , chills , reduced blood pressure . symptoms include dizziness , lightheadedness , fluid in the lungs . all symptoms could be signs of a condition called cytokine release syndrome . loss of consciousness , decreased level of consciousness ( confusion ), memory loss , disturbances of brain
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and infusion bag after exp . store in a refrigerator ( 2 - 8 ). store in the original package in order to protect from light . the solution for infusion bag contains liquid nitrogen equivalent to 150 micrograms per vial . this medicine is made from genetically modified human blood cells or human - derived material . the product is stable for 36 hours at room temperature ( up to 25 ). do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw
what tecartus contains - the active substance is autologous anti - cd19 - transduced cd3+ cells . each specific single infusion bag contains a dispersion of anti -cd19 car t cells ( equivalent to 68 x 2 cd3 + cells ). - the other ingredients are : 106 the active substances are : sodium chloride , human albumin ( see section 2 " teCartus contains sodium ") and water for injections . what tecartu looks like and contents of the pack tecartuc is a clear , colourless to pale yellow solution for infusion . it is supplied as an infusion bag in a
januvia contains the active substance sitagliptin , which belongs to a group of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - four inhibitors ). this medicine lowers blood sugar levels in adult patients with type 2 diabetes mellitus . this medicine increases the levels of insulin produced by your body . by increasing the amount of this medicine , your blood sugar can be lowered . this helps to control the level of sugar in your blood and helps to prevent the progression of your type2 diabetes . if you are taking this medicine with certain other medicines , such as insulin , metformin , sulphony
do not take januvia if you are allergic to sitagliptin or any of the other ingredients of this medicine ( listed in section 6 ). if you have inflammation of the pancreas ( pancreatitis ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have ever had pancreatitis ( see section 4 ) blistering of the skin ( bullous pemphigoid ) you have a disease of the pancreatreas called pancreatitis . you have gallstones ( alcohol dependence ). you have very high levels of triglycerides in your blood . if any of these medical conditions
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended starting dose is one 100 mg coated tablet taken by mouth once a day . if you have kidney problems , your doctor may increase your dose to 25 mg or 50 mg twice a day depending on how you respond to this medicine . this medicine may be taken with certain other medicines that lower blood sugar . your doctor will check your blood sugar regularly while you are taking januvia . do not take more than the recommended daily dose . if any of the above apply to you , talk to your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking januvia and contact your doctor immediately if you experience any of the following side effects : severe and persistent pain in the abdomen ( stomach area ), which may reach through to your back , nausea or vomiting . these may be signs of an inflamed pancreas ( pancreatitis ). this is a serious allergic reaction with frequency not known ( cannot be estimated from the available data ). rash , hives , blisters on the skin , peeling skin , swelling of the face , lips , tongue , and throat , which may cause difficulty
what januvia contains - the active substance is sitagliptin . one tablet of each film - coated tablet ( tablet ) contains the following excipients : - the other ingredients are tablet core : sitaglptin phosphate monohydrate , equivalent to 25 mg of sitaglioptin . - tablet coating : microcrystalline cellulose , calcium hydrogen phosphate , croscarmellose sodium , magnesium stearate , sodium stearyl fumarate . - the tablet film - coating : poly ( vinyl alcohol ), macrogol 3350 , talc , titanium dioxide ( e171 ), red iron oxide (
xultophy is a type of insulin that works by helping your body make better use of the insulin it produces . it is used to treat type 2 diabetes mellitus in adults . diabetes is when your body does not make enough insulin . the insulin that your body makes does not work as well as it should . this helps to control blood sugar . insulin degludec is a long - acting basal insulin . it works by lowering your blood sugar levels . liraglutide is another type of glp - 1 insulin used to make insulin during meals . xultophy can be taken with or without oral medicines .
do not take xultophy : - if you are allergic to insulin degludec , liraglutide or any of the other ingredients of this medicine ( listed in section 6 ). - if 39 you are taking a sulfonylurea ( such as glimepiride or glibenclamide ). your doctor will tell you how much to take and how often you should take it . your doctor may adjust your sulfonyla dose depending on your blood sugar levels . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine : if you have type 1 diabetes mell
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one tablet once a day . do not take more than one tablet a day unless your doctor tells you to . this is to make sure that you are blind or have poor eyesight . your doctor will check your blood sugar level regularly while you are using xultophy . the usual starting dose is 41 mg twice a day ( two tablets a day ). your doctor may increase your dose depending on your condition . if you have any further questions on the use of
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are low blood sugar . very common ( may affect more than 1 in 10 people ): if your blood sugar level gets low you may pass out or become unconscious . serious hypoglycaemia ( which can lead to brain damage ) is very common . if you notice any of the above , talk to your doctor or pharmacist immediately . if the effects are not treated with xultophy , you should contact your doctor straightaway . if yourblood sugar level is too low , you may be more likely to develop hypogly
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep the bottle tightly closed in order to protect from light . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would not normally be longer than 8 hours at room temperature ( up to 8 ). if used within 21 hours , the product should be used immediately . if used more
what xultophy contains - the active substances are insulin degludec and liraglutide . each vial contains 100 units of insulin degluudec 3 . 6 mg / ml ( corresponding to 300 units / ml ) of the active substance . - the other ingredients are glycerol , phenol , zinc acetate , hydrochloric acid , sodium hydroxide ( for ph adjustment ) and water for injections . see section 2 for further information on sodium . what xultos looks like and contents of the pack the vial is a clear , colourless to pale yellow solution . it is
giotrif is a medicine that contains the active substance afatinib . it works by blocking the activity of two proteins called egfr [ epidermal growth factor receptor - 1 ] ( egfr1 and her2 [ erbb2 ]) and erbb3 . both of these proteins are involved in the growth of cancer cells . this medicine stops these proteins from working properly and stops cancer cells from growing . your doctor has prescribed this medicine for the treatment of cancer of the lung ( non - small cell lung cancer ). your doctor will tell you how much and how often you will be given giotriif .
do not take giotrif if you are allergic to afatinib or any of the other ingredients of this medicine ( listed in section 6 ). if you have low body weight ( less than 50 kg ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have kidney problems . tell your doctor straight away if you experience any of these side effects . you have lung inflammation ( interstitial lung disease ). you have liver problems . your doctor may need to perform some liver tests before you start treatment with this medicine . if you suffer from a severe liver disease . you may have eye problems
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 40 mg tablet once a day . swallow the tablet whole with a glass of water . do not chew or crush the tablet . if you take more giotrif than you should if you accidentally take too many tablets of this medicine , talk to a doctor or go to the nearest hospital straight away . if possible , take the tablet at the same time each day . this medicine can be taken with or without food . you may need to take it at different times of the day
like all medicines , giotrif can cause side effects , although not everybody gets them . the following side effects have been reported during treatment : diarrhoea common ( may affect up to 1 in 10 people ) diarrhoeas may occur in more than 2 out of 10 people . if you have severe diarrhoehoea , fluid loss may occur very commonly ( common may affect more than 1in 10 people ). low blood potassium may be a sign of worsening kidney function . tell your doctor immediately if you experience any of the following after taking the first dose of the first two doses of the second dose . if any of these
what giotrif contains - the active substance is afatinib . each film - coated tablet contains 20 mg of afinib . - the other ingredients are : tablet core : lactose monohydrate , microcrystalline cellulose , colloidal anhydrous silica , crospovidone , magnesium stearate . tablet coating : hypromellose , macrogol 400 , titanium dioxide ( e171 ), polysorbate 80 ( e433 ). what giotrarif looks like and contents of the pack giotratif 20 mg film - coating tablets are white to off - white ,
orkambi contains the active substance lumacaftor . it is a medicine that is used for long - term treatment of cystic fibrosis ( cf ) in adults and adolescents aged 6 years and older . it works by blocking a protein called f508del mutation , which is involved in the synthesis of a substance called cftr . this protein is a type of protein known as " cyst fibrosis transmembrane conductance regulator ". it is found in the airways of the lungs . the mutation results in an abnormal cdr protein that cannot be made by your body . when or kambi works
do not take orkambi : - if you are allergic to lumacaftor or ivocaftor , or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given or kambi . if you think you may have been given too much or too little or if the f508del mutation is too strong or too weak , tell your doctor or pharmacist before you have any further questions . if any of these apply to you , or if you have liver or kidney disease , your doctor may lower the dose of or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended starting dose is one 6 mg tablet once a day for 12 hours . your doctor will tell you how many tablets to take . the recommended orkambi tablet should be taken at least 6 to 11 times a day . if you take more than the recommended dose , your doctor may tell you to take a smaller dose . the usual starting dose of either kambi 100 mg twice a day ( 2 tablets in the morning ) for 2 to 12 hours , depending on your
like all medicines , this medicine can cause side effects , although not everybody gets them . some of the side effects may be serious . stop taking orkambi with ivacaftor and talk to your doctor straight away if you notice any of the following serious side effects while you are being treated with this medicine : - raised levels of liver enzymes in the blood - liver injury - pre - existing severe liver disease - the worsening of liver function common side effects ( may affect up to 1 in 100 people ): - pain or discomfort in the upper right stomach ( abdominal ) area yellowing of your skin or the whites of your eyes
what orkambi contains - the active substance is lumacaftor . each tablet contains either ivocaftor or two other active substances . - or kambi 100 mg / 125 mg film - coated tablets one tablet contains 100 micrograms of lumiacaftor and two other ingredients ( e . g . 125 mg and 150 mg ) of ivacafter . - either orkibi 200 mg / 200 mg tablets two tablets contain 200 microgramms of lumacftor and 125 mg of iviacafter , respectively . - the other ingredients are : tablet core : cellulose , micro
the active substance of lynparza is olaparib ( a type of cancer medicine known as a parp inhibitor ( poly [ adenosine diphosphate - ribose ] polymerase inhibitor ). it works by stopping mutations ( changes ) in a gene called brca ( breast cancer gene ). cancer medicines called parp inhibitors cause death of cancer cells by blocking an enzyme that helps to repair dna . lynpalza is used to treat ovarian cancer ( brca ) in adults . brca is a form of mutated ovarian cancer that occurs when the cancer has not responded to previous treatment or standard platinum - based chemotherapy
do not take lynparza - if you are allergic to olaparib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking the medicine . children and adolescents do not give this medicine to children below the age of 6 years . the recommended dose is 2 mg per kg body surface area . if you have any further questions on the use of this product , ask your doctor or pharmacist . if any of these apply to you , or you are not sure , talk to a doctor or nurse straight away . other medicines and lynpar
always take lynparza capsules exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose for adults is one 100 mg capsule twice a day . your doctor may increase your dose to 150 mg once a day depending on how you respond to the doses . the doses of yalpa capsules should be taken in combination with tablets . if you take more of a capsule than you should if you accidentally take too many of the tablets , contact your doctor straight away ( see section 2 " warnings and precautions "). if you forget to take a tablet if you miss a dose of
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): feeling short of breath , feeling very tired , pale skin , fast heart beat . these may be symptoms of a decrease in the number of red blood cells ( anaemia ). uncommon ( might affect up to 1 in 100 people ): allergic reactions such as hives , difficulty breathing , swallowing or dizziness . signs and symptoms of hypersensitivity reactions are listed below . other side effects very common : may affect less than 1in 10 people : feeling sick ( nausea ) being sick ( vomiting )
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep any lynparza capsules in the outer carton in order to protect from light . after first opening of the bottle , the bottle may be kept at room temperature ( up to 30 ) for a single period of up to 3 days . if any capsules are not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not
what lynparza contains - the active substance is olaparib . each hard capsule contains 50 mg of olamide . - the other ingredients are lauroyl macrogol - 32 glycerides , hypromellose , titanium dioxide ( e171 ), gellan gum , potassium acetate , iron oxide black ( e172 ). what lynparparza looks like and contents of the pack the hard capsule is a white , opaque , hard capsule imprinted with " loparib 50 mg " on one side and " astrazeneca logo on the other side . the hard capsules are supplied in
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . nyxoid contains the active substance naloxone , which is used to treat opioids such as heroin , methadone , fentanyl , oxycodone , buprenorphine or morphine . your doctor will tell you how many nyxoids to use and how often you should use them . this medicine is also used as a nasal spray for the emergency treatment of opioid overdose . opioid overdose is a serious , life - threatening , and can affect up to 14 people .
do not use nyxoid : - if you are allergic to naloxone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . you may need emergency medical care or emergency services if you have an opioid overdose . it is important that you tell your doctor if you experience the signs and symptoms of an overdose overdose . if you use this nasal spray for more than 2 to 3 days , use a new nasal spray at the same time each day . do not inject this medicine into a child who is physically dependent on opioids
always use nyxoid nasal spray exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one inhalation once a day . if you have symptoms such as : - shoulders , ears , breastbone , sternum , ear , fingernail . - clear the mouth and nose of any blockers . - open the mouth or nose . 1 . breathing is the chest moving through the chest . you can hear breathing sounds and breath on the cheek . overdose may occur if your response to touch or sounds is slow uneven breathing , breathing , sn
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with this medicine : acute withdrawal symptoms may occur with opioid drugs . symptoms include fast heart rate , high blood pressure body aches , stomach cramps , feeling sick , vomiting , diarrhoea , sweating , fever , goose bumps , shivering , trembling changes in behaviour , including violent behaviour , nervousness , anxiety , excitement , restlessness , irritability unpleasant , uncomfortable mood , increased skin sensitivity difficulty in sleeping . these are uncommon ( may affect up to 1 in 100 people ). if you experience any of these
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nyxoid contains - the active substance is naloxone . each nasal spray contains 1 . 8 mg of the following active substances : - the other ingredients are : - hydrochloride dihydrate ), trisodium citrate diydrate , sodium chloride , hydrochloric acid , sodium hydroxide , purified water . - the following ingredients are present in the solution for injection : - each spray contains 0 . 1 ml of solution . - a pre - filled nasal spray is supplied in a single dose container . - one vial of nxoid is available in a carton containing 2 nasal sprays
what ovaleap is this medicine contains the active substance follitropin alfa , which is a gonadotropin ( a type of hormone that stimulates the growth of the cells ( follicles ) in the ovaries ). it is used for the production of sperm ( a mature egg cell ) after treatment with a medicine called " clomifene citrate ". this medicine is used in assisted reproductive technology procedures ( procedures that allow women to become pregnant ) in women who are unable to take a medicine containing " lutropin anfa " or " luteinising hormone " or who are not able to take
do not use ovaleap : if you are allergic to follitropin alfa or any of the other ingredients of this medicine ( listed in section 6 ) if you have a tumour in your hypothalamus or pituitary gland ( part of the brain ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : you have ovarian cysts , unexplained vaginal bleeding , cancer in your ovaries , womb or breasts , any condition that makes normal pregnancy impossible , ovarian failure in early menopause , fibroid tumours of the womb , malformed reproductive organs or testicular failure .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of this medicine is one injection into the tissue under the skin ( subcutaneous injection ). if you have irregular periods , your doctor may give you this medicine for the first 7 days of your menstrual cycle . your doctor will tell you how many cycles of the medicine you should use . if you use more ovaleap than you should if you inject too much this medicine , talk to your doctor . the usual starting dose is 75 mg once a day . this medicine may be increased to 150
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects : women allergic reactions such as skin rash and raised itchy areas of skin . severe allergic reactions may include weakness , drop in blood pressure , difficulty breathing and swelling of the face . 37 uncommon ( may affect up to 1 in 10 , 000 people ) the severity of reaction may vary depending on the type of reaction you have experienced . your doctor may decide to delay your ovaleap injection until you feel better . if you experience any of these symptoms , stop using ovale
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). keep the cartridge in the outer carton in order to protect from light . this medicine may be stored for up to 3 months at room temperature ( up to 25 ). do not freeze . keep this medicine in the original carton and keep it out of reach of light . after reconstitution , the solution should be used within 3 hours . if the solution is not clear or colourless , it must be used
what ovaleap contains - the active substance is follitropin alfa . each vial of the product for injection ( injection ) contains 300 micrograms or 0 . 5 ml of solution . each ml of the solution for injection contains 22 mg of follitonropin alpha ( equivalent to 0 . 95 mg of solution ). - the other ingredients are : one 600 microgram / ml vial ( 0 . 75 mg / ml ) vial : each cartridge contains 450 microgram ( 1 . 5 mg ) of solution for injections . - each cartridge containing 900 microgram or 33 microgram vial contains 66 mg
voriconazole accord is an antifungal medicine that works by stopping the growth of the fungus that causes infections . it is used to treat invasive aspergillosis ( a type of fungal infection ) in adults , adolescents and children aged 2 years and older . it works by reducing the amount of invasive apergillus sp ) in the body and reducing the risk of candidaemia ( an increased risk of serious fungal infections ). candida sp is non - neutropenic and causes abnormally low white blood cells count ( a condition in which the immune system ( the body ' s natural defence system
do not take voriconazole accord : - if you are allergic to any of the ingredients of this medicine ( listed in section 6 ). - if any other medicines ( herbal medicines ) have been taken with this medicine . warnings and precautions talk to your doctor , pharmacist or nurse before taking any of these medicines . the medicines that may be taken with voricoazole accord treatment 46 terfenadine ( for allergy ) astemizole ( to allergy ) cisapride ( for stomach problems ) pimozide ( for mental illness ) quinidine ( for irregular heart beat ) rifampic
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is based on your weight and the type of infection you have . the usual starting dose is 40 mg twice a day . this will be increased to 40 mg once a day for 24 hours . your doctor may increase your dose to 400 mg three times a day ( for 12 hours ) and to 200 mg once every 24 hours , or to 100 mg once daily , depending on how you respond to treatment . the maximum recommended dose for mild to moderate cirrhosis ( see section 2 ) is
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any side effects not listed in this leaflet . serious side effects that have been reported with voriconazole accord include rash , jaundice , changes in blood tests of liver function and pancreatitis . other side effects include : very common ( may affect more than 1 in 10 people ): visual impairment ( change in vision , blurred vision , visual color alterations , abnormal intolerance to visual perception of light , colour blindness , eye disorder , halo vision , night blindness , swinging vision , seeing sparks , visual
what voriconazole accord contains - the active substance is voricazole . each 50 mg film - coated tablet contains 200 mg ( 1 . 5 mg ) ( 1 tablet ). - the other ingredients are : tablet core : voricoazole ( 50 mg ), pregelatinised starch , croscarmellose sodium , povidone , magnesium stearate . tablet coating : hypromellose , titanium dioxide ( e171 ), lactose monohydrate , triacetin . the film - coating is white to off - white , round and marked with " nvr " on one side
mvabea is a vaccine to prevent ebola virus disease in the future . it is given to adults , adolescents and children from 1 year of age and older . if you have been given more than one dose of ebola virus , you will be given a 2 - dose course of vaccinations . the active substances in this vaccine are thezaire ebolavirus and filovirus . this vaccine works by stopping the production of more than 1 % of the white blood cell ( lymphocyte - colony stimulating factor ) in your body . if any of the above applies to you , you should not receive mvabe
follow carefully all instructions given to you by your doctor or nurse . the vaccination course should be initiated by a doctor experienced in the use of the vaccine . if you have had a severe allergic reaction to an antibiotic called ' gentamicin ' or any of the other ingredients in the vaccine ( listed in section 6 . warnings and precautions talk to your doctor , nurse or pharmacist before you are given mvabea if you think you have ( or have ever had asevere allergic reaction ) to any other vaccine injection . fainted during the injection , bleeding or bruise easily if you currently have a fever or an infection . medicines
the recommended dose of vaccine is one injection into a muscle ( intramuscular injection ) in the upper arm , thigh or blood vessel . vaccination with zabdeno vaccine 8 weeks later the first dose of mvabea vaccine will be given in combination with the second vaccine . if you have any further questions on the use of this vaccine , ask your doctor , pharmacist or nurse . the recommended duration of vaccination is one week . primary vaccination first vaccination followed by two weeks later . second vaccination follow - up with the first vaccination with m vabea yellow cap vial ( available in packs containing 8 vaccines ). the
like all medicines , this vaccine can cause side effects , although not everybody gets them . the following side effects have been reported since the marketing of mvabea : very common ( may affect more than 1 in 10 people ): pain , warmth and swelling at the site of the injection very tired muscle ache joint pain very common : may affect up to 1 out of 10 people : feeling sick ( vomiting ) itching at the place where the injection was given uncommon : may affects up to one in 100 people : redness or skin hardness at the area where it was given generalised itching . the most common side effects reported since marketing
what mvabea contains - the active substance is zaire ebolavirus 29 . one ml of solution contains tai forest orbiolavirus nucleoprotein marburg equivalent to 0 . 7 mg / 108 micrograms . - the other ingredients are : chicken embryo fibroblast cells . this vaccine contains trace residues of gentamicin , sodium chloride , trometamol , water for injections , hydrochloric acid ( for ph adjustment ). what mvoabea looks like and contents of the pack mvaraa is a suspension for injection in a single - dose glass vial with a rubber
bridronat contains the active substance ibandronic acid , which belongs to a group of medicines called bisphosphonates . it is used to treat breast cancer that has spread to your bones called ' bone ametastases '. it prevents your bones from breaking ( fractures ). it is also used to prevent other bone problems from occurring after surgery or radiotherapy bondronat helps to prevent a raised calcium level in your blood due to a tumour that has been lost from your bones . this makes your bones stronger .
do not take bondronat if you are allergic to ibandronic acid or any of the other ingredients of this medicine ( listed in section 6 ). if you have low levels of calcium in your blood . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have ever had or might now have a side effect called osteonecrosis of the jaw ( onj ). onj is a form of bone damage in the jaw . your doctor may need to adjust your dose or stop your treatment if you think you may be at risk of developing onj . you have cancer or related conditions
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . if you have cancer , your doctor will give you an infusion into your vein ( intravenously ) every 3 - 4 weeks . this will be given as an infusion in your vein over a period of at least 15 minutes . your doctor may also give you a raised calcium level in your blood ( see section 2 " how to use bondronat "). if your doctor thinks that the medicine is too strong or too weak , he or she may give you
like all medicines , this medicine can cause side effects , although not everybody gets them . if you notice any of the following side effects you may need urgent medical treatment : very common ( may affect more than 1 in 1 , 000 people ): persistent eye pain inflammation new pain or weakness or discomfort in your thigh , hip or groin . unusual fracture of the thigh bone . common : may affect up to 1 in 10 , 000 users : pain or sore in your mouth or jaw . severe jaw problems ( necrosis ( dead bone tissue that lines the jaw and bone ). ear pain or discharge from the ear . these may be signs of an
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial label after exp . after dilution the infusion solution should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 - 8 . if you have any further questions on the use of this medicine , ask your pharmacist .
what bondronat contains - the active substance is ibandronic acid . each vial contains 2 mg of this substance as a concentrate for solution for infusion . - the other ingredients are : sodium monohydrate , sodium chloride , acetic acid , sodium acetate , water and water for injections . what bondonat looks like and contents of the pack the vial is a clear , colourless to pale yellow solution . it is supplied in packs containing 1 or 2 vials with a bromobutyl rubber stopper . not all pack sizes may be marketed .
zeposia is a medicine that contains medicines that stimulate the production of white blood cells ( lymphocytes ) in the body . what zepoesia is used for zeposias is used to treat relapsing remitting multiple sclerosis ( rms ), a type of active disease that affects the nerves of the brain and spinal cord . symptoms include numbness , difficulty in walking , and problems with vision and balance . relapses remitting ms is a disease that causes attacks on the nerve cells . the symptoms usually disappear within a few days or for periods of time . some problems may be life - threatening . zep
do not take zeposia if you are allergic to zanimod or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severely weakened immune system . if you had a heart attack ( angina ), stroke ( mini - stroke ), or transient irishemic attack ( tia ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have severe heart failure in the last 6 months ( see section 6 ) you have irregular or abnormal heartbeats ( arrhythmia ). you have problems with your heart . your doctor may stop treatment
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of zeposia is based on your heart rate . you will be given a ' treatment initiation pack ' for treatment . the recommended starting dose is 4 mg ( 0 . 23 mg ozanimod ) once a day . this will be gradually increased to 1 mg every 4 weeks . after 4 weeks of treatment , your doctor may increase your dose to 3 mg / 0 . 46 mg of zanimod every 5 to 6 weeks . if you take more zep
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects : very common ( may affect more than 1 in 10 people ): slow heart rate urinary tract infection ( blood pressure may increase up to 1 in 100 people ): allergic reaction . the signs may include a rash . other possible side effects include : side effects that may occur with zeposia are : common : may affect less than 1in 10 people : infections of the nose or nostrils , nasal cavity , mouth , throat ( pharynx ), voice box
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . store below 25 . this medicine does not require any special temperature storage conditions . any damage to the pack should be investigated by your healthcare provider .
what zeposia contains - the active substance is ozanimod . each capsule contains 0 . 23 mg / ml of solution for injection . - the other ingredients are : - capsule contents : 0 . 22 mg : hydrochloride ( see section 2 ). - the capsule shell : 1 capsule containing 0 . 46 mg of solution ( for injection ). - capsule content : 2 capsule shells : microcrystalline cellulose , silica , colloidal anhydrous , croscarmellose sodium , magnesium stearate ( e470b ). capsule shell ( 0 . 03 mg ): gelatin , titanium dioxide ( e171
the active substances of temybric ellipta are fluticasone furoate , umeclidinium bromide and vilanterol . flilitasone fiburoate belongs to a group of medicines called corticosteroids . steroids are substances produced by the body that contain the active substance , umclidine , which can be taken with or without food . the other active substances are vilterol and bronchodilators ( medicines that help to control breathing difficulties ). what temmybric ellipta is used for temy bric elliptea is used to
do not use temybric ellipta : - if you are allergic to fluticasone furoate , umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using temiybric ellipta : if you have asthma . if you think you may have asthma , ask your doctor for advice . - if your doctor has told you that you have heart problems , high blood pressure , liver problems , tuberculosis ( tb ) of the lung , or any long standing or
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . take this medicine at about the same time each day . you should take temybric ellipta every day for 24 hours . do not take more than the recommended daily dose . if you take more temybi than you should if you accidentally take too many tablets , talk to a doctor or go to the nearest hospital straight away . take the tablet pack with you so that you can easily describe the symptoms of your copd symptoms such as breathlessness
like all medicines , this medicine can cause side effects , although not everybody gets them . immediate breathing difficulties your breathing and wheezing may be more intense when taking this medicine . pneumonia is a serious infection of the lung ( copd ). the most common side effect of temybric ellipta is symptoms of a lung infection such as fever , chills , increased mucus production , change in mucus colour , increased cough and increased breathing difficulties common side effects ( may affect up to 1 in 10 people ) are sore , raised patches in the mouth or throat , a fungal infection ( candidiasis ) if you take tem
what temybric ellipta contains the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . each inhalation contains 92 micrograms of the two active substances , respectively . each delivered dose is : one inhalation ( dose 65 mg ) of the three active ingredients , respectively , of the four active substances : umclidinicium nebide ( dose 55 mg ) and of the other ingredients ( dose 22 mg ). the other ingredient is trifenatate , lactose monohydrate ( see end of section 2 under ' temy
zinforo is an antibiotic medicine that contains the active substance ceftaroline fosamil . it belongs to a group of medicines called 'cephalosporin antibiotics '. zinforo helps to prevent infections of the skin and the tissues around the skin . it is used to treat an infection of the lungs known as ' pneumonia ' that has spread to other parts of the body . it can be used in adults , adolescents and children aged less than 18 years . zinforto works by killing certain bacteria that cause serious infections .
do not take zinforo : if you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to othercephalosporin antibiotics . if you have previous severe allergic reactions to other antibiotics such as penicillin or carbapenem . warnings and precautions talk to your doctor or pharmacist before taking zin foro if you : have kidney problems . have ever had seizures or convulsions . have or have had any non - severe allergic reaction to any other antibiotics ( e . g . penic
always take zinforo exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 600 mg once a day for 12 weeks . your doctor may increase your dose to 600 mg every 8 weeks . if you have some infections that have not responded to treatment for 8 weeks or more , your doctor will give you a dose of 12 mg once daily . this dose is given as a drip into a vein ( subcutaneously ) over a period of 5 to 60 minutes . it may be given up to 120 minutes after you have taken the dose . an increased dose
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : sudden swelling of your lips , face , throat or tongue , a severe rash , swallowing or breathing problems . these could be signs of a severe allergic reaction ( anaphylaxis ). diarrhoea , stool , blood or mucus may occur during treatment with zinforo . medicines to slow bowel movement common ( may affect up to 1 in 10 people ): a blood test called a 'ombs test ' ( antibiotic ). this test will
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store below 30 . store in the original package in order to protect from light . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zinforo contains - the active substance is 600 mg ceftaroline fosamil . - the other ingredients are arginine and water for injections ( see section 2 ). what zzinforo looks like and contents of the pack zinforto is a pale yellowish to light yellow powder for concentrate for solution for infusion in a vial . each pack contains 10 vials .
pregabalin pfizer belongs to a group of medicines used to treat epilepsy , neuropathic pain or generalised anxiety disorder ( gad ) in adults . peripheral and central neurological pain is a form of long lasting pain caused by damage to the nerves . a variety of diseases have been associated with peripheral neurological pain , such as diabetes , shingles , pain sensations such as burning , throbbing , shooting , stabbing , sharp , cramping , aching , tingling or numbness , pins and needles . in patients with peripheral and peripheral neuropathicpain , mood changes , sleep disturbance , fatigue and tiredness have been
do not take pregabalin pfizer : - if you are allergic to any of the ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given any of these medicines . before you have been given the dose , you should check with your doctor or pharmacist if you have any questions about the safety and efficacy of any medicine . if you miss a dose , take it as soon as you remember and then take your next dose at the usual time . if it is less than one hour until your next scheduled dose , skip the missed dose . if
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . pregabalin pfizer is used to treat peripheral and central neuropathic pain ( epilepsy ) and generalised anxiety disorder in adults . the recommended dose is 150 mg twice a day . your doctor may increase your dose to 600 mg once a day depending on how you respond to the medicine . if you take more preggabalin fizer than you should if you accidentally take too many tablets , talk to a doctor or go to the nearest hospital straight away . you may need to take preg
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): dizziness , drowsiness , headache . common : may affect up to 1in 10 people : increased appetite , feeling of elation , confusion , disorientation , decrease in sexual interest , irritability , disturbance in attention , clumsiness , memory impairment , loss of memory , tremor , difficulty with speaking , tingling feeling , numbness , sedation , lethargy , insomnia , fatigue , feeling abnormal , blurred vision , double vision , vertigo , problems
what pregabalin pfizer contains - the active substance is preguabalin . each hard capsule contains either 25 mg , 50 mg , 75 mg , 100 mg , 150 mg , 200 mg , 225 mg or 300 mg of preguibalin . - the other ingredients are lactose monohydrate , maize starch , talc , gelatine , titanium dioxide ( e171 ), sodium laurilsulphate , anhydrous colloidal silica , black ink , shellac , black iron oxide ( e172 ), propylene glycol , potassium hydroxide ). - the 75 mg and 100 mg
xadago is a medicine that contains the active substance safinamide . it works by blocking the action of dopamine in the brain , a chemical that is important in the functioning of the brain . it is used to treat parkinson ' s disease in adults . xadago helps to control the signs of parkinson ', such as sudden swings in the ability to move or difficulties moving . it can also be used in combination with levodopa or other medicines for parkinson '.
do not take xadago : - if you are allergic to safinamide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking the following medicines : monoamine oxidase ( mao ) inhibitors ( such as selegiline , rasagiline ), moclobemide , phenelzine , isocarboxazid and tranylcypromine . before starting treatment for parkinson ' s disease or depression , your doctor may prescribe pethidine ( a strong pain killer ). see section 7 "
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended starting dose of xadago is 50 mg twice a day . this may be increased to 100 mg once a day by mouth . if you have moderately reduced liver function , your doctor may prescribe a lower dose of 50 mg per day . your doctor will tell you how many tablets to take . take your tablet at the same time each day . do not take more than the recommended dose . take the tablet with a glass of water . swallow the tablet whole with a sufficient amount of food . if
like all medicines , this medicine can cause side effects , although not everybody gets them . hypertensive crisis ( very high blood pressure which can lead to collapse ). neuroleptic malignant syndrome ( confusion , sweating , muscle rigidity , hyperthermia ), increase level of enzyme creatine kinase in your blood ( serotonin syndrome ), confusion , hypertension , muscle stiffness and hallucinations ( hypotension ). the following side effects have been reported with the use of parkinson ' s disease in combination with safinamide or levodopa . other medicines and xadago tell your doctor or pharmacist if you are taking , have recently taken or
what xadago contains - the active substance is safinamide . each tablet contains 50 mg or 100 mg safrinamide . - the other ingredients are : tablet core : methansulfonate , microcrystalline cellulose , crospovidone type a , magnesium stearate , silica colloidal anhydrous - tablet coating : hypromellose , macrogol , titanium dioxide ( e171 ), iron oxide red ( e172 ), and water for injections ( see section 2 ). what xADago looks like and contents of the packxadago 50 mg film - coated tablets of 7
zytiga is a medicine that contains the active substance abiraterone acetate . it is used to treat prostate cancer that has spread to other parts of the body . zytiga increases the amount of testosterone in your body . this helps to control the level of prostate cancer . your doctor will tell you how long you should continue to take it .
do not take zytiga : if you are allergic to abiraterone acetate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be pregnant . warnings and precautions talk to your doctor or pharmacist before taking ztiga if you have severe liver damage or prostate cancer . this medicine is not recommended for use in pregnant women . if any of these apply to you , tell your doctor before taking this medicine . if you suffer from liver problems , such as high blood pressure , heart failure or low blood potassium . if your doctor has told you that you may have low blood
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 1 , 000 mg tablet once a day . swallow the tablet whole with a glass of water . do not chew or crush the tablet . this medicine should be taken by mouth . if you take more zytiga than you should if you accidentally take too many tablets , talk to a doctor or go to the nearest hospital straight away . how much to take the recommended daily dose is 2 tablets . take your tablet at the same time each day . take the tablet with or without food
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zytiga and contact your doctor immediately if you experience : muscle weakness , muscle twitches , a pounding heart beat or palpitations . the level of potassium in your blood is low . your doctor will check your potassium regularly . other possible side effects may include : very common ( may affect more than 1 in 10 people ): fluid in your legs or feet . low blood potassium ( shown in liver function test ). high blood pressure . urinary tract infection . diarrhoea . common : may affect up to 1 in 100 people : high
what zytiga contains - the active substance is abiraterone acetate . each tablet contains 250 mg abiraateroneacetate . - the other ingredients are : tablet core : microcrystalline cellulose , croscarmellose sodium , lactose monohydrate , magnesium stearate , povidone ( k32 ), colloidal anhydrous silica , sodium laurilsulfate . see section 2 for further information on the use of this product in children . what ztiga looks like and contents of the pack - zytigo tablets are white to off - white , round ,
hefiya contains the active substance adalimumab . it is a medicine that is used for the treatment of inflammatory diseases : polyarticular juvenile idiopathic arthritis , enthesitis - related arthritis , paediatric plaque psoriasis and paediatric crohn ' s disease . paediatric non - infectious uveitis is a disease in which the immune system ( the body ' s natural defence system ) does not produce enough of a monoclonal antibody ( a type of protein that is involved in the development of antibodies against other proteins ). monoclal antibodies are proteins that attach to specific proteins in the
do not take hefiya if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe infection , such as tuberculosis , sepsis ( blood poisoning ), or other opportunistic infections . unusual infections may be a sign of a weakened immune system . symptoms of infections may include fever , wounds , feeling tired , dental problems . if you suffer from moderate or severe heart failure or have a serious heart condition . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . allergic reaction allergic reactions include symptoms such as chest tightness
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 40 mg tablet once a day . your doctor will tell you how many tablets to take . the usual starting dose is 20 mg twice a day ( morning and evening ). your doctor may increase the dose to 40 mg once daily . the dose may later be increased to 20 mg once every day . for polyarticular juvenile idiopathic arthritis age and body weight the recommended starting dose for adults is 2 tablets ( 30 mg ) once daily , followed by 40 mg two days later
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . if you notice any of the following side effects after 4 weeks after the last hefiya injection , tell your doctor straight away : allergic reaction ( e . g . heart failure ), severe rash , hives , swollen face , hands , feet , trouble breathing or swallowing , shortness of breath or swelling of the feet . signs and symptoms of infection such as fever , feeling sick , wounds , dental problems , burning on urination , feeling weak or tired
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . after first opening , the product may be stored at room temperature ( up to 25 ) for a period of up to 14 days . once the product has been opened , it should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the
what hefiya contains - the active substance is adalimumab . each pre - filled syringe contains 20 mg of adhalimumab in 0 . 4 ml solution . - the other ingredients are adipic acid , citric acid monohydrate , sodium chloride , mannitol , polysorbate 80 , hydrochloric acid and sodium hydroxide . - water for injections . what hefaya looks like and contents of the pack hefiYA 20 mg / 0 . 04 ml solution is a clear , colourless to slightly yellowish solution supplied in a clear type i glass syringe with a stainlessless
what ritemvia is rituximab is a type of protein called a " monoclonal antibody ". it attaches to a specific type of white blood cell called " b - lymphocyte ". when a member of your immune system attaches to it , the cell ' s immune system ( the body ' s natural defence system ) produces a new type of cell called a lymphocyte . this is known as a " lymphocyte - colony stimulating factor " ( b ) lymphocytes . what rromvia looks like and contents of the pack this medicine is used for the treatment of a ) non - hodgkin '
do not take ritemvia : - if you are allergic to rituximab , other proteins that contain the active substance , or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor if you have a severe active infection , a weak immune system , severe heart failure , severe uncontrolled heart disease ( granulomatosis , polyangiitis , microscopic polyangiaitis or pemphigus vulgaris ). warnings , precautions , and precautions before taking ritvia , tell your doctor or pharmacist if you : - have a hepatitis infection . ritem
always take ritemvia exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of this treatment is one tablet once a day . you should take this medicine at the same time each day to reduce any side effects you may experience . your doctor will tell you exactly how many tablets to take . the usual starting dose is one half a tablet ( intravenous infusion ). your doctor may change the dose of medicines you take at the start of each ritemvia administration . if you take more rithvia than you should if you have taken other medicines ( pre -
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some reactions have been fatal . infusion reactions may occur within the first 24 hours of the infusion . fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number of platelets
what ritemvia contains - the active substance is rituximab . each ml of concentrate contains 100 mg of ritukimab ( as 10 mg / ml ). - the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . - the solvent is a clear , colourless solution for infusion in a glass vial . see section 2 for further information .
capecitabine teva belongs to a group of medicines called " cytostatic medicines ". they work by stopping the growth of cancer cells . capecitabrine teva is used to treat adult patients with advanced stage of colon , rectal , gastric , or breast cancers who have not responded to treatment with other medicines or have advanced stages of colon cancer . complete removal of the tumour by surgery is usually required . if you have any further questions on the use of this medicine , ask your doctor or pharmacist .
do not take capecitabine teva : - if you are allergic to the active substance of this medicine ( listed in section 6 ). - if any of the above applies to you ( or you are not sure ), talk to your doctor or pharmacist before taking this medicine . warnings and precautions severe reactions to fluoropyrimidine therapy ( a group of anticancer medicines called fluorouracil ) may occur if : - you are pregnant or breast - feeding . - you have low levels of white cells or platelets in the blood ( leucopenia , neutropenia or thrombocytopenia
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . capecitabine belongs to a group of anticancer medicines called " anti - fungal medicines ". a dose and treatment regimen is based on your body surface area ( height ) and weight . the recommended dose for adults is 1250 mg / m2 ( i . e ., total surface area ). your doctor will work out the right dose for you based on body weight and height . the usual starting dose is 1 . 64 mg per m2 of body weight . your doctor may increase your dose to
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking capecitabine teva and contact your doctor immediately if you experience any of these symptoms : diarrhoea , an increase of 4 or more bowel movements ( see section 4 ). if you have bowel movements at night , vomiting , vomit , nausea , or lose your appetite . stomatitis ( pain , redness , swelling or sores in your mouth and / or throat , especially in your hand or foot ). skin - reaction , including pain , swelling , or redness or tingling of hands and/ or feet
what capecitabine teva contains - the active substance is capecabine . each film - coated tablet contains 150 milligrams of capectabine ( as tablet core ). - the other ingredients are lactose , microcrystalline cellulose , hypromellose ( e464 ), croscarmellose sodium , magnesium stearate , macrogol 400 ( e553 ). - tablet coating : hypromellaose , titanium dioxide ( e171 ), yellow iron oxide ( e172 ), red iron oxide [ e172 ] ( see end of section 2 ). what capecitabe teva looks like
silodosin recordati belongs to a group of medicines called alpha1a - adrenoreceptor blockers ( alpha1s ) and is used to treat prostate , bladder , urethra , and smooth muscle in the tissues of the prostate . your symptoms should be controlled by your doctor or nurse . how silodosic recordati works silosin Recordati helps to control the urinary symptoms associated with benign enlargement of the prostatic hyperplasia ( difficulty in starting to pass water , a feeling of not completely emptying the bladder ).
do not take silodosin recordati : - if you are allergic to silosin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . if you have had eye surgery , you may experience cloudiness of the lens during cataract surgery . the recommended dose is 26 mg / m2 of body surface area per day . if this applies to you , tell your doctor . if any of these apply to you ( or you are not sure ), consult your doctor or pharmacist before being given silod
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of silodosin recordati is one 8 mg tablet once a day . if you have kidney problems or moderate kidney problems , your doctor may prescribe a lower dose . swallow the tablet whole with a glass of water . try to take the tablet at the same time each day . you can take this tablet with or without food . do not crush or chew the tablet . if it is more than 4 hours until your next dose , skip the tablet and take the next dose at the usual
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions swelling of the face or throat , difficulty in breathing , feeling faint or itchy skin , hives are the most common side effect of silodosin recordati . dizziness or dizziness , occasionally fainting . if you feel weak or dizzy , tell your doctor straight away . the symptoms may include dizziness and fainty . if any of these apply to you ( or you are not sure ), talk to your doctor or pharmacist immediately . you may be more likely to experience complications following a cataract
what silodosin recordati contains - the active substance is silosin . each hard capsule contains 8 mg of siliodosin ( as 8 mg ). - the other ingredients are mannitol ( e421 ), magnesium stearate , sodium laurilsulfate , gelatin , titanium dioxide ( e171 ). see section 4 for further information on the ingredients . - the printing ink is silodosein . 4 mg hard capsules : silodosesin . e421 ( e433 ) and magnesiumstearate . printing ink : gelatin , tartan dioxide , yellow iron oxide ( e172 ). what sil
kinzalmono belongs to a group of medicines known as angiotensin ii receptor antagonists . angiotENSin ii is a substance produced in the body that causes blood vessels to narrow . this causes your blood pressure to rise . kinzalono blocks the effect of this effect and helps the blood vessels relax . this helps to control the level of your blood blood pressure . what is essential hypertension ? essential hypertension ( high blood pressure ) is a condition in which the blood pressure is not controlled enough by diet and exercise alone . in this condition , highblood pressure can damage blood vessels in several organs , which can
do not take kinzalmono if : you are allergic to telmisartan or any of the other ingredients of this medicine ( listed in section 6 ). you are more than 3 months pregnant . if you are breast - feeding . warnings and precautions talk to your doctor , pharmacist or nurse before taking kinzdalmono . pregnancy and breast - feed tell your doctor or pharmacist if you : have severe liver problems such as cholestasis or biliary obstruction ( problems with drainage of the bile from the liver and gall bladder ). have any other severe liver disease . have diabetes . have impaired kidney function
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of kinzalmono is one tablet a day . swallow the tablet whole with a glass of water . do not chew or crush the tablets . take the tablet with or without food . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse . how much to take your doctor will tell you how many tablets to take . your doctor may prescribe a lower dose of 20 mg per day . if your doctor thinks that the effect of kin
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious : sepsis ( blood poisoning ), a severe infection with whole - body inflammatory response , rapid swelling of the skin and mucosa ( angioedema ). these side effects are rare ( may affect up to 1 in 1 , 000 people ). the following side effects have been reported with kinzalmono common side effects these may affect more than 1 in 10 people : low blood pressure ( hypotension ) cardiovascular events uncommon side effects this may affect 1 in 100 people : urinary tract infections ( upper respiratory tract
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . keep your medicine in the outer carton in order to protect from light . once your kinzalmono tablet has been removed from the blister , do not throw away any medicines via wastewater . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what kinzalmono contains - the active substance is telmisartan . each vial contains 20 mg . - the other ingredients in the vial are povidone , meglumine , sodium hydroxide , sorbitol and magnesium stearate ( see section 2 ). what kinzalao looks like and contents of the pack kinzalanmono 20 mg tablets are white to off - white , round and debossed with " gsi " on one side and " 20 " on the other side . the tablet is available in blister packs of 14 , 28 , 56 , 98
afstyla is a human clotting ( coagulation ) factor viii product ( lonoctocog alfa ) produced by recombinant dna technology in the manufacturing process in the laboratory at the manufacturing facility in the Netherlands . it is used to treat bleeding episodes in patients with haemophilia a ( inborn factor v iii deficiency ) in adults , adolescents and children aged 2 years and above . factors viii are involved in blood clotting and clotting , but there is an increased tendency to bleed . if you have not been given enough of the active substance in your blood , your doctor will check
do not use afstyla - if you have had an allergic reaction to afster proteins 46 warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if you are allergic to hamster proteins . the recommended dose is 46 mg / kg of body weight . your doctor will check the batch number and the contents of your treatment diary to make sure that you are fully protected from the active substance . warnings , precautions and precautions tell your doctor or pharmacist if you : have ever had allergic ( hypersensitivity ) reactions to afstila . symptoms of allergic reactions are listed below . allergic reactions
your treatment will be supervised by a doctor experienced in the treatment of blood clotting disorders . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of afstyla is one tablet per day . your doctor will work out the right dose for you . duration of treatment depending on the severity of your disease the site of administration and the bleeding your clinical condition will be checked by your doctor . reconstitution and administration general instructions the powder and the solvent ( liquid ) should be used immediately . if you have aseptic conditions , your doctor
like all medicines , afstyla can cause side effects , although not everybody gets them . symptoms of allergic reactions allergic reactions may include hives , generalised urticaria ( itchy rash ), tightness of the chest , difficulty in breathing , wheezing , low blood pressure , dizziness , anaphylaxis ( bleeding caused by factor viii medicines ) inhibitor antibodies ( see section 2 " warnings and precautions "). common side effects ( may affect up to 1 in 10 people ) previous treatment with factor v iii ( less than 150 days of treatment ) was not successful and may result in up to 100 days of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the afstyla powder in the outer carton in order to protect from light . after reconstitution , the reconstituted product should be used immediately .
what afstyla contains - the active substance is lonoctocog alfa . each vial contains 250 micrograms of 2 . 5 ml of solution for injection . - the other ingredients are : - injections the solution contains 100 microlitres of lonctococog alpha . - reconstitution the 2. 5 ml solution contains 200 microlitre of lonoectocog α . - injections one vial of solution contains 1000 microliters . - solvent the solution is clear , colourless and has no visible particles . - solution for infusion : - after reconstation the 2 .
what praxbind is and what it is used for the active substance is idarucizumab , which is a recombal agent . it belongs to a group of medicines called dabigatran ( pradaxa ). it is a blood thinner medicine used to prevent blood clot formation in adults . what is it used for ? what is the name of this medicine ? it is given to you by your doctor or nurse as a rapid trap dabgatran in your blood . how it works what is used to treat your condition ? it works by blocking the action of one of the active substances in your body called
do not take praxbind : if you are allergic to idarucizumab or any of the other ingredients of this medicine ( listed in section 6 . if you have a genetic disease known as hereditary fructose intolerance ( haf ) or to the substance sorbitol . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . serious adverse reactions have been reported with this medicine in patients taking dabigatran and other medicines to prevent blood clots from forming ( see section 4 ). if you do not take this medicine , you should contact your doctor immediately . if any of these apply to
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one 5 mg tablet ( 2 . 5 mg ) of dabigatran per day . this medicine is for oral use . swallow the tablet whole with a glass of water . you can take this medicine with or without food . if you take more praxbind than you should if you accidentally take too many tablets , talk to a doctor or go to a hospital straight away . do not take more than the prescribed dose . you should contact your doctor if you
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with praxbind : reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what praxbind contains - the active substance is idarucizumab . - the other ingredients are sodium acetate trihydrate , acetic acid , sorbitol ( e420 ), polysorbate 20 and water for injections . what Praxbind looks like and contents of the pack the clear , colourless to slightly opalescent , slightly yellow solution is supplied in a butyl rubber stopper with an aluminium cap .
temomedac contains a medicine called temozolomide . this medicine is an antitumour agent . temomedac is used to treat brain tumours in adult patients with newly - diagnosed glioblastoma multiforme ( gli ) in adults , adolescents and children aged 3 years and older . it is used for the treatment of malignant glioma , gliOBlastoma multififorme and anaplastic astrocytoma in adults who are unable to receive standard treatment .
do not take temomedac : if you are allergic to temozolomide or any of the other ingredients of this medicine ( listed in section 6 ). if you have had an allergic reaction to dacarbazine ( an anticancer medicine ) or dtic . if you experience signs of allergic reaction such as feeling itchy , breathlessness , wheezing or swelling of the face , lips , tongue or throat . if blood cells are severely reduced ( myelosuppression ). if your white blood cell count ( platelet count ) is too low . these blood cells help you in fighting infection by preventing proper blood
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage and duration of treatment the recommended dose of temomedac is based on your height and weight . if you have a recurrent tumour that has not responded to chemotherapy treatment in the past . your doctor may give you other medicines ( anti - emetics ) to reduce the risk of nausea and vomiting . in patients with newly - diagnosed glioblastoma multiforme , your doctor will decide how long you should continue treatment . treatment will be started in combination with treatment with radiotherapy ( concom
like all medicines , this medicine can cause side effects , although not everybody gets them . if you experience a severe allergic ( hypersensitive ) reaction , such as hives , wheezing or other breathing difficulty , uncontrolled bleeding , seizures , convulsions , fever , chills , severe headache , temomedac treatment may result in a reduction in certain kinds of blood cells , increased bruising and bleeding ( anaemia ), reduction in the number of red blood cells and fever , reduced resistance to infections . the reduction in blood cell counts may lead to anaemia ( aplastic anaemia ) in your blood . specific treatment may be
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . once opened , temomedac is stable for up to 30 days at room temperature without any change in the appearance of the capsules .
what temomedac contains - the active substance is temozolomide . each capsule of temomedic 5 mg contains 5 mg of temozolsomide ( as temogac 20 mg ). each capsule contains 20 mg or more temozotomide in each capsule . - temomediac 100 mg : each capsule delivers 100 mg temozosomide to your child . - the other ingredients are : tablet core : temomedax 140 mg : one capsule contains 140 mg temosolomid ( as mesogolomides ). tablet coating : temmedax 180 mg : two capsules contain 180 mg
cialis is a treatment for adult men with erectile dysfunction who cannot get or keep an erect penis suitable for sexual activity . cialis works by stimulating the blood vessels in the penis to relax . this makes a hard erect penis easier to get and keeps it open for sex . the active substance tadalafil belongs to a group of medicines known as phosphodiesterase type 5 inhibitors . it works by blocking the action of these substances . what it is used for and how it works it is important that you have a hard erection while you are being treated with a medicine to treat adult men at risk of erectile
do not take cialis if you are allergic to tadalafil or any of the other ingredients of this medicine ( listed in section 6 ). if you have a problem with organic nitrate or nitric oxide donors ( such as amyl nitrite ) or medicines (" nitrates ") used to treat angina pectoris (" chest pain "). warnings and precautions talk to your doctor or pharmacist before you are given any of these medicines . taking nitrate may increase the risk of serious heart disease . tell your doctor if you recently had a heart attack in the last 90 days . if you think you may have
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . cialis tablets are for oral use . swallow the tablets whole with a glass of water . the tablets can be taken with or without food . the recommended starting dose is 5 mg twice a day . your doctor may increase the dose to 2 . 5 mg once a day depending on how you respond to the medicine . if you take more cialises than you should if you accidentally take too many tablets , talk to a doctor or go to the nearest hospital straight away . how long to take cial
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with the medicine : allergic reactions ( rashes , frequency not known ) chest pain common ( may affect up to 1 in 10 people ) nitrates ( frequency cannot be estimated from the available data ) priapsim may cause a prolonged and possibly painful erection . stop taking cialis and see your doctor straight away if you notice any of the following : very common : may affect more than 1 in 100 people headache back pain muscle aches pain in arms and legs facial flushing nasal congestion indigestion
what cialis contains - the active substance is tadalafil . each tablet contains 2 . 5 mg of the other ingredient ( s ). - the other ingredients ( excipients ) are lactose monohydrate ( see end of section 2 ), croscarmellose sodium , hydroxypropylcellulose , microcrystalline cellulose , sodium laurilsulfate , magnesium stearate . - film - coating : the following ingredients are present in the tablet core ( s ) and the tablet coating ( s ): hypromellose , triacetin , titanium dioxide ( e171 ), iron oxide
enyglid is an oral antidiabetic medicine that contains the active substance repaglinide . it works by helping your pancreas produce more insulin to control your blood sugar ( glucose ). type 2 diabetes is a disease in which the body does not make enough insulin when the sugar builds up in the body . the insulin that your body produces does not work as well as it should . enyglide helps control the level of sugar in your blood and helps your body make better use of the insulin it produces . your doctor will tell you how long you should continue to take it . if you take more eny
do not take enyglid : if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). if you have type 1 diabetes . if the acid level in your blood is too high . if you suffer from diabetic ketoacidosis ( a severe liver disease ). warnings and precautions gemfibrozil is a medicine used to lower increased fat levels in the blood . it is used to treat liver problems in adult patients with moderate liver 28 disease . see section 2 . if any of these apply to you , tell your doctor or pharmacist before taking eny
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 0 . 5 mg tablet once a day . swallow the tablet whole with a glass of water . you can take enyglid with or without food . take the tablet at about the same time each day . the usual starting dose is 30 mg twice a day for the first 4 days . your doctor may increase your dose to 30 mg once daily for a maximum of 16 days . if your blood sugar is too low , you may experience a hypo . do not take a
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia is the most common side effect of enyglid . it is very common ( may affect more than 1 in 10 people ) in patients taking it . in general , the following symptoms are generally mild / moderate . however , in some cases , hypoglycasemic unconsciousness ( coma ) may occur . allergy allergy is rare ( might affect up to 1 in every 10 , 000 people ). symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy or sweating ( anaphylactic reaction ). other side effects
what enyglid contains - the active substance is repaglinide . each vial contains 0 . 5 mg , 1 mg or 2 mg repagginide . - the other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate , anhydrous , croscarmellose sodium , povidone k25 , glycerol , magnesium stearate , meglumine , poloxamer , yellow iron oxide ( e172 ) ( see section 1 ). tablet coating : red iron oxide (< e172 ). see section 2 under " contents of the pack " eny
azacitidine mylan is an anti - cancer agent . the active substance in this medicine is azapitidine . what is azacitine mylan used for ? the active ingredient of azacitas mylan belongs to a group of medicines called stem cell transplantation . it is used to treat : higher - risk myelodysplastic syndromes ( mds ), chronic myelomonocytic leukaemia ( cmml ), acute myeloid leukemia ( aml ), diseases that affect the bone marrow and which affect normal blood cell production . what the effect is on the production of az
do not take azacitidine mylan : - if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . if you have advanced liver cancer , your doctor may need to monitor you more closely . warnings , precautions and precautions the use of azacilitidine melan in patients with decreased counts of platelets ( a type of red or white blood cells ) is not recommended . kidney disease and liver disease tell your doctor if you suffer from a heart condition known as heart attack or lung
azacitidine mylan will be given to you by a doctor or nurse as another medicine to treat nausea and vomiting . the recommended dose is 75 mg once a day . your doctor will tell you how many tablets of this medicine you need to take . the dose will depend on your height and weight . the usual duration of treatment with azacitine mylan is 3 weeks , followed by this " treatment cycle " for 4 to 6 weeks . this medicine is given under the skin ( subcutaneously ) on the skin of the thigh , tummy or upper arm . if you have any further questions on the use of
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following side effects : drowsiness , shaking , jaundice , abdominal bloating , easy bruising . these may be symptoms of liver failure . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness and fatigue . these are symptoms of kidney failure . a fever may be a sign of an infection . low levels of white blood cells may cause chest pain , shortness
keep this medicine out of the sight and reach of children . do not use azacitidine mylan after the expiry date which is stated on the vial label and the carton after exp . this medicinal product does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . the suspension must be used within 1 hour after preparation . the contents of the zacitine mylan suspension are clear to opalescent and colourless to pale yellow . water for injections the suspension should be stored for 8 hours at room temperature ( up to 8 ). if not used immediately , in
what azacitidine mylan contains - the active substance is azapitidine . one vial of powder contains 100 mg of azacinidine . after reconstitution , each vial contains 4 ml of water for injections . - the reconstituted suspension contains 25 mg / ml of azaitidine ( as mannitol ). - the other ingredients are : powder for concentrate for solution for injection ( see section 4 ). solvent for solvent for injection : water , water , and injections . the dissolved suspension contains a minimum of 25 mg ( 23 . 5 %) of the total active substance in azac
duotrav eye drop solution contains two active substances , travoprost and timolol . travaprost is a prostaglandin analogue . it works by blocking the flow of fluid from the eye to the eye through the dropper ( a beta blocker ). this reduces the amount of fluid within the eye and reduces pressure within theeye . duotraveye drops are used to treat high pressure in the eye in adults with an illness called glaucoma .
do not take duotrav if you are allergic to travoprost , prostaglandins , timolol , beta blockers or any of the other ingredients of this medicine ( listed in section 6 ). if you have respiratory problems such as asthma , severe chronic obstructive bronchitis , severe lung disease , wheeziness , difficulty in breathing , long - standing cough , breathing problems , severe hay fever , a slow heartbeat , heart failure ( a disorder of heart rhythm , irregular heartbeat ), or if your eye becomes cloudy . warnings and precautions talk to your doctor or pharmacist before taking duotrev if : you have
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one drop in each eye each day . do not open or close your eyes until your doctor tells you to . duotrav is for single use only . use in children and adolescents do not try to open your eyes without talking to your doctor first . if you have any further questions on the use of this medicine , ask your doctor . how much to use the recommended daily dose of eye drops is 1 , 2 , 3 or 4 drops . use a bottle
like all medicines , this medicine can cause side effects , although not everybody gets them . when the drops are mixed with duotrav , very common side effects ( may affect more than 1 in 10 people ) are : the eye eye redness . these side effects are usually mild to moderate and generally go away within a few days . common side side effects these may affect up to 1 out of 10 people are : inflammation of the eye surface inflammation , surface damage , eye pain , blurred vision , abnormal vision , dry eye , itchy eye , eye discomfort , signs and symptoms such as eye irritation , burning or stinging . uncommon
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . the date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the blister in the outer carton in order to protect from light . once opened , duotrav can be used within 4 hours to prevent infections .
what duotrav contains - the active substances are travoprost and timolol . each vial contains 40 mg of tricoloprost ( 5 mg / ml ). - the other ingredients in the vial are timolole maleate , polyquaternium - 1 , mannitol , propylene glycol , polyoxyethylene hydrogenated castor oil 40 mg . - the ingredients are : boric acid , sodium chloride , sodium hydroxide , hydrochloric acid , purified water ( e420 ) and sodiumhydroxide ( e470b ). - solvent for acidity levels ( ph
what nplate is nplate ' s active ingredient is romiplostim . it is a protein that helps to control low platelet counts in the immune ( idiopathic ) thrombocytopenic purpura ( itp ). itp is a disease that affects your body ' s immune system ( platelets ). platelets are important in helping your blood to form blood clots . very lowplatelet counts can lead to bruising and serious bleeding ( see section 1 " nplate contains lactose "). what nplate looks like and contents of the pack nplate belongs to a group of medicines called "
do not take nplate if you are allergic to romiplostim or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to other medicines containing escherichia coli ( e . coli ). warnings and precautions talk to your doctor , pharmacist or nurse before taking nplate . if you have a low blood platelet count ( thrombocytopenia ). nplate may increase yourplatelet count , which may increase the risk of blood clots forming . if any of these apply to you ( or you are not sure ), tell your doctor . blood cl
always use nplate exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one injection under the skin ( subcutaneous ) every 1 month . do not inject more than 1 ml of nplate . your doctor will check your platelet counts regularly and will give you regular blood samples to check the number of your platelets in your blood . if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse . how much nplate to use your doctor may decide to increase your dose . how often to inject nplate
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with itp : very common ( may affect more than 1 in 10 people ): headache allergic reaction upper respiratory tract infection common : may affect up to 1 in every 10 people : bone marrow disorder , increased bone marrow fibres , trouble sleeping ( insomnia ), dizziness , tingling or numbness of the hands or feet ( paraesthesia ) migraine , redness or the skin ( flushing ), blood clot in a lung artery ( pulmonary embolism ), nausea , diarrhoea , abdominal pain , ind
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep this medicine in the outer carton in order to protect from light . once removed from the refrigerator , it should be used within 30 days .
what nplate contains - the active substance is romiplostim . each vial of nplate 125 mg solution for injection contains 230 mg ( 1 , 000 iu ) of romplostim ( as 125 mg ). each ml of solution contains 125 mg ( 2 , 500 iu ). - the other ingredients are : nplate 250 mg : one vial contains 375 mg ( 3 , 600 iu) of romclostim and 250 mg ( 4 , 600i ) of the other ingredient . - nplate 500 mg : two vials contain 375 mg of romlostim , as 250 mg of the
this medicine contains an active substance called glycopyrronium bromide which belongs to a group of medicines called bronchodilators . what tovanor breezhaler is used for this medicine is used to relieve breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). copd is a condition in which the muscles around the airways tighten , making breathing difficult . this medicine works by tightening these muscles , making it easier for air to get in and out of the lungs . this helps to reduce the amount of air that leaves the lungs and makes breathing easier . when this medicine
do not take tovanor breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you : - have kidney problems - have an eye problem called narrow - angle glaucoma - have difficulty passing urine . your doctor may decide to delay or stop treatment if any of these apply to you . if you have any further questions on the use of the product , ask your doctor or pharmacist . before you start to receive tovan
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much tovanor breezhaler to use the recommended dose of this medicine is one capsule once a day . this medicine may be used for up to 24 hours at room temperature ( up to 75 ). if you use more than one capsule a day , your doctor will tell you how many capsules to use . if you forget to use to take this medicine if you have forgotten to use an inhaler and capsules ( in blisters ), use the medicine as soon as you
what tovanor breezhaler contains - the active substance is glycopyrronium bromide . each hard capsule contains 63 micrograms ( 23 . 5 mg ) glycoprroniumbromide , equivalent to 50 microg / ml ( 3 . 6 mg ). - the other ingredients are : - the content of the inhalation powder is lactose monohydrate and magnesium stearate . - the contents of the blister are white to off - white , capsule - shaped , hard capsules with a white powder and a device called an inhaler . capsules are supplied in blisters . each blister strip
adasuve contains the active substance loxapine , which belongs to a group of medicines called antipsychotics . it works by stimulating the brain to produce more dopamine and serotonin , which are involved in calming effects and relieving aggressive behaviour . adasuve is used to treat acute symptoms of mild - to - moderate agitation in patients with schizophrenia or bipolar disorder . these are diseases characterised by symptoms such as : ( schizophrenia ) hearing , mistaken beliefs , incoherent speech and behaviour , emotional flatness , feeling depressed , guilty , anxious , tense , bipolar disorder , feeling " high ", excessive amounts of energy , needing much less
do not take adasuve : - if you are allergic to loxapine or amxapine . symptoms of wheezing or shortness of breath may include lung problems like asthma , chronic obstructive pulmonary disease ( copd ), narrowing of the airways ( bronchospasm ), wheeze , cough , chest tightness and shortnessof breath . see section 25 " warnings and precautions " for more information . neuroleptic malignant syndrome ( nms ). symptoms of antipsychotic medicines may include high fever , rigid muscles 47 , irregular or fast heart rate . nms can lead to death .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 9 . 1 mg once a day ( 2 to 4 . 5 mg twice a day ). if your condition is not being controlled by your doctor , your doctor may prescribe a lower dose . always take adasuve by mouth . always use the device exactly as described in this leaflet . if you have any of the following symptoms : extreme tiredness , sleepiness , trouble breathing , low blood pressure , throat irritation , a bad taste in the mouth , muscle or eye movements . if
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any breathing symptoms such as wheezing , cough , shortness of breath or chest tightness , which may be irritating . these may be signs of problems with your airways ( asthma or copd ). if you experience light - headedness or fainting , your blood pressure may be increased . worsening agitation , confusion , fever and muscle stiffness may be a sign of a severe condition called neuroleptic malignant syndrome . the following side effects have been reported : very common ( may affect more than
keep this medicine out of the sight and reach of children . do not use adasuve after the expiry date which is stated on the carton and the blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the blister in the outer carton in order to protect from light . keep it in the original carton to avoid physical damage .
what adasuve contains - the active substance is loxapine . each single - dose inhaler delivers 5 mg of loxepine ( as delivers 4 . 5 mg / m2 of body weight ). - the other ingredients are : tablet core : lactose , water for injections ( see section 2 ). - solvent : solvent : clear , colourless to pale yellow solution for injection . - the solution is a clear to slightly opalescent solution . each inhaler comes in a sealed foil pouch . - adasve is available in packs containing 4 , 5 or 5 inhalers . not all pack sizes may be
azacitidine betapharm contains the active substance azapitidine . it is an anti - cancer agent . it belongs to a group of medicines called cytokines . what azacitid betaparm is used for azacitonidine betabarm is a stem cell transplantation for patients with higher - risk myelodysplastic syndromes ( mds ). it is used to treat chronic myelomonocytic leukaemia ( cmml ), acute myeloid leukemia ( aml ), and diseases that affect the bone marrow that affect normal blood cell production . what the use of az
do not take azacitidine betapharm : - if you are allergic to azapitidine or any of the other ingredients of this medicine ( listed in section 6 ). if you have advanced liver cancer . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . if you suffer from decreased counts of platelets ( a type of red or white blood cells ) in your blood . tell your doctor or pharmacist if you know that you have kidney disease . if any of these apply to you ( or you are not sure ), your doctor may ask you to have blood tests before you
azacitidine betapharm is used in combination with another medicine to treat nausea and vomiting . the recommended dose is 75 mg once a day . your doctor will tell you how many tablets of this medicine you need to take . the dose will depend on your height and weight . the usual starting dose of azaccitidinebetapharm will be given every 3 weeks during this " treatment cycle " ( cycle 4 to 6 ). this medicine is given by injection under the skin ( subcutaneously ) on the skin of the upper thigh , tummy or upper arm . if you have any further questions on the use of this
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following side effects : drowsiness , shaking , jaundice , abdominal bloating , easy bruising . these may be symptoms of liver failure . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness and fatigue . these are symptoms of kidney failure . a fever may be a sign of an infection . low levels of white blood cells may cause chest pain , shortness
keep this medicine out of the sight and reach of children . do not use azacitidine betapharm after the expiry date which is stated on the vial label and the carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep this medicine in the outer carton in order to protect from light . the suspension must be used within 45 minutes of preparation . after preparation with water for injections , the suspension may be stored at room temperature ( up to 8 ) for 8 hours . the azacsitidinebetapharm suspension should be used immediately . if not used immediately , in
what azacitidine betapharm contains - the active substance is azapitidine . each vial contains 100 mg of azaitidine ( as monohydrate ). after reconstitution , each ml contains 4 mg of water for injections . - the reconstituted suspension contains 25 mg / ml of azaxitidine in the form of mannitol ( e421 ). - the other ingredients are water for injection ( see section 2 ). what the solvent looks like and contents of the pack azacitonidinebetapharm is a white to off - white powder supplied in a glass vial containing 100 mg
cedelga contains the active substance eliglustat . it is used for the long term treatment of gaucher disease type 1 in adults . gaucher diseases type 1 is inherited condition in which a substance called glucosylceramide is removed from the body by the spleen , liver or bones . when the medicine is used , it helps to protect your affected organs . if you have any further questions on the use of this medicine , ask your doctor or pharmacist .
do not take cerdelga if you are allergic to eliglustat or any of the other ingredients of this medicine ( listed in section 6 ). if you take medicines called moderate cyp2d6 inhibitors ( e . g . quinidine , terbinafine ) 31 if you do not take moderatecyp3a inhibitors such as erythromycin or itraconazole . if any of these medicines affect your body ' s ability to function properly , tell your doctor or pharmacist . warnings and precautions talk to your doctor , pharmacist or nurse before you are given Cerdelga . cerdel
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one tablet a day . your doctor will tell you how many tablets of metaboliser to take . if you take more cerdelga than you should if you accidentally take too many tablets , contact your doctor . swallow the tablets whole with a glass of water . if possible , take the tablets with a sufficient amount of food . do not take more than the recommended daily dose of 84 tablets . if the tablets are too strong or too weak , talk to your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): headache , dizziness , change in taste ( dysgeusia ), palpitations , throat irritation , heartburn ( dyspepsia ), feeling sick ( nausea ), diarrhoea constipation , abdominal pain , stomach ache ( upper abdominal pain ) acid reflux disease ( gastrooesophageal reflux diseases ) bloating ( abdominal distension ) inflammation of the stomach ( gastritis ) 34 difficulty swallowing ( dysphagia ) vomiting , dry mouth gas ( flat
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the sleeve after exp . this medicinal product does not require any special temperature storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep the container in the outer carton in order to protect from light .
what cerdelga contains - the active substance is eliglustat . each capsule contains 84 mg of eliglustit . - the other ingredients are : capsule content : microcrystalline cellulose , lactose monohydrate ( see section 2 under ' cerDelga contains lactose '), hypromellose , glycerol dibehenate , gelatin , potassium aluminium silicate , titanium dioxide ( e171 ), yellow iron oxide ( e172 ), indigotine , shellac , black iron oxide , propylene glycol and ammonia solution . what Cerdelga looks like and contents of the pack cerdelga
the active substance in zoledronic acid hospira is zoledic acid , which belongs to a group of substances called bisphosphonates , which are involved in the development of cancer . they work by slowing down the rate of bone change . this reduces the risk of bone complications , e . g . fractures , in patients with bone metastases ( a type of cancer that affects the primary site of bone that makes calcium in the blood ). this is known as tumour - induced hypercalcaemia ( tih ).
your doctor will carry out blood tests before and during treatment with zoledronic acid hospira . your doctor will check whether you are suitable for treatment . if you are not sure , talk to your doctor , pharmacist or nurse before you start treatment . warnings and precautions talk to a doctor , nurse or pharmacist before you begin treatment if you : are allergic ( hypersensitive ) to any of the active substances ( listed in section 6 ). your doctor may decide to change your dose or stop you from taking zolingronic acid if you have a kidney problem . pain , swelling or numbness of the jaw , or heaviness in
the recommended dose of zoledronic acid hospira is bisphosphonates intravenously ( into a vein ) followed by ' iv ' administration . the recommended dose is one tablet per day . if you are dehydrated , your doctor may decide to increase your dose or stop you from taking it altogether . the usual recommended dose for patients with a kidney problem is two tablets per day , with or without food . if your kidney problem does not go away , your dose may be increased . your doctor will discuss with you the best way to reduce the risk of bone complications ( e . g ., bone metastases ). the recommended
like all medicines , zoledronic acid hospira can cause side effects , although not everybody gets them . the most common side effects are : common ( may affect up to 1 in 10 people ): severe kidney impairment . your doctor will do blood tests to check for low level of calcium in the blood . very rare ( may affects more than 1 in 100 people ): pain in the mouth , teeth and / or jaw , swelling or non - healing sores inside the mouth . jaw discharge , numbness or feeling of heaviness or loosening of a tooth . these may be signs of bone damage in the jaw ( osteonec
keep this medicine out of the sight and reach of children . do not use zoledronic acid hospira after the expiry date which is stated on the carton and the blister after exp . this medicine does not require any special storage conditions .
what zoledronic acid hospira contains - the active substance is zedronic acid . one vial of zolingronic acid contains 4 mg zoledron acid . - the other ingredients are : monohydrate , mannitol , sodium citrate and water for injections . what zoledic acid hospisira looks like and contents of the pack zoledidronic acidic hospira is a liquid concentrate for solution for infusion . it is a clear to slightly opalescent , colourless to pale yellow concentrate . each pack contains one or two vials of concentrate .
varuby contains rolapitant . it is used to treat cancer feeling sick ( nauseous ) or being sick ( vomiting ) at the start of cancer treatment chemotherapy . these nerve cells are involved in the normal functioning of the brain . they help to control nausea and vomiting . if you feel sick ( vomit ) when you are being sick , you should contact your doctor straightaway . varuby works by blocking the action of these nerve cell cells , which can cause nausea or vomiting .
do not take varuby if you are allergic to rolapitant or any of the other ingredients of this medicine ( listed in section 6 ). if you take an herbal medicine containing st john ' s wort ( hypericum performatum ) which is used to treat depression and difficulty sleeping ( see section 2 " warnings and precautions "). if this applies to you , tell your doctor or pharmacist before taking this medicine . 27 if you have severe liver or kidney problems . you should not take certain medicines ( e . g . rifampicin ) that are used for tuberculosis or other infections such as carbamazep
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 180 mg once a day for up to 90 days . swallow the tablet whole with a glass of water . take the tablet at least 2 hours before your chemotherapy cycle . if you take more varuby than you should if you have taken too many tablets , talk to a doctor or go to the nearest hospital straight away . your doctor will tell you how many tablets to take and how often to take them . the duration of chemotherapy depends on how long you have been taking it . if
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with varuby : very common ( may affect more than 1 in 1 , 000 people ): symptoms of an allergic reaction may include : sudden shortness of breath , swelling of the lips or tongue , change in taste or swelling of skin or tissue , sudden rash , fever and faster heartbeats . contact your doctor immediately if you experience any of these effects . appropriate treatment is available . other possible side effects : common : may affect up to 1 in 10 people : headache constipation feeling tired uncommon : might affect
what varuby contains - the active substance is rolapitant . each vial contains 90 mg rolapitant . - the other ingredients are : tablet core : lactose monohydrate ( see section 2 under ' varubsy contains lactose '), pregelatinised starch , microcrystalline cellulose , povidone ( k - 30 ), croscarmellose sodium , colloidal silicon dioxide , magnesium stearate . film - coating : polyvinyl alcohol , titanium dioxide ( e171 ), macrogol , polysorbate 80 . the colour of the vial is blue .
what enerzair breezhaler is the active substance is indacaterol . it belongs to a group of medicines called bronchodilators . it works by tightening the muscles in the lungs . this helps to open the airways and allows air to get in and out of the lungs more easily . mometasone furoate is a substance present in a substance called corticosteroids , which are used to reduce the swelling and irritation ( inflammation ) in the small airways in which the lungs are closed . this results in breathing problems and makes it easier for the air to come in . cortic
do not use enerzair breezhaler : if you are allergic to indacaterol , glycopyrronium , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if you : - have heart problems - have an irregular or fast heartbeat - have thyroid gland problems or diabetes - have high blood sugar - have seizures - have severe kidney problems , have severe liver problems or low level of potassium in your
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of the medicine is one inhaler per day . always use enerzair breezhaler at the same time each day . your doctor will tell you how many capsules to use to control your asthma and how long you should continue to use it . if your symptoms do not respond to the medicine , talk to your doctor . how to use the active substance in the inhaler and capsules the medicine should be inhaled by a doctor or nurse . do not inhale the medicine through the
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious . stop using enerzair breezhaler and see a doctor straight away if you notice any of the following : very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching and hives . these may be signs of allergic reaction ( see section 2 ). other possible side effects other side effects include the following side effects : common : may affect up to 1in 10 people : sore throat , runny nose , sudden
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special temperature storage conditions . the capsules should be kept in the outer carton in order to protect from light .
what enerzair breezhaler contains the active substances are indacaterol ( as acetate ), glycopyrronium ( as bromide ), mometasone furoate . each capsule contains 150 micrograms ( 23 . 5 mg ) of the active substance . the other ingredients are : - capsule content : 63 microgram ( 3 . 8 mg ) glycoprronium bromides : 50 microgram glycopromronium : 160 microgram mometsone unfuroate in the mouthpiece of the inhaler . - capsule shell : 114 microgram( 3 . 9
clopidogrel acino pharma gmbh contains the active ingredient clopidiogrel . it belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures that clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( thrombosis ). clopidigrel acina pharma is used to reduce the number of bloodclots ( also known as thrombi ) forming in hardened blood vessels ( arteries ), which can lead to atherothrombotic events ( such as
do not take clopidogrel acino pharma gmbh : - if you are allergic ( hypersensitive ) to any of the other ingredients of clopidiogrel ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are taken : if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , tell your doctor or pharmacist before you have taken or might take any other medicines . if your doctor thinks that you may be taking
always take clopidogrel acino pharma gmbh exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 75 mg tablet once a day . your doctor will tell you how many tablets to take . you should swallow the tablet whole with a glass of water . do not crush or chew the tablet . if you take more tablets than you should if you accidentally take too many tablets , talk to a doctor or go to the nearest hospital emergency department immediately . to reduce the risk of bleeding , take the tablet at the same time each day .
like all medicines , clopidogrel acino pharma gmbh can cause side effects , although not everybody gets them . the most common side effects are : very common ( may affect more than 1 in 10 people ): very common : may affect up to 1 in 100 people : very rare : may affects up to one in 1 , 000 people : common : might affect less than 1 out of 10 people : rare decrease of some blood cells : liver problems : yellowing of the skin or the whites of the eyes ( jaundice ), bleeding under the skin ( red pinpoint dots ), confusion ( see section 2 "
keep out of the sight and reach of children . do not use clopidogrel acino pharma gmbh after the expiry date which is stated on the carton and on the blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the tablet in the outer carton in order to protect from light . do this to prevent damage of blister or film - coated tablets . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what clopidogrel acino pharma gmbh contains - the active substance is clopidiogrel . each tablet contains 75 mg of clopidoogrel ( as monohydrate ). - the other ingredients are : tablet core : macrogol 6000 cellulose , microcrystalline ( e460 ), crospovidone ( a castor oil ), hydrogenated film - coating : macrool 6000 ethylcellulose ( e462 ) titanium dioxide ( e 171 ) what clopidineogrel akino pharmha gmb h looks like and contents of the pack clopridog
delstrigo is used to treat hiv (' human immunodeficiency virus ') infection in adults . it belongs to a group of medicines called ' antiretroviral medicines '. the active substance is doravirine , a non - nucleoside reverse transcriptase inhibitor ( nnrti ). the other ingredient is lamivudine , which is aucleoside analogue reverse transcriptases inhibitor ( trti ) and tenofovir disoproxil , which are both active substances in the treatment of hiv . delstrigo works by blocking the virus and aids (' acquired immune deficiency
do not take delstrigo : - if you are allergic to doravirine , lamivudine , tenofovir disoproxil or any of the other ingredients of this medicine ( listed in section 6 . warnings and precautions talk to your doctor or pharmacist before taking the following medicines : carbamazepine , oxcarbazepine and phenobarbital , phenytoin ( medicines used to prevent seizure ) rifampicin and rifapentine ( medicines to treat tuberculosis ) st . john ' s wort ( hypericum perforatum ), a herbal remedy used
always take delstrigo exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is a complete regimen of a single tablet to treat hiv infection in adults , adolescents and children aged 1 year and above . your doctor may prescribe certain medicines ( e . g . doravirine ). medicines like this medicine swallow the tablet whole with a glass of water . do not chew or crush the tablet . take this medicine with or without food . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse . how long
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking this medicine and tell your doctor straight away if you notice any of the following : very common ( may affect more than 1 in 10 people ): abnormal dreams difficulty in sleeping ( insomnia ) headache dizziness sleepiness cough nasal symptoms feeling sick ( nausea ) diarrhoea stomach pain vomiting wind ( flatulence ) hair loss rash muscle symptoms pain ( stiffness ) feeling tired fever blood tests showing increased levels in liver enzymes uncommon ( might affect up to 1 in 100 people ): nightmares , depression , anxiety , irritability , confusion , suicidal thoughts 45 trouble
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the medicine in the bottle tightly closed in order to protect from light . once the bottle has been opened , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what delstrigo contains the active substance is doravirine . each tablet contains 300 mg lamivudine ( equivalent to 245 mg ). the other ingredients are tenofovir disoproxil ( as fumarate ), croscarmellose sodium e468 , hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose e460 , silica , colloidal anhydrous , sodium stearyl firarate . the film - coating material is carnauba wax e903 . the printing ink is hypromella , iron oxide yellow ( e172 ),
spravato contains the active substance esketamine . this belongs to a group of medicines known as anti - depressants . this medicine helps to control your depression and reduces the symptoms of depression such as feeling sad , anxious , worthless , sleeping difficulties , change in appetite , loss of interest in favourite activities and a feeling of being slowed down . spravato is used alone or in combination with another antidepressant ( see section 2 under " other antidepressant medicines ").
do not take spravato if you are allergic to esketamine , ketamine or any of the other ingredients of this medicine ( listed in section 6 ). if you have an aneurysm ( a weak spot in a blood vessel wall that bulges out due to bleeding in the brain ) or have recently had a heart attack ( within 6 weeks ). if any of these apply to you , tell your doctor straight away . warnings and precautions talk to your doctor or pharmacist before taking this medicine if : you have a heart problem ( such as poor blood flow to the blood vessels to the heart ), chest pain ( ang
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the spravato nasal spray should be used immediately after the nasal spray device has been removed . the recommended dose is 1 inhalation per day , followed by 2 inhalations per day . you should use 3 nasal spray devices at the same time each day . if you use more sprays than you should if you have used more than one spray device , contact your doctor straight away . if more than 4 sprays have been used , your doctor may decide to change the dose of spravatos . if
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with spravato : very common ( may affect more than 1 in 10 people ): feeling disconnected , feelings and things around you feeling dizzy , headache , change in sense of taste feeling sleepy , decreased feeling or sensitivity to light , spinning sensation ( vertigo ), vomiting nausea common ( might affect up to 1 in every 10 people ) feeling extremely happy , euphoria , feeling agitated , feeling anxious , eyes or ears , sense of touch are distorted or mimicked , irritable panic attacks , a change in perception 37
what spravato contains - the active substance is esketamine . each nasal spray device contains esketam hydrochloride . each spray contains 28 mgesketamine - the other ingredients are citric acid monohydrate disodium edetate sodium hydroxide ( for ph adjustment ) water and water for injections . see the end of this leaflet for further information . what sprevato looks like and contents of the pack spravatos is a nasal spray solution for injection . this medicine is a clear , colourless solution that is supplied as a single - use nasal spraydevice . each box contains one box of sp
zelboraf is an anticancer medicine that contains the active substance vemurafenib . it is used to treat melanoma that has spread to other parts of the body after surgery . melanoma is a type of cancer that arises from a change ( mutation ) in a gene that controls the growth and spread of melanoma cells . by attaching to proteins that are involved in the growth of your cancer .
do not take zelboraf - if you are allergic to vemurafenib or any of the other ingredients of this medicine ( listed in section 6 ). symptoms of allergic reactions include swelling of the face , lips or tongue , difficulty breathing , rash and fainting sensation . warnings and precautions talk to your doctor , pharmacist or nurse before you are given zelberaf . allergic reactions tell your doctor or pharmacist if you have allergic reactions to any of these substances . if you develop allergic reactions while you are being treated with this medicine , stop taking it and contact your doctor immediately . if allergic reactions occur while
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended starting dose is 4 mg once a day for up to 8 days . if you take more zelboraf than you should if you accidentally take too many tablets , talk to a doctor or go to the nearest hospital straight away ( see section 4 , possible side effects ). your doctor may adjust your dose depending on your response to your treatment . swallow the tablet whole with a glass of water . do not crush or chew the tablet . if any of the above apply to you , tell your doctor
like all medicines , zelboraf can cause side effects , although not everybody gets them . serious allergic reactions such as swelling of the face , lips or tongue , difficulty breathing rash fainting sensation have been reported in patients treated with zelfboraf during radiation treatment . if you notice any of the following symptoms : skin rash , blistering , peeling , discoloration of the skin shortness of breath , a cough , fever , chills ( pneumonitis ), difficulty or pain when swallowing , chest pain , heartburn , acid reflux ( esophagitis ), any changes in your skin . other side
keep this medicine out of the sight and reach of children . do not use zelboraf after the expiry date which is stated on the carton and the blister after exp . this medicinal product does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep the blister in the outer carton in order to protect from light . after first opening , the product should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would not normally be longer than 24 hours at 2 to 8 and should not be
what zelboraf contains the active substance is vemurafenib . each film - coated tablet contains 240 milligrams ( milligram ) of vemurabenib ( as a co - precipitate of vial ). the other ingredients are : tablet core : hypromellose acetate succinate , colloidal anhydrous silica , croscarmellose sodium , hydroxypropyl cellulose , magnesium stearate film - coating : iron oxide red ( e172 ), macrogol 3350 , polyvinyl alcohol , talc and titanium dioxide ( e171 ). what zel
duoplavin contains the active substance clopidogrel , which is acetylsalicylic acid ( arsa ). arsa belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood that clump together during blood clotting . by preventing this clumping , the blood vessels relax and become thinner . by blocking this action , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called atherothrombosis ). by blocking the action of arsa , the body can reduce the risk of bloodclots forming in hardened arteries ,
do not take duoplavin : if you are allergic to clopidogrel , acetylsalicylic acid ( arsa ), or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to other products containing non - steroidal anti - inflammatory products . if you have painful and / or inflammatory conditions of muscles or joints , such as a medical condition called asthma , nasal discharge , runny nose , polyps ( a type of growth in the nose ), or if you currently have a risk of bleeding such as : - a stomach ulcer or bleeding within the
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of duoplavin is one tablet once a day . take your medicine at the same time each day . do not take more than one tablet at a time . if you have a heart attack , take the tablet with you . contact your doctor , pharmacist or the nearest hospital emergency department immediately if you notice any signs of bleeding . if your doctor thinks that you may have taken too many tablets , talk to a doctor or go to a hospital straight away . the usual dose is one
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin or the whites of the eyes ( jaundice ). - bleeding that appears under the skin as red pinpoint dots and / or confusion ( see section 2 " warnings and precautions "). - swelling in the mouth . - skin disorders such as rashes , itching and blisters of theskin . these could be signs of an allergic
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicinal product does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . after dilution , the product should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would not normally be longer than 24 hours at room temperature ( up to 25 ).
what duoplavin contains - the active substance is clopidogrel . each 75 mg film - coated tablet contains 46 mg of the active substances ( listed in section 6 ). - the other ingredients are : - acetylsalicylic acid (asa ) 75 mg : each 75 milligram tablet contains : clopidsogrel ( hydrogen sulphate ) 75mg : each 100 mg film − coated tablets contain : acetylSalicylic acids , mannitol , macrogol 6000 , microcrystalline cellulose , low substituted hydroxypropylcellulose , maize starch , hydrogenated cast
simbrinza contains the active substance brinzolamide . brimonidine tartrate belongs to a group of medicines called carbonic anhydrase inhibitors , which work by blocking the action of a substance called brinzoamide . this substance is a substance produced in the body called alpha - 2 adrenergic receptor agonists . it works by reducing the amount of pressure within the eye . simbranza is used in the eyes of adults and adolescents aged 18 years and older to treat eye conditions such as glaucoma , ocular hypertension ( high pressure on the front of the eyes ).
do not take simbrinza if you are allergic to brinzolamide , brimonidine tartrate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to sulphonamides ( medicines used to treat diabetes or infections ) or to diuretics ( water tablets ) or a monoamine oxidase ( mao ) inhibitors ( medicines to treat depression or parkinson ' s disease ). if any of these apply to you , tell your doctor or pharmacist . warnings and precautions talk to your doctor , pharmacist or nurse before you are given any antidepressant medicines
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . simbrinza should only be used in the eyes . do not use it in your eyes unless instructed by your doctor . wash your hands thoroughly with soap and water ( see section 2 under ' simbitalza contains sodium '). remove the cap and snap collar from the bottle . gently squeeze the medicine through your fingers . hold the bottle tightly closed with a clean finger or a ' pocket ' between the eyelid and the back of the eye . gently press the bottle tip into the corner of the
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following side effects while taking this medicine : - a reaction to the medicine ( frequency not known ). signs of an allergic reaction may include severe skin reactions such as rash , redness , itching all over your body , eyes trouble breathing , chest pain or irregular heart beat . contact your doctor or pharmacist immediately . - extreme tiredness or dizziness . other side effects that may occur while taking simbrinza with other medicines such as brinzolamide or brimonidine : common side
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and bottle after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep the bottle in the outer carton in order to protect from light . after first opening , use within 4 hours to prevent infections . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at room temperature . if you use more simbrin
what simbrinza contains the active substances are brinzolamide and brimonidine tartrate . each ml of suspension contains 10 mg of brin zolamide ( corresponding to 2 micrograms ) and 5 milligrams ( 0 . 5 microgram ) of ( 5 . 3 microgram ). the other ingredients are benzalkonium chloride ( see end of section 2 " important information about the active substance "). the other ingredient in simbrinusza is benzalkonaium chloride . the other excipients are propylene glycol , carbomer 974p , boric acid , mann
filgrastim ratiopharm is a medicine that contains the active substance filgrastam . filgrasterim is a protein produced by your body called escherichia coli . it is a natural protein produced in the body called granulocyte - colony stimulating factor ( gffr ), which helps your body make new blood cells . more blood cells are made than white cells . white cells are important in helping your body fight infection . how much to take the amount that you take in each day of the day depends on how much you have taken . your doctor will tell you how many white blood cells you have
do not take filgrastim ratiopharm : - if you are allergic ( hypersensitive ) to any of the ingredients of filgraspim ratisopharm ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before you are given this medicine . if you have ever had a cough , fever or difficulty breathing , this may be a sign of a pulmonary disorder . the following side effects have been reported in patients with sickle cell disease 57 - left upper abdominal pain or pain in the upper left shoulder ( a symptom of a spleen disorder ). if you experience any of these side effects
always take filgrastim ratiopharm exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take your doctor will tell you exactly how many tablets to take . the recommended dose is one tablet once a day . your doctor may prescribe a lower dose depending on your condition . the usual starting dose of filgrasteim ratiopharm is two tablets per day . you will start taking the tablet at about the same time each day . the doctor may increase your dose to a maximum of one tablet per day , depending on how you respond to filgr
you must not be given filgrastim ratiopharm : if you have sickle cell disease 57 if you experience left upper abdominal pain or pain at the tip of your shoulder if you suffer from a spleen disorder ( see section 4 . possible side effects ). your doctor will do regular blood tests before and during treatment with this medicine . neutrophils ( a type of white blood cells ) are important in helping your blood to work properly during treatment . your doctor may need to adjust your dose or stop treatment if you are being treated with other medicines . tell your doctor or pharmacist if you take , have recently taken
keep out of the sight and reach of children . do not use filgrastim ratiopharm after the expiry date which is stated on the outer carton and on the label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the original package in order to protect from light and moisture . keep it in the refrigerator at room temperature ( up to 25 ) for a single period of up to 8 days . do this to protect the product from light . if you notice that the solution is cloudy or contains particles , tell your pharmacist . medicines should not be disposed
what filgrastim ratiopharm contains - the active substance is filgrasterim . one ml of solution for infusion contains 60 mg of filgrateim . filgrasteim ratisopharm 30 mg solution for injection contains 0 . 5 mg / ml . each 30 ml pre - filled syringe contains 30 mg filgraspim . each 50 ml vial contains 1 mg or 2 mg of solution . - the other ingredients are sodium hydroxide , glacial acetic acid , sorbitol , polysorbate 80 and water for injections . the ingredient risol ( see section 2 .
raluzole zentiva contains the active substance riluzole . it works by stimulating the nervous system to make better use of its own energy . what riluxole zENTiva is used for rilsuzolezentiva has been prescribed for the treatment of amyotrophic lateral sclerosis ( amy ), a form of motor neurone disease in which the nerve cells in the muscles contract , leading to weakness , muscle waste and paralysis . this results in the destruction of nerve cells . the most common cause of motor neuron disease is too much glutamate ( a chemical messenger ) in the brain and spinal cord . ril
do not take riluzole zentiva : if you are allergic to rilsuzole or any of the other ingredients of this medicine ( listed in section 6 ). if you suffer from any liver disease . if you have increased blood levels of some enzymes of the liver called transaminases . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you think you may have any liver problems . yellowing of your skin or the whites of your eyes ( jaundice ). itching , feeling sick or being sick . problems with your kidneys . fever . a low number of white blood cells .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . take the tablets by mouth once a day for at least 12 hours . if you take more riluzole zentiva than you should if you accidentally take too many tablets , contact your doctor , pharmacist or the nearest hospital emergency department . do not take a double dose to make up for a forgotten tablet . take your tablet at the same time each day . it is important that you take the tablet as soon as possible , even if it is within
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience fever ( increase in temperature ). during treatment with riluzole zentiva there may be a decrease in the number of white blood cells . your doctor will do a blood sample to check whether white blood cell counts are sufficient to prevent infections . if you have any of the following symptoms : yellowing of your skin or the whites of your eyes ( jaundice ), itching , feeling sick or being sick ( liver disease ( hepatitis ). your doctor may do regular blood tests while you are being treated with r
what riluzole zentiva contains - the active substance is rilanuzole . - the other ingredients are : tablet core : anhydrous dibasic calcium phosphate , micro crystalline cellulose ( e460i ) and ahydrous colloidal silica ( e470i ). tablet coating : magnesium stearate , croscarmellose sodium , hypromellose , macrogol 6000 , titanium dioxide ( e171 ). what rilizole zintiva looks like and contents of the pack the tablets are white to off - white , round and marked with " 50 " on one
emgality contains the active substance galcanezumab . it is a medicine that blocks the action of a protein called calcitonin gene , which is involved in migraine . this results in increased levels of cgrp in the blood . emgality is used to treat migraine in adults and adolescents aged 4 years and older . migraines are usually mild to moderate and usually go away within a few weeks . your doctor will monitor your condition and may adjust the dose or frequency of migraine headache if necessary to improve your quality of life . if you have any further questions on the use of this product , ask your
do not use emgality : if you are allergic to galcanezumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a serious cardiovascular disease . serious cardiovascular diseases can be life - threatening . warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if you : have ever had or might now have any of these conditions . if you think you may have had any of this , ask your doctor or nurse for advice . serious cardiac diseases can cause allergic reactions ecgality can cause serious allergic reactions . these reactions may occur up to 40 minutes after
always use emgality exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg once a day . your doctor will work out the right dose for you based on your body ( subcutaneous injection ). if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects allergic reactions to emgality include rash and itching . serious allergic reactions ( may affect up to 1 in 1 , 000 people ) include : difficulty breathing or swallowing , low blood pressure , dizziness or light - headedness , swelling of the neck , face , mouth , lips , tongue or throat , severe itching of the skin , a red rash and raised bumps . other side effects very common side effects these may affect more than 1 in 10 people : injection site pain injection site reactions including red skin , itching , bruising and swelling
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the blister in the outer carton in order to protect from light . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would not normally be longer than 8 hours at room temperature ( up to 7 ). if used within 30 days , do not throw away any medicines via wastewater or household waste . ask your pharmacist how
what emgality contains - the active substance is galcanezumab . each pre - filled pen contains 120 mg of galcanesumab in 1 ml of solution . - the other ingredients are l - histidine , l- histidine hydrochloride monohydrate , polysorbate 80 , sodium chloride and water for injections . what emgonality looks like and contents of the pack emgalis is a solution for injection in a clear glass syringe . the solution is clear and colourless to slightly yellow . the syringe is a single - dose pen . pack sizes of 1 , 2 or 3
defitelio is a medicine that contains the active substance defibrotide . it is used to treat a condition called hepatic veno - occlusive disease ( hep ) in which blood vessels in the liver become damaged , leading to blood clots . it can also be used in combination with medicines obtained prior to a stem cell transplantation . if you have any further questions on the use of this medicine , ask your doctor or pharmacist .
do not use defitelio if you are allergic to defibrotide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine : - if you have a history of blood clots ( tissue plasminogen activator warnings ). this medicine is used to prevent bleeding . if you experience heavy bleeding after a blood transfusion or surgery , or problems with blood circulation ( such as a constant blood pressure ). see section 1 for further information . other medicines that may affect blood clotting : - acetylsalicylic acid
the treatment with defitelio will be started by a doctor experienced in the treatment of stem cells transplantation . it will be given by infusion into one of your veins as an ' intravenous infusion ' ( drip ). the duration of this treatment is 21 days . if your symptoms do not improve within this time period , contact your doctor . if you have any further questions on the use of this medicine , ask your doctor or pharmacist .
like all medicines , defitelio can cause side effects , although not everybody gets them . if you get any of the side effects listed below , talk to your doctor or pharmacist immediately . very common ( may affect more than 1 in 10 people ): low blood pressure ( common ) may affect up to 1 out of 10 people : bleeding in general bleeding ( the nose bleeding ), the brain bleeding , the gut vomiting , blood bleeding from the lungs bleeding , blood in the urine , the mouth bleeding , and the skin coagulopathy ( disturbance of blood clotting ) nausea vomiting diarrhoea rash itching fever uncommon ( may
keep this medicine out of the sight and reach of children . do not use defitelio after the expiry date which is stated on the label and carton after exp . store in the original package in order to protect from light . the infusion storage will be stored in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton at room temperature ( up to 25 ) to protect it from light and from moisture . if the solution is cloudy or discoloured , it should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the
what defitelio contains - the active substance is defibrotide . each ml solution contains 2 . 5 mg / ml of solution for injection ( equivalent to 200 mg / m2 ). - the other ingredients are : defabrotide , sodium citrate dihydrate , hydrochloric acid , sodium hydroxide ( for ph - adjustment ) and water for injections . see section 2 for further information on the use of this product .
daklinza contains the active ingredient daclatasvir . hepatitis c is an infectious disease that affects the liver . it is caused by the hepatitis c virus . this medicine works by blocking the growth of a type of virus called " hepatitis c " in your body . it stops the virus from spreading to other parts of your body and reduces the amount of the virus in your blood . your doctor will tell you how long you should continue to take daclinza and how often you should take it . other medicines to treat hepatitis c infection tell your doctor or pharmacist if you are taking , have recently taken or might
do not take daklinza if you are allergic to daclatasvir or any of the other ingredients of this medicine ( listed in section 6 ). if you take it by mouth with the following medicines : phenytoin , carbamazepine , oxcarbazepine and phenobarbital ( used to prevent epileptic seizures ) rifampicin , rifabutin and rifapentine ( antibiotics used to treat tuberculosis ) dexamethasone ( a steroid that can cause allergic and inflammatory diseases ) medicines containing st . john ' s wort ( hypericum perfor
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of daklinza is 60 mg once a day . do not take more than that if you notice an unpleasant taste . your doctor may tell you to take some other medicines . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse . how much to take the usual dose is one tablet a day , with or without food . take the tablet at the same time each day . it is important that you take the tablets with food .
like all medicines , this medicine can cause side effects , although not everybody gets them . when daklinza is taken together with sofosbuvir or ribavirin , the following side effects may occur : very common ( may affect more than 1 in 10 people ): headache fatigue common : difficulty sleeping dizziness migraine nausea ( feeling sick ) diarrhoea abdominal pain joint pain aching or tender muscles when daclinza has been given together with the combination of both of these active substances , it can increase the risk of side effects such as : common : headache nausea feeling sick fatigue reduction in red blood cells ( ana
what daklinza contains - the active substance is daclatasvir . each film - coated tablet contains 30 mg or 60 mg of daclaasvir ( as dihydrochloride ). - the other ingredients are : tablet core : anhydrous lactose , microcrystalline cellulose , croscarmellose sodium , silicon dioxide , magnesium stearate . tablet coating : hypromellose , titanium dioxide ( e171 ), macrogol 400 , indigo carmine aluminum lake ( e132 ), yellow iron oxide ( e172 ) and 51 film - coating : do not use d
proquad is a vaccine that protects against measles , mumps , rubella , chickenpox ( varicella ) viruses . the vaccine contains antibodies against the diseases that cause mumps and rubella . the antibodies help to prevent diseases caused by these viruses . proquad is used in adults , adolescents and children aged 9 years and older . it is given to you by a doctor or nurse .
do not use proquad : - if you are allergic to any varicella vaccine , measles , mumps or rubella vaccine , or any of the other ingredients of this vaccine ( listed in section 6 ). - if your doctor has given you neomycin . warnings and precautions talk to your doctor , pharmacist or nurse before using proquad if : - you have a blood disorder ( a type of cancer that affects the immune system ). treatment with medications that weaken your immune system ( e . g . low - dose corticosteroid therapy , asthma or replacement therapy ). - you suffer from a weakened immune system . -
proquad is given by injection under the skin ( subcutaneously ) into the thigh or upper arm . injections will be given into the muscle ( upper thigh area ) at the injection site . if you have a blood clotting disorder with low levels of platelets , the vaccine may not be suitable for you . the vaccine should not be injected into the skin to prevent bleeding from the muscle . proquad should only be given to children and adolescents 12 years of age and older who have not been vaccinated against chickenpox or measles . the recommended dose of proquad is 12 micrograms per kg body surface area . your doctor will
like all vaccines , including medicines obtained without a prescription , this vaccine can cause side effects , although not everybody gets them . allergic reactions ( hives ) these reactions may cause difficulty in breathing or swallowing . if you experience an allergic reaction , contact your doctor immediately . other side effects that have been reported with proquad include : very common ( may affect more than 1 in 100 people ): seizures with a fever uncommon ( might affect up to 1 in 1 , 000 people ): bronchiolitis ( difficulty breathing , cough , unsteadiness with walking ) other side side effects reported with the use of proquad are : very rare (
what proquad contains the active substances are : measles virus1 , edmonston strain 3 . 00 mg : mumps virus1 ( level b ) strain 4 . 30 mg : rubella virus2 ( type a ) strain 2 . 0 mg : varicella virus3 ( type b ), merck strain ( type c ), 3 . 99 mg : tissue culture : plaque - forming units 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 28 , 25 , 30 , 33 , 28
jylamvo is injected into the body as an anticancer medicine to prevent unwanted reactions . it is an immunosuppressive agent . it acts as an anti - inflammatory effect jylimvo is used to treat rheumatic and skin diseases : active rheumatoid arthritis with polyarthritic forms in the joints in adult patients with severe juvenile idiopathic arthritis ( jia ). it is used in children and adolescents aged 3 years and older who have not been previously treated with non - steroidal inflammatory drugs ( nsaids ) or inadequate o severe psoriasis . treatment with phototherapy ( psoral
do not use jylamvo if you are allergic to methotrexate or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe kidney impairment or a liver impairment . if you suffer from blood disorders such as bone marrow hypoplasia ( leukopenia or thrombocytopenia ), significant anaemia ( see section 34 ) or a weakened immune system . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you have ever had a serious infection such as tuberculosis or hiv . you have ulcers in the stomach
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of jylamvo is one tablet once a day . if you have severe side effects that may lead to even death , your doctor may change the dose of the treatment . rheumatoid arthritis and severe juvenile idiopathic arthritis . severe psoriasis . if severe psoriatic arthritis is not treated , your physician may decide to stop the treatment and give you a long - term treatment . how jymlamvo works rheumatic and skin diseases such as jia
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : wheeziness , difficulty in breathing , swelling of the eyelids , face or lips , rash or itching on the whole body . other possible side effects include breathing problems , feeling of illness , dry , irritating cough , shortness of breath , chest pain ( fever ), spitting or coughing blood , serious peeling or blistering of the skin unusual bleeding ( vomiting blood ), bruising , nose bleeds , nausea , vomiting , abdominal discomfort , severe diarrhoea mouth ulcers , black or tarry stools
keep this medicine out of the sight and reach of children . do not use the medicine after the expiry date which is stated on the label and carton after exp . store below 25 . store in the original package in order to protect from light . the medicine should be used immediately . accidental spillage may occur up to 3 hours after reconstitution . any unused medicine or waste material should be disposed of in accordance with local requirements for cytotoxic products .
what jylamvo contains - the active substance is methotrexate . each ml of solution contains 2 mg of methotroxybenzoate . - the other ingredients are macrogol 400 mg , glycerol , orange flavour , sucralose , ethyl parahydroxybenzzoate ( e420 ), sodium methyl parahhydroxybenziate ( a ), citric acid , tri - sodium citrate , purified water ( see section 2 " what jylimvo looks like and contents of the pack "). what jyklamvo is a clear , colourless to pale yellow solution
what enurev breezhaler is this medicine contains the active substance glycopyrronium bromide . this belongs to a group of medicines called bronchodilators . this medicine is used to relieve breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). copd causes the muscles around the airways to tighten , making breathing difficult . when this medicine works by tightening these muscles , it makes breathing easier for air to get in and out of the lungs . if you use this medicine for copd , your doctor will tell you how long it will take to work properly .
do not take enurev breezhaler if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). if you have kidney problems . if you suffer from an eye problem called narrow - angle glaucoma ( difficulty passing urine ). if any of these apply to you , talk to your doctor before taking this medicine . tell your doctor immediately if you experience tightness of the chest , coughing , wheezing or breathlessness . if this happens , contact your doctor or hospital immediately . warnings and precautions talk to a doctor or pharmacist before
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one inhaler once a day . this medicine can be used for up to 24 hours at room temperature ( up to 75 ). do not change the dose of this medicine unless your doctor tells you to . do not take this medicine without first talking to your doctor . how to use use enurev breezhaler this medicine is provided as an inhaler and capsules ( in blisters ). the medicine contains inhalation powder . the capsules should be swallowed whole
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious : very common ( may affect more than 1 in 100 people ): irregular heart beat high level of blood sugar ( hyperglycaemia ) typical symptoms include excessive thirst , hunger ( frequent urination ), rash , itching , hives , difficulty breathing , swallowing or dizziness . allergic reaction ( swelling mainly of the tongue , lips , face or throat ). angioedema ( the most common side effects ). if any of the side effects gets serious , stop taking enurev breezhaler and contact your doctor
what enurev breezhaler contains - the active substance is glycopyrronium bromide . each hard capsule contains 63 micrograms ( 0 . 5 ml ) glycoprroniumbromide , equivalent to 50 microgram ( 1 . 4 ml ). - the other ingredients are : - the content of the inhalation powder contains lactose monohydrate and magnesium stearate . what enurevo breez inhaler looks like and contents of the pack enurevan breezer 44 microgram hard capsules are white to off - white powder supplied in a device called an inhaler . capsules
the active substance of riximyo is called a " monoclonal antibody ". it attaches to a specific type of white blood cell . when rituximab sticks to the target of the antibody , it stops the action of the protein . the treatment is given to patients with : a ) non - hodgkin ' s lymphoma ( a disease of the lymph tissue that affects the immune system ). b - lymphocytes are an important part of the body ' s immune system . they are a part of a group of cells called " white blood cells " ( a type of b- lymphocytes ). r
do not take riximyo - if you are allergic to rituximab , other proteins or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you : - have a severe active infection at the moment - have had a weak immune system - have severe heart failure ( severe uncontrolled heart disease ) - have granulomatosis ( polyangiitis ), microscopic polyagiitis or pemphigus vulgaris ( see section 4 ). if any of these apply to you , tell your doctor before
always use riximyo exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this treatment will be given to you by a doctor or nurse experienced in the use of this medicine . if you have any side effects , talk to your doctor , pharmacist or nurse before you are given the dose . the dose you receive will depend on the severity of your condition . your doctor will decide how often you should be given the treatment . the recommended dose is one tablet once a day . you may receive a drip ( intra - venous infusion ) of medicines at the same time each
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion , fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number of platelets
what riximyo contains - the active substance is rituximab . each vial contains 10 mg of 100 mg of ritukimab in 10 ml solution . - each ml contains 50 mg of 500 mg of the other ingredients ( listed in section 6 ). - the other ingredient ( s ) are : sodium citrate , polysorbate 80 , sodium chloride , sodium hydroxide , hydrochloric acid ( see section 2 for further information on the use of this product ). - solvent : clear , colourless to slightly yellowish solution for infusion . pack sizes of 2 , 3 , 1 or
topotecan actavis is a medicine that contains the active substance topotecaan . it is used to treat adult patients with small cell lung cancer that has not responded to chemotherapy or advanced cervical cancer that is not treated with surgery or radiotherapy . in this case topoteca actavis treatment is given in combination with medicines called cisplatin .
do not take topotecan actavis : - if you are allergic to topecan or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . your doctor will check your blood cell counts regularly to make sure that they are not too low . if any of these apply to you , tell your doctor straight away . if you have any kidney problems , your doctor may need to adjust your dose of toprotecan actingavis . if this applies to you ( or you are not sure ), contact your doctor . warnings and
always use topotecan actavis exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is based on the severity of the disease and on the results of blood tests . treatment in adults small cell lung cancer : 1 . 5 mg per kilogram of body surface area ( m2 ) for the first 5 days of this treatment cycle . in adult cervical cancer : 0 . 75 mg / m2 ( m3 ) of bodysurface area , once every 3 days during the first 3 weeks of thistreatment cycle . if you have cervical cancer , your doctor may
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor or pharmacist straight away if you notice any of the following : signs of infections common ( may affect up to 1 in 10 people ): fever . this may be a sign of your general condition . local symptoms include sore throat , burning sensation , severe stomach pain , fever , diarrhoea , bowel inflammation ( neutropenic colitis ). topotecan actavis may affect your ability to fight infections . signs of lung inflammation may include : very common : may affect more than 1 in 1 , 000 people :
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the vial label after " exp ". after reconstitution and dilution chemical and physical in - use stability has been demonstrated for 24 hours at a concentration of 25 micrograms / ml ( equivalent to 2 mg / ml ) for a period of up to 24 hours ( corresponding to 2 to 8 hours ). the drug product solution should be used immediately after dilution in solutions for infusion ( nacl 0 . 9 %) or glucose 5 % ( 3 to 4
what topotecan actavis contains - the active substance is topoteecan . each 1 ml ampoule contains 4 mg of topotecaan ( as hydrochloride ). after reconstitution , 1 ml of solution contains 1 mg / ml of the other ingredients ( listed in section 6 ). - the other ingredient ( excipients ) are mannitol ( e421 ), tartaric acid , hydrochloric acid and sodium hydroxide ( see section 4 ). what topottecan actsavis looks like and contents of the pack topotican actav is a clear , colourless to
what rivastigmine hexal is and what it is used for the active substance is rivestigmine , which belongs to a group of substances called cholinesterase inhibitors . it is given to patients with alzheimer ' s dementia or dementia associated with parkinson ' s disease . certain nerve cells die in the brain , resulting in low levels of the neurotransmitter acetylcholine ( a substance that allows nerve cells to communicate with each other ). rivasterigmine works by blocking the enzymes that break down this substance . this allows the levels to be increased in the blood , allowing acetyl
do not take rivastigmine hexal : - if you are allergic to rivestigmine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you have had a previous skin reaction , such as allergic contact dermatitis . if any of these apply to you , tell your doctor before you are given the medicine . if you think you may have been given too much , talk to a doctor or nurse straight away before you take this medicine . - if your doctor has told you that you have an active stomach
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how long to take treatment with rivastigmine hexal your doctor will start treatment with a low dose . your doctor may increase your dose depending on how you respond to treatment . the highest dose is 6 . 0 mg per kilogram of body weight . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse . the recommended dose is one tablet once a day . do not take more than three days without talking to your doctor first . take this
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor or pharmacist if you notice any of the following side effects while you are taking your medicine : very common ( may affect more than 1 in 10 people ): dizzy loss of appetite stomach problems such as feeling sick ( nausea ) being sick ( vomiting ) diarrhoea common : common : anxiety sweating headache heartburn weight loss stomach pain feeling agitated feeling tired or weak generally feeling unwell trembling or feeling confused decreased appetite nightmares uncommon : may affect up to 1 in 100 people : depression difficulty in sleeping fainting or accidentally falling changes
keep this medicine out of the sight and reach of children . do not use rivastigmine hexal after the expiry date which is stated on the carton and the blister after exp . this medicinal product does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep the blister in the outer carton in order to protect from light . once removed from the refrigerator , the product should be used within 30 . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user .
what rivastigmine hexal contains the active substance is 64 mg of powder for concentrate for solution for injection . the other ingredients are : capsule content : capsule contents : hypromellose , magnesium stearate , microcrystalline cellulose , colloidal anhydrous silica , gelatin , yellow iron oxide red iron oxide ( e172 ) printing ink : titanium dioxide ( e171 ) and shellac . capsule shell : each ritigminehexal 1 . 5 mg / ml capsule contains 1 . 05 mg of rivostigmine . capsule size : 3 . 3 mg . capsule contents of
cabometyx is a cancer medicine that contains the active substance cabozantinib . it is used to treat kidney cancer ( renal cell carcinoma ) and liver cancer in combination with a specific anticancer medicine called sorafenib . cabometyx works by blocking the action of a protein called receptor tyrosine kinases ( rtyks ), which are involved in the formation of new blood vessels . by blocking these proteins , it prevents high amounts in cancer cells from growing . if you have any further questions on the use of this product , ask your doctor or pharmacist .
do not take cabometyx 45 - if you are allergic to cabozantinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking cabometrix 45 if you have high blood pressure or have had an aneurysm ( enlargement or weakening of a blood vessel wall ). if you experience a tear or a tear in a bloodstream vessel wall , such as diarrhoea , recent or significant bleeding from surgery , including within the last month , or surgical procedures , dental surgery , inflammatory bowel disease , crohn ' s disease
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of this medicine is one tablet once a day . your treatment should be started at the same time each day . if you take more cabometyx than you should if you accidentally take too many tablets , talk to a doctor or go to the nearest hospital straight away . do not stop your treatment unless your doctor tells you to . serious side effects may occur after stopping treatment . how much to take the recommended starting dose is one 60 mg tablet once daily . you should continue to take cabomet
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with cabometyx and other medicines : tell your doctor straight away if you notice any of your side effects . if any of the side effects gets serious , you may need urgent medical treatment . symptoms include pain in the abdomen ( nausea or feeling sick ), vomiting , constipation and fever . these may be signs of a gastrointestinal perforation ( a hole in the stomach or intestine ). if you experience severe or uncontrollable bleeding , symptoms include vomiting blood , black stolls , bloody urine , headache , coughing up blood
what cabometyx contains the active substances are cabozantinib ( s ) and malate . each tablet contains either one tablet of cabozentinib or malate ( 20 mg / ml ). each tablet is available in blister packs containing one tablet ( s ), with or without cabozatinib in the morning and with or with malate in the evening . the tablet can be taken in a glass vial containing 20 tablets ( s ). the tablet must be taken with or just after cabozartinib . each blister contains one tablet (" s "). each tablet (" m ") contains caboz
pemetrexed hospira is a medicine used to treat the following types of cancer : pemrexed hospira is given in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . pemetrexED hospira can also be given alone or in association with cispleratin for the initial treatment of patients with advanced stage of lung cancer . your doctor will decide on the best treatment for you . how is pemetreedospira given
do not use pemetrexed hospira : - if you are allergic ( hypersensitive ) to any of the other ingredients of pemrexed . warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . children and adolescents do not give this medicine to children below the age of 6 years . breast - feeding during treatment with pemetreedospira , your doctor may give you a vaccine to prevent yellow fever . your doctor will check whether pemetresed hospir is working for you . if you have problems with your kidneys , please tell your doctor . before you are given pemet
always use pemetrexed hospira exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 500 micrograms per kilogram of your body ' s surface area . your height and weight will be measured by your doctor to work out how much of this body surface area you should be treated with . your doctor will determine the dose you should receive . the duration of treatment will depend on your blood cell counts and on how well you are responding to treatment . if you have any further questions on the use of this product , ask your doctor , pharmacist or
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following : fever ( signs of infection ) with a temperature of less than 38ºc . sweating ( sign of infection ). if you have fewer white blood cells than normal . if you are at risk of infection ( sepsis ), which can lead to death . chest pain with a fast heart rate . pain , redness , swelling or sores in your mouth . allergic reaction : skin rash , burning , prickling sensation or fever . skin reactions that may be life - threatening may be
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . infusion solution : the product should be used immediately . infusion solutions of pemetrexed should be stored at room temperature ( up to 25 ) for 24 hours prior to use . the reconstituted solution should be administered immediately after preparation . parenteral medicines : if there is discolouration prior to administration , this medicine should be discarded . any unused solution
what pemetrexed hospira contains - the active substance is pemrexed . one vial of pemeprexedospira 100 mg contains 100 mg of petrexed ( as pexyrexed disodium hemipentahydrate ). each vial ( 500 mg ) contains 500 milligrams ( 1 , 000 micrograms ) of pererexed (" as peyrexed desodium hampentahhydrate ). - the other ingredient is pemetoxed . each carton ( 1, 000 ml ) contains 1 . 000 milligram ( 2 . 5 mg
ganfort contains two active substances called bimatoprost and timolol . both help to control pressure in the eye . bimatraoprost belongs to a group of medicines called prostamides . it is a prostaglandin analogue that works by blocking the activity of a substance called beta - blockers . what ganfort looks like and contents of the pack the eye is a clear , watery liquid that is clear and colourless . it comes into contact with the back of the eye , which helps to protect the eye from light . this helps to prevent glaucoma from coming back . g
do not use ganfort eye drops : if you are allergic to bimatoprost , timolol , beta - blockers or any of the other ingredients of this medicine ( listed in section 6 ). if you have respiratory problems such as asthma , severe chronic obstructive bronchitis or severe lung disease . if you experience wheeziness , difficulty in breathing or long - standing cough . warnings and precautions talk to your doctor or pharmacist before using this medicine . coronary heart disease ( symptoms such as chest pain , tightness , breathlessness or choking ). heart failure ( symptoms include low blood pressure 44 ). disturbances of heart
always use ganfort exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one drop in the eye once a day . treatment should be started as soon as possible . keep the bottle tightly closed in order to protect from moisture . do not put the bottle near your neck or eye . 1 . wash your hands with soap and water . 2 . remove the bottle from the eyelid and put it in a small pocket . 3 . put your eye back in the corner of the eye after treatment . 4 . gently press down on the
like all medicines , ganfort can cause side effects , although not everybody gets them . stop using the drops and tell your doctor straight away if you notice any of the following side effects after taking granfort ( multi - dose or single - dose ). very common side effects ( may affect more than 1 in 10 people ) the eye redness . commonside effects ( might affect up to 1 in 9 people ) 100 the eye burning , itching , stinging , irritation of the conjunctiva ( the part of the eye that produces sensitivity to light ), eye pain , sticky eyes , dry eyes , feeling of something in the
keep this medicine out of the sight and reach of children . do not use ganfort after the expiry date which is stated on the carton and on the vial label after exp . this medicine does not require any special storage conditions . it must be used immediately if you notice any visible signs of eye infections ( see section 4 ). do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what ganfort contains - the active substance is bimatoprost . each vial contains 0 . 3 mg timolol ( 5 mg / ml ) and 1 mg of the other ingredients ( listed in section 6 ). - the other ingredient ( s ) are benzalkonium chloride ( a preservative ), sodium chloride , sodium phosphate dibasic heptahydrate , citric acid monohydrate , purified water , hydrochloric acid , sodium hydroxide . what gansfort looks like and contents of the pack the vial is clear , colourless to slightly yellow . it is supplied in
gefitinib mylan contains the active substance gefitinib . this protein is involved in the growth and spread of cancer cells and is very similar to a natural protein found in the body . gefitoninib melan is used to treat non - small cell lung cancer in adults . this cancer is a disease in which malignant ( cancer ) cells form in the tissues of the lung .
do not take gefitinib mylan : - if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you : - have ever had or might now have any other lung problems . some lung problems may be life - threatening . if any of these apply to you , tell your doctor or pharmacist before you are given this medicine . - have or might have had problems with your liver . warnings , precautions and precautions before you start taking the following medicines : - phenyto
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 250 mg antacids taken once a day on the same stomach ( see section 2 " how to take gefitinib mylan "). if you have trouble swallowing the tablets , you can take them with or without food . if you take more tablets than you should if you accidentally take too many tablets , talk to a doctor or go to the nearest hospital straight away . do not take a double dose to make up for a forgotten tablet . take the next tablet at the
like all medicines , this medicine can cause side effects , although not everybody gets them . if you notice any of the following side effects you may need urgent medical treatment : allergic reaction with symptoms such as swollen face , lips , tongue or throat , difficulty to swallow , hives , nettle rash , difficulty breathing , serious breathlessness or sudden worsening breathlessness with a cough or fever . these may be signs of an inflammation of the lungs known as ' interstitial lung disease '. uncommon ( may affect up to 1 in 100 people ) gefitinib mylan can cause severe skin reactions that affect the entire body . the signs
what gefitinib mylan contains - the active substance is gefinib . each film - coated tablet contains 250 mg of gefib . - the other ingredients are : tablet core : lactose monohydrate , microcrystalline cellulose , crospovidone ( type a ), povidoone ( k30 ), sodium laurilsulfate , magnesium stearate . tablet coating : polyvinyl alcohol , macrogol 4000 , titanium dioxide ( e171 ), red iron oxide ( e172 ) and yellow iron oxide . what gefitoninib looks like and contents of the
reblozyl contains the active substance luspatercept . it is used to treat myelodysplastic syndromes ( mds ). mds is a group of many different blood and bone marrow disorders in which red blood cells become abnormal . signs and symptoms include a low red blood cell count ( anaemia ), which can be caused by the lack of red blood vessel transfusions . your doctor or nurse will give you the medicine to help you recover from your mds . it can also be given to you by your doctor , nurse or pharmacist if you are not able to receive redblood cell transfusions
do not take reblozyl if you are allergic to luspatercept or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be pregnant or planning to have a pregnancy , ask your doctor or pharmacist for advice before taking this medicine . if you have thalassaemia ( a condition where the spleen is removed from the body ) or have had a blood clot . your doctor may recommend hormone replacement therapy to prevent a previous blood clot from forming . preventive measures should be taken in case of medicines that may cause a blood clot . high blood pressure if you take
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will do blood tests before and during treatment with reblozyl . the recommended dose is one injection under the skin . the injections should be given at least 1 . 0 mg / kg of body weight . the dose may be adjusted by your doctor depending on your blood pressure . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse . in patients with myelodysplastic syndromes the maximum single dose is 1 . 75 mg
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects include difficulty in walking or speaking , dizziness , loss of balance and coordination , numbness or paralysis in the face , leg or arm , blurred vision , symptoms of a stroke , blood clots swelling in the area around the eyes , lips , mouth or tongue throat allergic reactions 36 reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . after reconstitution , reblozyl may be stored at room temperature ( up to 8 ) for up to a maximum of 25 days , or up to 24 hours at 2 to 8 , depending on the storage conditions and on the type of medicinal product . any unused medicinal product or waste material should be disposed of in accordance with local requirements .
what reblozyl contains - the active substance is luspatercept . each ml of solution contains 25 mg or 75 mg ( corresponding to 75 mg of lsuspatercept ). - after reconstitution , one vial contains 50 mg ( equivalent to 50 mg / ml ) of luspaterscept . - the other excipients are citric acid monohydrate , sodium citrate 80 , sucrose , hydrochloric acid ( for ph adjustment ) and sodium hydroxide ( to adjust ph adjustment ). what rebloxyl looks like and contents of the pack rebl ozyl is a white to off
fotivda contains the active substance tivozanib . it is a protein kinase inhibitor . it works by stopping the growth of the cancer . it stops cancer cells from growing and attaching to new blood vessels . it can be used in adult patients with advanced kidney cancer or in combination with other treatments containing alpha or interleukin - 2 , to treat your disease .
do not take fotivda - if you are allergic to tivozanib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine : - st . john ' s wort ( hypericum perforatum ), a herbal remedy used to treat depression and anxiety . if you think any of these apply to you , tell your doctor or pharmacist before being given fotvda . - high blood pressure your doctor will check your blood pressure regularly . your doctor may prescribe you a medicine to lower your blood
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of fotivda is 1340 mg once a day for 21 days . this will be given to you by a doctor or nurse as a 7 mg capsule . capsules should be swallowed whole with a glass of water . your doctor will tell you how many capsules to take and how long you should take them . the maximum recommended dose is 4 mg twice a day . do not take more than the recommended daily dose . if you have unacceptable side effects , your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects high blood pressure is a common side effect ( may affect up to 2 in 10 people ). tell your doctor immediately if you experience any of the following symptoms : severe headaches , blurred vision , shortness of breath , changes in your mental state , feeling anxious , confused or disorientated . your doctor may need to adjust your dose of fotivda to control your blood pressure . if you take more fotvda than you should if you accidentally take too many tablets of a medicine , contact your doctor straight away . if
what fotivda contains the active substance is tivozanib . each tablet contains 890 micrograms of the other ingredients ( listed in section 6 ). the other ingredient ( excipients ) are : tablet core ( e460b ): tablet content ( e464b ): tiv ozanib hydrochloride monohydrate ( e487b ). tablet core : 890 micrometres ( e463b ). printing ink : mannitol , magnesium stearate , gelatin , titanium dioxide ( e171 ), tartrazine aluminium lake ( e553b ), shellac , propylene glycol ,
stribild contains the active substance elvitegravir . it is an antiretroviral medicine known as an integrase inhibitor cobicistat . it acts as a booster ( pharmacokinetic enhancer ) for the body to produce its own immune system ( immune system ) ( the body ' s natural defence system ) and is used to treat the following conditions in adults : one of the active substances of stribild ( e . g ., an antipsychotic medicine called a nucleoside reverse transcriptase inhibitor ( nrti ) tenofovir disoproxil , an antir
do not take stribild : - if you are allergic to elvitegravir , cobicistat , emtricitabine , tenofovir , ten ofovir disoproxil or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before starting treatment . you should not take any medicine that contains tenfuzosin . your doctor will check your kidney function before you start taking any of these medicines . - if your doctor has told you that you have an increased prostate gland ( amiodarone
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults 12 to less than 18 years of age the recommended dose is 35 mg taken by mouth once a day . take your medicine at the same time each day . your doctor will tell you how long you should take it . the treatment may be continued with medicines called oral supplements ( such as antacids , laxatives containing minerals such as magnesium , aluminium , calcium , iron , zinc ) for up to 4 weeks . if you take more stribild than you should if you accidentally take too many
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this may be partly linked to restored health and life style , and in some cases to the restored health of your body . this is linked to the way your body works as it prevents the hiv disease from returning to normal . as with all medicines , this medicine can cause side effects , although not everybody gets them . hiv infection can cause unwanted effects when stribild is used in combination with other medicines . some hiv diseases itself can cause serious side effects . tell your doctor immediately if you notice any of the following
what stribild contains - the active substances are elvitegravir , cobicistat , emtricitabine and tenofovir disoproxil . each stribil film - coated tablet contains 150 mg of the two active substances , respectively . each tablet contains 300 mg of both of them , corresponding to a total of 150 mg ( 2 tablets of both , respectively ). - the other ingredients are : tablet core : emtpistat 200 mg ( 3 tablets of two , respectively ) and emtuistat 245 mg ( 4 tablets of one , respectively). tablet coating : tenof
zyprexa contains the active substance olanzapine . zyprexa belongs to a group of medicines called antipsychotics . it is used to treat schizophrenia , a disease with symptoms such as hearing , seeing or sensing things that are not there , feeling depressed , anxious or tense . moderate to severe manic episodes ( symptoms of excitement or euphoria ) have been reported in patients treated with zypoxa . however , recurrence of these symptoms in patients with bipolar disorder ( manic episode ) has not been confirmed in patients receiving olan zapine treatment .
do not take zyprexa : if you are allergic ( hypersensitive ) to olanzapine or any of the other ingredients of this medicine ( listed in section 6 ). if you have an allergic reaction such as a rash , itching , a swollen face , swollen lips or shortness of breath . if you suffer from eye problems such as glaucoma or increased pressure in the eye . warnings and precautions talk to your doctor or pharmacist before you take any of these conditions . if any of them apply to you , tell your doctor before you are given this medicine . if your doctor has told you that you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of zyprexa tablets is one 5 mg tablet once a day . your doctor may increase your dose to one 20 mg tablet twice a day depending on your symptoms . swallow the tablet whole with a glass of water . do not crush or chew the tablet . take your zypoxa tablets at the same time each day . take the tablets with or without food . swallow your tablets whole with some water . you can take your tablets at any time of the day
like all medicines , this medicine can cause side effects , although not everybody gets them . unusual movement ( a common side effect that may affect up to 1 in 10 people ) mainly of the face and tongue . this may be a sign of blood clots in the veins . this side effect is uncommon ( may affect more than 1 in 100 people ). in the legs , symptoms include swelling , pain and redness in the leg which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing . if you experience any of these symptoms , contact your doctor immediately . fever , faster breathing , sweating , muscle stiffness and d
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . zyprexa must not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zyprexa contains - the active substance is olanzapine . each zkyprexa tablet contains 2 . 5 mg , 5 mg or 7 . 5mg . each tablet contains 10 mg , 15 mg or 20 mg . - the other ingredients are : tablet core : lactose monohydrate , hyprolose , crospovidone , microcrystalline cellulose , magnesium stearate . tablet coating : hypromellose , titanium dioxide ( e171 ), carnauba wax . see the end of the leaflet for further information on the different zzyprexa tablets streng
what prolia is prolia contains denosumab , a protein ( monoclonal antibody ). this is another protein that plays an important role in preventing bone loss in patients with osteoporosis . how prolia works prolia helps your body to make bone stronger by reducing the amount of oestrogen that your body makes . this helps your bones make better use of their blood before the menopause . after treatment with prolia , your body becomes bone stronger , and your bones become thin and fragile . osteopORosis is a condition in which your body does not make enough of its own blood . oste
do not use prolia : if you have low calcium levels in the blood ( hypocalcaemia ). if you are allergic to denosumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using prolia . prolia may cause a skin infection . symptoms include a swollen , red area of skin on one side of your leg that feels hot and tender ( cellulitis ). symptoms include fever . if any of these symptoms indicate an allergy to latex , please remove the needle from the pre - filled syringe and use a derivative of latex .
always use prolia exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one pre - filled syringe ( 60 ml ) once a day for up to 6 weeks . your doctor will give you a single injection under the skin ( subcutaneous ) in the thighs , abdomen or upper arm . if you have any further questions on the use of prolia , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . prolia can cause skin infections such as cellulitis . if you experience any of these symptoms , stop taking prolia and contact your doctor straight away : swollen , red area of skin or leg that feels hot and tender . symptoms may include fever , which may be associated with prolia . pain in the mouth and / or jaw , swelling or non - healing of sores in the jaw , discharge , numbness or feeling of heaviness or loosening of a tooth . these could be signs of bone damage in the gaw ( osteone
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the pre - filled syringe label after " exp ". this date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the syringe tightly closed in order to protect from light . if prolia is not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 25 days at room temperature ( up to 30 ). however , if you
what prolia contains - the active substance is denosumab . 1 ml solution contains 60 mg of denosumaab in 60 ml . - the other ingredients are acetic acid , glacial , sodium hydroxide , sorbitol ( e420 ), polysorbate 20 and water for injections . what prolia looks like and contents of the pack prolia is a clear , colourless to slightly yellow solution for injection in a pre - filled syringe with a needle guard .
always use ambirix exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one vaccine for adults and adolescents aged 1 to 15 years . two diseases are hepatitis a and hepatitis b : infection with the hepatitis a virus causes the liver to become swollen and inflamed . the virus can infect any part of the body ( including faeces , serum or saliva ). symptoms usually occur 3 to 6 weeks after infection . if you feel sick , have a fever , aches and pains , feel very tired , dark urine , pale faec
do not use ambirix : - if you are allergic to any of the ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using the vaccine if you : - have an allergic reaction such as itchy skin rash , shortness of breath or swelling of your face or tongue . if you think you may have an allergy reaction to any vaccine containing hepatitis a or hepatitis b diseases . - have a severe infection with a high temperature . the vaccine should not be given if you have a minor infection such as a cold . if any of these apply to you , tell
always use ambirix exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one injection in the muscle of your upper arm . the injection will be given by injection into your thigh muscle . your doctor will give you a total of two injections . the injections should be given within 12 months of the first injection . the second injection may be given between 6 and 12 months after the first . if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse . the doctor may prescribe extra doses to prevent future booster dosing
like all medicines , this vaccine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : allergic and anaphylactic reactions . the signs may include a rash , itchy , blistering , swelling of the eyes and face , difficulty in breathing or swallowing , or a sudden drop in blood pressure or loss of consciousness . other possible side effects reported in clinical trials with ambirix were : very common ( may affect more than 1 in 10 people ): headache loss of appetite feeling tired irritable pain or redness
what ambirix contains 26 the active substance is hepatitis a virus . each 1 ml pre - filled syringe contains 720 micrograms of elisa units ( hepatitis b surface antigen ). the other ingredients are human diploid ( mrc ), cells of aluminium hydroxide , hydrated in 0 . 05 ml , saccharomyces cerevisiae , aluminium phosphate , 0 . 4 ml , sodium chloride , and water for injections . what ambiraix looks like and contents of the pack suspension for injection is a white , slightly milky liquid . it is supplied in a pack containing 1 , 10 or 50 pre -
bexsero is a meningococcal group b vaccine . it is given to adults , adolescents and children aged 2 years and older . it works by preventing the development of disease caused by the meningitidis group b bacteria . these bacteria cause infections ( such as meningitis , inflammation of the brain and spinal cord ) and sepsis ( blood poisoning ). the vaccine works by stopping the spread of the disease .
do not use bexsero - if you are allergic to any of the ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before being vaccinated . if you have a severe infection , such as a high temperature , your vaccination should be postponed until a minor infection ( such as cold ) is resolved . vaccination should not be given in patients with haemophilia or any other problem that prevents your blood from clotting properly . blood thinners ( anticoagulants ) should be used during treatment with eculizumab . if any of these apply to
always use bexsero exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 5 mg injection into a muscle ( usually in the thigh or upper arm ). the first two injections should be given at least 2 weeks apart . your doctor may give you three injections to make up for three missed doses . the vaccine may be given as an additional injection ( booster ) at the end of the first injection ( see section 2 ). the interval between injections should not exceed 1 month . if you miss a dose of the vaccine , your doctor will give you a booster
like all vaccines , this vaccine can cause side effects , although not everybody gets them . stop using bexsero and tell your doctor straight away if you notice any of the following side effects : very common ( may affect more than 1 in 10 people ): pain / tenderness at the injection site , redness of the skin at the site of injection , swelling of theskin at the injected site , hardness of the surface of the injected area . other possible side effects that may occur with this vaccine are listed below : common : may affect up to 1 in every 10 people : fever , loss of appetite , tenderness on the
what bexsero contains the active substance is recombinant neisseria meningitidis group b nhba fusion protein . each vial contains 1 , 2 , 3 or 50 micrograms of recombinant nisseria manningitidis . the other ingredients are group b noada protein , which is contained in the vial ( 1 ), 2 or 3 vials ( 3 or more vials ). each vials contains 50 million iu ( 1 . 5 milligrams ) ( 3 to 10 milligram ) ( 1 ). the excipients are : outer membrane vials containing omv (
what nitisinone mdk is and what it is used for this medicine is used to treat a rare disease called hereditary tyrosinemia ( hty ) in adults , adolescents and children aged 1 year and above . because of this disease your body does not produce enough of the amino acid tyrosine ( amino acids ) that are naturally present in the body . this means that the substances that are normally present in your body do not work as well as they should . nitisinsone dk works by blocking the action of these substances . this helps to reduce the amount of tyrosinine in the blood and
do not take nitisinone mdk if you are allergic to any of the active substances in this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . pregnancy , breast - feeding and fertility if you breast - feed , think you may be pregnant or are planning to have a baby , ask your doctor or pharmacist for advice before taking the medicine . driving and using machines if you have red eyes , tell your doctor immediately . you may need an eye examination . eye problems may be due to inadequate diet . see section 4 for further information on the treatment .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . treatment with this medicine will be started by a doctor experienced in the treatment of the disease ( hereditary tyrosinemia type 1 ). the recommended dose is 1 mg / kg of body weight taken once a day . this dose may be increased to a maximum of 20 mg once daily . in this patient population , swallowing the capsules should be done with a small amount of water or formula diet . if you take more nitisinone mdk than you should if you accidentally take too many capsules , contact your
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . after dilution , nitisinone mdk should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would not be longer than 2 hours at a temperature not above 25 .
what nitisinone mdk contains - the active substance is nisinone . each hard capsule contains either one or two active substances . - the other ingredients are : - the capsule content of nitisginone dk is as follows : - one capsule contains 2 active substances , each containing one or more active substances ( listed in section 6 ). - the second capsule contains 5 active substances which are similar to those of the first two . - each capsule contains one active substance , which is listed in the section 5 of the package leaflet . - if you are not sure , talk to your doctor or pharmacist .
docetaxel accord is a medicine that contains the active substance docetaxelo . docetxel accord belongs to a group of anti - cancer medicines known as taxoids . it is used to treat the following types of breast cancer : - breast cancer , non - small cell lung cancer , prostate cancer , gastric cancer , head and neck cancer . - advanced breast cancer that has spread to other parts of the body ( see section 2 ). - the other ingredients are docetoxel , doxorubicin , trastuzumab , capecitabine . - early breast cancer with lymph node
do not take docetaxel accord : - if you are allergic ( hypersensitive ) to any of the active substances in this medicine ( listed in section 6 ). - if your white blood cells are not working properly . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . your doctor will do blood tests to check that you have enough blood cells and that your liver is working properly ( see section 4 ). warnings , precautions and precautions before you have been given the medicine , your doctor may need to perform blood tests . if you have or have ever had too many blood cells in your liver
docetaxel accord will be given to you by a doctor or nurse . the dose will depend on your weight and your general condition . method and route of administration docetaxell accord is given as an infusion into one of your veins . the infusion will last approximately one hour . your infusion will be repeated every 3 weeks . your doctor will check your blood tests to make sure that you have the general condition to be treated . the usual dose of docetAXel accord is one tablet once a day . if you have diarrhoea , sores in the mouth , numbness , pins and needles , fever and 63
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking docetaxel accord and talk to your doctor immediately if you experience any of the following adverse reactions while taking it : reduction in the number of red blood cells and white blood cells ( alopecia ), nausea , vomiting , sores in the mouth , diarrhoea and tiredness . if you notice any of these adverse events , stop taking the medicine and contact your doctor straight away . if any of them occur , stop the treatment and contact the doctor immediately . the infusion may be stopped . allergic reactions very common ( may
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and the carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the container in the outer carton in order to protect from light . the product should be used immediately after dilution . once the medicine has been diluted , the infusion bag may be stored for up to 6 hours at room temperature ( up to 25 ) prior to infusion . the infusion solution should be stored in non - pvc bags for 48 hours ( 2 to 8 ).
what docetaxel accord concentrate for solution for infusion contains 20 micrograms of the active substance . each ml of concentrate contains 20 milligrams of the other ingredient ( listed in section 6 ). each vial contains 20 mg of the two active substances . each 1 ml concentrate contains 160 milligram of the three active substances ( active substances ). each 4 ml vial of concentrate contain 80 microgramms of the one active substance ( active substance ). each 8 ml or 160 microgramm of the four active substances in the concentrate ( the other ingredients ) are : tablet core : polysorbate 80 , ethanol an
intuniv contains the active substance guanfacine . this medicine belongs to a group of medicines that affect the electrical activity of the brain . intuniv is used to treat impulsive , hyperactive , or not - recognising signs of a problem called ' attention deficit hyperactivity disorder ' ( adhd ). this medicine is used in combination with current stimulant medication to treat adhd symptoms . the medicine is a treatment programme that consists of psychological therapy , educational therapy and social therapy . it is also used in adults 38 years of age and older who have adhd and who have not previously been treated with adhd .
do not take intuniv - if you are allergic to guanfacine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you have low or high blood pressure , heart problems , or heart problems . tell your doctor if you fainted recently or have thoughts or feelings of suicide or any other psychiatric conditions . withdrawal symptoms may include increased heart rate , highblood pressure . if any of these apply to you ( or you are not sure ), contact your doctor or pharmacist . if you think any of this applies to
your treatment will be supervised by a doctor experienced in the treatment of adolescent behavioural disorders . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of intuniv is one tablet once a day . your doctor will work out the right dose for you . the recommended starting dose for your treatment is 1 tablet per day . this will be gradually increased over the course of 1 to 3 weeks . the usual dose for treatment is 0 . 05 mg twice a day ( 0 . 12 mg per kg of bodyweight ). your doctor may
like all medicines , this medicine can cause side effects , although not everybody gets them . if you feel unwell , stop taking your medicine and contact your doctor immediately . serious side effects tell your doctor straight away if you notice any of the following side effects : feeling drowsy or feeling dizzy ( hypotension ), slow heart beat ( bradycardia ), feeling faint , loss of concentration ( syncope ), a serious withdrawal side effect ( high blood pressure ). symptoms include headaches , feeling confused , nervousness , agitation and tremors ( hypertensive encephalopathy ). if you experience any of these side effects during treatment , stop
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister pack after exp . this medicine does not require any special storage conditions . keep the tablets in the original blister pack in order to protect from light .
what intuniv contains the active substance is guanfacine hydrochloride . each prolonged - release tablet contains 1 milligram ( mg ) of guanFacine ( as 2 milligrams ). each long - lasting tablet contains 3 milligams ( mg ). each extended - release film - coated tablet contains 4 milligms ( mg) of the other ingredients ( see end of section 2 ). the remaining ingredients ( excipients ) are : tablet core : guanedfacine ( mg ), 3 micrograms ( mg ); tablet coating : guanfuine ( μg ) ( 4 microgram ) gu
ecalta contains the active substance anidulafungin . ecalta is used to treat adults and adolescents ( aged 1 to 18 years ) with a type of fungal infection that affects the blood or other internal organs ( invasive candidiasis ). the infection is caused by fungal cells called echinocandins . these medicines help to prevent serious fungal infections from spreading to other organs , such as the lungs and the digestive system ( the part of the body that makes food ) by blocking the growth of the fungal cell walls . ecalda works by blocking these cells so that they can grow . ec
do not take ecalta - if you are allergic to anidulafungin , other echinocandins , caspofungin acetate or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . your doctor may need to monitor your liver function . if you have liver problems , your treatment may be interrupted or you may be given anaesthetics . if any of these apply to you , tell your doctor or pharmacist before you start your treatment . do not stop taking ecaltra unless
the treatment will be given to you by a doctor or nurse . the usual starting dose is 200 mg or 100 mg once a day . the recommended dose is 1 mg per kg body weight . adults and adolescents from 18 years of age and older : the usual dose is 3 . 0 mg , 200 mg , 1 . 5 mg , 100 mg or 200 mg . depending on the patient ' s weight , the dose may be increased or decreased . ecalta is given as slow infusion ( a drip into a vein ) over a period of up to 3 hours . the loading dose will depend on the severity of the infusion and the
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects : - threatening allergic reactions , such as difficulty breathing or wheezing . these may be signs of an existing rash . ecalta can cause serious sideeffects such as convulsion ( seizure ), flushing , rash , pruritis , itching , hot flush , hives , sudden contraction of the muscles , wheeing or coughing , difficulty of breathing other side effects very common side effects ( may affect more than 1 in 10 people ): low blood potassium ( hyp
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . the reconstituted solution should be used within 24 hours after preparation . the infusion solution may be stored at room temperature ( up to 25 ) for up to 48 hours . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 48 hours at 2 to 8 .
what ecalta contains - the active substance is anidulafungin . each vial of powder contains 100 mg of the active ingredient in this medicine . - the other ingredients are mannitol , polysorbate 80 , tartaric acid , sodium hydroxide , hydrochloric acid and 30 micrograms of the solvent in the vial ( see end of this leaflet for further information on the use of this medicine ). what ecaltas looks like and contents of the pack ecaltfa is supplied as a box containing 1 vial containing 100 mg concentrate for solution for infusion . the powder
adynovi contains the active substance rurioctocog alfa pegol , which belongs to a group of substances called pegylated human coagulation factor viii ( hffvviii ). the human coating factor iii viii is produced by recombinant dna technology in the blood . it helps to form clots and stop bleedings in patients with haemophilia a and b . adynovi is used for the treatment of bleeding in adults and adolescents 12 years of age and older . in this group of patients , the hfviii factor vii is not produced in the body
do not use adynovi if you are allergic to rurioctocog alfa pegol or octocog aluminium or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , talk to your doctor or pharmacist . warnings and precautions tell your doctor , pharmacist or nurse if you : - have ever had an anaphylactic reaction ( a severe , sudden allergic reaction to any ingredient or product of the medicine that is used to treat allergic reactions ). - have rash 95 - have hives , wheals , generalised itching , swelling of lips and tongue
always use adynovi exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . if you have haemophilia , your doctor will tell you how many tablets to use . the duration of treatment will depend on the type of bleeding you are suffering from . your doctor may decide to stop the replacement therapy . if your doctor thinks that the effect of adynov is too strong or too weak , you may need a life - long treatment . use this medicine to reduce the risk of bleeding . the usual dose for adults is one
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience sudden allergic reactions ( anaphylactic ) following the injection . early symptoms of allergic reactions may include rash , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , wheezing , tightness in the chest , feeling of being unwell , dizziness and loss of consciousness . if you have severe symptoms such as difficulty in breath , fainting , prompt emergency treatment . previous treatment with factor viii ( 150 mg / treatment ) inhibitor antibodies ( see section
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . store in a refrigerator ( 2 - 8 ). keep the vial in the outer carton in order to protect from light . the powder vial may be kept at room temperature ( up to 30 ) for a maximum period of 3 days . once this medicine has been removed from the refrigerator , it must be used within 3 days or discarded . if it has been frozen for more than 3 days , it should be used immediately . if not used immediately
what adynovi contains - the active substance is rurioctocog alfa pegol ( pegylated human coagulation factor viii produced by recombinant dna technology ). each powder vial contains either 250 , 500 , 1000 or 2000 iu of the corresponding active substance ( as pgeol ). - the solvent vial consists of 5 ml of sterilised water for injections . - the other ingredients are mannitol , trehalose dihydrate , histidine , glutathion , sodium chloride , calcium chloride diydrate , tris ( hydroxymethyl ) aminometh
rekovelle contains the active substance follitropin delta , a follicle stimulating hormone . it belongs to a group of hormones called gonadotropins and is used to stimulate female fertility . it is used in women undergoing assisted reproduction programmes ( i . e . in vitro fertilisation ( ivf ) and intracytoplasmic sperm injection ( intrf ). it stimulates the ovaries to produce many eggacs .
do not use this medicine : - if you have or have had your fertility problems , or if you are allergic to follicle stimulating hormone . warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . children and adolescents rekovelle should not be used in children below 6 years of age . - if your tumour is in the uterus ( ovaries ), breasts ( pituitary gland or hypothalamus ). - if enlarged ovaries or cysts on your ovaries ( polycystic ovarian disease ), bleeding from the vagina ( an early menopause ), malformations of the sexual organs
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the rekovelle dose will be given to you by a doctor or nurse during your first treatment cycle . your doctor will give you anti - müllerian hormone to stimulate your ovaries to produce stimulation with gonadotropins . the dose will depend on your blood weight and on the results of a blood sample taken in the last 12 months . the duration of treatment depends on your body weight and the type of treatment you are taking . the recommended dose is one single injection of a medicine called
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects caused by hormones can lead to infertility . this medicine may cause a high level of activity in the ovaries ( ovarian hyperstimulation syndrome ). symptoms include pain , discomfort , swelling of the abdomen , nausea , vomiting , diarrhoea , weight gain and difficulty breathing . if you experience any of these symptoms , stop taking rekovelle and contact your doctor straight away . a side effect that may affect up to 1 in 10 people is headache . nausea is a symptom that may be associated with ovarian hyper stimulation syndrome ( pelvic pain
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . rekovelle may be stored at room temperature ( up to 25 ) for up to 3 days . after 3 days , the solution should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 28 days at 25 . after the treatment any unused solution must be discarded
what rekovelle contains - the active substance is follitropin delta . each multidose cartridge contains 12 mg of follitopin delta in 0 . 36 millilitre of solution . each ml of solution contains 33 . 3 mg of the other ingredients of follnitropin Delta in each millilitere of solution , which are : phenol , polysorbate 20 , l - methionine , sodium sulphate decahydrate , disodium phosphate dodecahhydrate , concentrated phosphoric acid , sodium hydroxide and water for injections . what recovelle looks like and
what revinty ellipta contains the active substances are fluticasone furoate and vilanterol . each inhalation of the two active substances is given by a doctor or nurse . the recommended dose for ellipta is one inhalation ( inhalation ) each day of the week . the usual daily dose for the first week is two inhalations ( inhalations ). the second week is 92 inhalation . the dose is two doses each day . the first two doses are 22 inhalations . the second dose is 22 inhalation per day . if you have chronic obstructive pulmonary disease ( copd ), your doctor
do not take revinty ellipta - if you are allergic to fluticasone furoate , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking ellipta . ellipta should not be used if you have liver disease . the following side effects have been reported with ellipta in patients with moderate or severe liver disease : - if the lower strength of ellipta 92 / 22 is used to treat heart problems , high blood pressure , tuberculosis ( tb ) of the lung , or any long standing or
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . asthma the recommended dose for asthma is fluticasone furoate ( 22 mg vilanterol ) once a day . if you have severe asthma , your doctor may prescribe the higher strength inhaler ( fluticasaone firoate 22 mg per day ) with vilansterol . copd if you suffer from copd , the dose that your doctor prescribes will depend on the severity of your asthma . the higherstrength inhaler should be used once daily . the usual dose is
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions to ellipta are rare ( may affect up to 1 in 1 , 000 people ). if you experience any of the following symptoms while taking ellipta , stop taking this medicine and contact your doctor immediately : skin rash , hives , redness swelling of the face or mouth ( angioedema ), feeling very wheezy , coughing , difficulty in breathing , feeling weak , light headed , collapse or loss of consciousness . immediate breathing difficulties if you have immediate breathing problems while taking revinty ellipta your breathing may become
what revinty ellipta contains - the active substances are fluticasone furoate and vilanterol . each inhalation contains 92 micrograms of the two active substances . - the other ingredients ( excipients ) are : - the solvent for inhalation is flitasone multifuroate 22 mg / m2 , which is soluble in water ( e . g . in flitash ) and trifenatate 184 mg/ m2 . the solvent is sucrose ( e464 ) and is soluble ( e468 ) in water . each 22 mg ampoule contains 184 micro
atripla contains three active substances that are used to treat human immunodeficiency virus ( hiv ) infection : efavirenz , a non - nucleoside reverse transcriptase inhibitor ( nnrti ), emtricitabine , which is a nucleotide reverse transcriptionase inhibitor . nrti belongs to a group of antiretroviral medicines called tenofovir , which are also used to prevent the virus from multiplying in the body . atripola is used as a treatment for adult patients who have been previously treated with a treatment to treat adult patients with human immun
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet taken by mouth once a day . take atripla on the same day each day . swallow the tablet whole with a glass of water . the tablet can be taken with or without food . take the tablet on your stomach at least 1 hour before or 2 hours after food . some side effects may be more common ( e . g . dizziness or drowsiness ). if you take more tablets than you should if you accidentally take too many tablets , contact your doctor
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in some cases to the restored health of the body . if this happens to you , you may need to stop taking atripla and see a doctor straight away . as with all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects lactic acidosis ( excess lactacid in the blood ) is rare ( may affect up to 1 in 1 , 000 people ). serious side effect tell your doctor immediately if you notice any
what atripla contains - the active substances are efavirenz , emtricitabine , and tenofovir disoproxil . each expiry date refers to the last day of that month . - the other ingredients are : tablet core : 600 micrograms ( as epidermal growth factor receptor ). tablet coating : efavairenz 200 microgram s ( as emptricitibine ). tablet shell : 245 microgram ( per millilitre ). tablet coat - coating : croscarmellose sodium , hyprolose , magnesium stearate , micro
orgalutran contains the active substance ganirelix . it belongs to a group of medicines called anti - gonadotrophin . the natural gonadonrophin releasing hormone ( gnrh ) is produced by the body . when gnrh regulates the release of gonadsotrophins , it stimulates the production of follicle stimulating hormone ( follicles ) in the ovaries . follicles are small round sacs that release the immature egg cells that are needed to make follicles . when follicles become large , they become small round sacs . when the egg cells are released from the sacs ,
do not use orgalutran : if you are allergic to ganirelix or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be hypersensitive ( hypersensitive ) to gonadotrophin releasing hormone ( gnrh ) or to a gnrh analogue . if you have a moderate or severe kidney or liver disease . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . if your doctor thinks you may have an active allergic condition , your doctor may recommend additional monitoring and treatment . allergic reactions allergic reactions are generalised ( h
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . orgalutran will be given to you by a doctor or nurse who is experienced in the treatment of assisted reproduction techniques ( i . e . in vitro fertilisation ( ivf ), ovarian stimulation , follicle stimulating hormone ( corifollitropin ), on day 2 or day 3 of the treatment . you will be injected with a single dose of orgaluitran under the skin ( subcutaneously ) every 5 to 6 weeks . your doctor will tell you how long you should use org
like all medicines , this medicine can cause side effects , although not everybody gets them . a side effect very common ( may affect more than 1 in 10 people ) is local skin reactions ( redness and swelling ). the local reaction usually disappears within 4 to 10 minutes . uncommon : may affect up to 1 in 100 people ( frequency cannot be estimated from the available data ) headache nausea ( malaise ) rare : affects less than 1 to 10 , 000 people allergic reactions such as rash facial swelling difficulty breathing ( dyspnoea ) swelling of face , lips , tongue , and / or throat which may cause difficulty in breathing or
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and syringes after exp . store in a refrigerator ( 2 - 8 ). store in the original package in order to protect from light . keep the syringe tightly closed . clear , particle - free solutions should be used immediately after preparation . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user .
what orgalutran contains - the active substance is ganirelix . each vial contains 0 . 5 ml of acetic acid . - the other ingredients are mannitol ( e421 ), water for injections ( for the ph ) and sodium hydroxide ( for ampoules ). - the excipients of the ampoule are acetic acids and manneitol . the solution is clear to opalescent and colourless aqueous solution . after reconstitution , the solution should be used immediately . subcutaneous administration is recommended . the needle is dry natural rubber / latex . what
what blitzima is blitzima contains the active substance rituximab , which is a " monoclonal antibody ". it attaches to a specific type of white blood cell called " b - lymphocytes ". when ritukimab sticks to this target , it stops the growth of these cells . how blitzima works blitzima can be used in adults to treat : a ) non - hodgkin ' s lymphoma ( a disease of the lymph tissue that affects the immune system ). this means that a type of small white blood cells called b- lymphocytes have been removed from the body . blitzima
do not use blitzima : - if you are allergic to rituximab or other proteins derived from ritukimab . warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine : 6 if you have a severe active infection , a weak immune system , severe heart failure , severe uncontrolled heart disease , granulomatosis , polyangiitis ( microscopic polyangiaitis ) or pemphigus vulgaris ( see section 2 ). warnings , precautions and precautions before using blitzima , tell your doctor or pharmacist if you : have a hepatitis infection . this is because
always take this treatment exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of this treatment is one tablet once a day . if you take more blitzima than you should if you accidentally take too many tablets , contact your doctor immediately . you may need to take other medicines ( pre - medication ) to reduce the risk of side effects during your treatment . non - hodgkin ' s lymphoma if you forget to take blitzima alone blitzima should be taken every 4 weeks . repeated treatment courses with blitzima will be given to you by your doctor .
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion , fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number of platelets
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light .
what blitzima contains - the active substance is rituximab . each ml contains 10 mg or 100 mg of ritukimab in 10 ml solution . each 50 ml ampoule contains 500 mg of the other ingredients ( excipients ). - the other ingredient ( s ) are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what blitzima looks like and contents of the pack blitzima is a clear , colourless solution for infusion . each pack contains 2 vials , 50 ml or 1 vial . not all pack sizes may be marketed
roactemra contains the active substance tocilizumab , which is a type of monoclonal antibody , which attaches to a protein called interleukin - 6 ( interlukin ) in your body . this is involved in preventing the inflammation in the body . roactema is used to treat symptoms such as pain and swelling in your joints , which have been reported in patients treated with roactamra . it reduces the damage to the cartilage that lines the bone in the joints . the disease is caused by a lack of immune response to previous therapies , which has not worked well enough
do not use roactemra : if you are allergic to tocilizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active , severe infection . if this applies to you , stop the infusion and contact your doctor immediately . warnings and precautions talk to your doctor , pharmacist or nurse before you are given the infusion . if you experience allergic reactions such as chest tightness , wheezing , severe dizziness , light - headedness , swelling of the lips or skin rash during the infusion , tell your doctor or nurse immediately . infections if you feel unwell ,
always use roactemra exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the intravenous infusion will be given by a doctor or nurse . the duration of the treatment will depend on your body weight . the recommended dose is rostemra ( 8 mg ) once a day for the first 4 days , followed by another 8 mg dose in the second week . your doctor will tell you how many days you need to use . the usual starting dose is one rosterel injection ( 4 mg ). your doctor may tell you to use ro
like all medicines , roactemra can cause side effects , although not everybody gets them . the following side effects have been reported in patients treated with 3 mg of roactamra : serious side effects ( may affect up to 1 in 10 people ): allergic reactions such as difficulty with breathing , chest tightness , light - headedness , rash , itching , hives , swelling of the lips , tongue or face . serious infections such as fever , chills , or skin blisters . stomach ache signs and symptoms of liver toxicity ( may occur in up to one in 1000 people ): tiredness , abdominal pain , j
keep this medicine out of the sight and reach of children . do not use roactemra after the expiry date which is stated on the outer carton and the vial label after exp . this medicine does not require any special storage conditions .
what roactemra contains the active substance is tocilizumab . each vial contains 4 mg of 80 mg of tociluzumab ( corresponding to 20 mg / ml ). each 10 ml vial delivers 200 mg of solution for injection . the other ingredients are sucrose , polysorbate 80 , disodium phosphate dodecahydrate , sodium dihydrogen phosphate dihydrate and water for injections . what roactoremra looks like and contents of the pack roactamra is a clear , colourless solution for infusion . it is supplied in packs containing 4 , 10 or 20 v
onbrez breezhaler contains the active substance indacaterol which belongs to a group of medicines called bronchodilators . it works by relaxing the muscles in the walls of the small air passages in the lungs . onbrez bronz inhaler is used to relieve breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). copd causes the muscles around the airways to relax , making breathing difficult . this medicine works by tightening the muscles of the lungs , making it easier for air to get in and out of your lungs .
do not take onbrez breezhaler if you are allergic to indacaterol or any of the other ingredients of this medicine ( listed in section 6 ). if you have asthma . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . you should not take this medicine if : you have heart problems , epilepsy , thyroid gland problems ( thyrotoxicosis ) or diabetes . your doctor may need to adjust your dose or stop treatment . if you think you may have been given on brez breeezhaler , tell your doctor immediately . you have tightness of the chest , coughing
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 150 microgram capsule twice a day . your doctor may increase your dose to 300 micrograms once a day depending on how you respond to the treatment . use your inhaler every 24 hours . how to use onbrez breezhaler your doctor will give you an inhaler and capsules ( in blisters ) to help you inhale the medicine . the inhalation powder is clear and colourless . do not change the dose without consulting your doctor . use the on
what onbrez breezhaler contains - the active substance is indacaterol . - the other ingredients in the capsule content are indaconaterol maleate , lactose and the capsule contains gelatin . each on brez breezyhaler 300 mg capsule contains 300 mg of indiacaterol ( as indapanaterol femaleate ). - the printing ink for the capsule is gelatin . - after reconstitution with an inhaler , capsules are supplied in blisters . the capsules are white to off - white powder . the powder is contained in a clear glass vial . - onbreez breez
clopidogrel hcs is a medicine that belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood that clump together during blood clotting . by preventing this clumping , anti platelet medicinalproducts reduce the chances of blood clots forming ( thrombosis ). clopidogsrel clcs is used to prevent bloodclots ( also known as thrombi ) forming in hardened blood vessels ( arteries ), which are atherothrombotic events ( such as stroke , heart attack , or death ). your doctor or nurse will give you cl
do not take clopidogrel hcs : - if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . warnings and precautions talk to your doctor , pharmacist or nurse before you are given any of these medicines . you should tell your doctor if you think you may be at an increased risk of bleeding . if this applies to you ( or you are not sure ), your doctor may need to adjust your dose
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if you have a condition called ' atrial fibrillation ' ( an irregular heartbeat ), your doctor may prescribe a lower dose of 75 mg of clopidogrel hcs per day to help control severe chest pain ( unstable angina or heart attack ). the recommended dose is 300 mg / m2 of body weight taken once a day . your doctor will tell you how many tablets to take . you should take the tablet at the same time each day . if your doctor tells you to take cl
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin or the whites of the eyes ( jaundice ). - bleeding that appears under the skin as red pinpoint dots and / or confusion ( see section 2 " warnings and precautions "). - swelling in the mouth . - skin disorders such as rashes , itching and blisters of theskin . these could be signs of an allergic
what clopidogrel hcs contains each film - coated tablet contains 75 mg of the active substance , as hydrochloride . see section 2 for further information . the other ingredients are : tablet core : cellulose ( e460 ), microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenated castor oil . tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , talc ( e1520 ), macrool 3000 . tablet coat : shellac
fetcroja contains the active substance cefiderocol . it is an antibiotic medicine that belongs to a group of antibiotics called cephalosporins . antibiotics help to fight bacteria that cause infections . fetcroja is used to treat infections caused by bacteria that are resistant to other antibiotics .
do not take fetcroja if you are allergic to cefiderocol or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to other antibiotics ( e . g . cephalosporins ) if you have had a severe allergic reaction to certain antibiotics , such as penicillins or carbapenems . if you experience severe skin peeling or swelling of the hands , face , feet , lips , tongue or throat that may cause difficulty swallowing or breathing , tell your doctor or pharmacist immediately . warnings and precautions talk to your doctor before taking fetcro
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . fetcroja is given as an infusion ( a drip ) into a vein ( intravenously ) over a period of 3 to 2 hours . your doctor will tell you how long you should continue to use it . the recommended dose is one tablet once a day . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : - severe allergic reaction , which may include sudden swelling of your lips , face , throat or tongue , a severe rash or other severe skin reactions , difficulty swallowing or breathing . this reaction may be accompanied by diarrhoea , stools , blood or mucus . treatment with medicines that slow bowel movement may cause the side effects listed below . other side effects include : very common side effects ( may affect more than 1 in 10
what fetcroja contains - the active substance is cefiderocol sulfate tosylate . each vial contains 1 mg ccfiderocol . - the other ingredients are sucrose , sodium chloride , sodium hydroxide and water for injections ( see section 2 ). what fetcroJA looks like and contents of the pack fetcroja is a white to off - white powder for solution for infusion . each carton contains 10 vials .
depocyte is used to treat the following conditions : lymphomatous meningitis ( lymphoma tumour cells ) in the brain and spinal cord . depocyte is a type of medicine that works by blocking the growth and spread of lymphoma cancer cells .
do not take depocyte if you are allergic to cytarabine or any of the other ingredients of this medicine ( listed in section 6 ). if you have a meningeal infection . warnings and precautions severe neurological side effects with depocyte are symptoms of the nervous system ( convulsions , pain , numbness , tingling ), blindness and visual disturbances . if you experience any of these symptoms , stop taking depocyte and contact your doctor immediately . you should not take any dexamethasone tablets to treat unwanted effects . your doctor will check your side effects regularly to make sure that any new side effects are not
treatment with depocyte will be given to you by a doctor experienced in the treatment of cancer in the lumber sac . the recommended dose of depocyte for injections is 1 mg , 5 mg dexamethasone ( 5 mg ). each depocyte dose should be given at the same time each day . if you experience any side effects , talk to your doctor , pharmacist or nurse before you are given depocyte . your doctor will determine the correct dose for you . the dose will depend on your body ' s response to the medicine and on the type of cancer you are being treated with . the usual dose is one 5 mg
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported during your treatment with depocyte : very common side effects ( may affect more than 1 in 10 people ): very common : common : may affect up to 1 in 100 people : very rare : not known ( frequency cannot be estimated from the available data ): very rare side effects : very rarely , 1 in 1 , 10 , or more uncommon : very commonly , 1 to 10 in 10 , but not commonly , not uncommonly , very rare cases of adverse events occur after the use of depocyte . depocyte
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . depocyte must be stored in a refrigerator ( 2 - 8 ). store in the original package in order to protect from light . once depocyte has been removed from the refrigerator , it must be used within 4 hours . if depocyte is not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at room temperature ( up to 30 ). do not throw away any medicines via
what depocyte contains - the active substance is cytarabine . each ml of solution for injection contains 10 mg cytarbine ( equivalent to 5 mg / ml ). each vial of 50 ml contains 50 mg of the other ingredients ( listed in section 6 ). - the other ingredient is cholesterol , triolein , dioleoylphosphatidylcholine ( type a ), dipalmitoyl phosphATidylglycerol ( type b ), sodium chloride and water for injections . what depocyte looks like and contents of the pack depocyte is a clear , colourless solution for
what bemrist breezhaler is the active substance is indacaterol , which belongs to a group of medicines called bronchodilators . it works by tightening the muscles in the lungs . this helps to open the airways and allows the air to get in and out of the lungs more easily . mometasone furoate is also a member of a medicine called corticosteroids ( steroids ) which work by blocking the swelling and irritation ( inflammation ) in the small airways in the lungs . this can lead to breathing problems and makes it easier for people to breathe normally . cortic
do not take bemrist breezhaler if you are allergic to indacaterol , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have heart problems , such as an irregular or fast heartbeat , thyroid gland problems , diabetes , high blood sugar , seizures , low level of potassium in your blood , severe liver problems , tuberculosis ( tb ) of the lung , or any long - standing
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . bemrist breezhaler capsules should be swallowed whole with water . swallow the capsules whole with a glass of water . do not chew or crush the capsules . the medicine should be used immediately . if your asthma does not improve or your symptoms get worse , your doctor may prescribe a lower dose . if you have any further questions on the use of this medicine , ask your doctor , pharmacist , or nurse . how to use and how much to use use the recommended dose is one inhaler and
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious . very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips , or face , skin rash , itching and hives . allergic reaction uncommon ( might affect up to 1 in 100 people ): swelling of either the tongue or lips , face or throat ( angioedema ). other side effects other possible side effects are listed below : very common : may affect less than 1in 10 people : sore throat , runny nose , sudden difficulty breathing , feeling of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicinal product does not require any special temperature storage conditions . the capsules should be kept in the original blister in order to protect from light .
what bemrist breezhaler contains - the active substances are indacaterol ( as acetate ) and mometasone furoate . each inhaler contains 125 micrograms of 62 . 5 mg or 173 microlitres of indiacaterol acetate in one inhaler . each 150 microgram s inhaler delivers 150 milligrams of indacatorol ( equivalent to 80 milligram ) and 40 microlitre of mometsone furuate . - the other ingredients are : the powder for the inhaler is a white to off - white powder . each bem
the active substance of zyllt is clopidogrel . it belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood that clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( thrombosis ). zylltt is used to reduce the risk of blood blots ( also known as thrombi ) forming in hardened blood vessels ( arteries ), which can lead to atherothrombotic events ( e . g . stroke , heart attack , or death ). z
do not take zyllt if you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . warnings and precautions talk to your doctor , pharmacist , or nurse before taking zllt if : you have bleeding that is not being treated or if it is due to an existing condition ( such as bleeding inside any tissues , organs , joints or other parts of the body ). you have recently had a recent serious injury
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ) is one 75 mg tablet of zyllt per day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may prescribe a lower dose of 300 mg of the medicine . your doctor will tell you how long you should continue to take it . the usual starting dose for adults is 75 mg once a day . however , if you take more tablets than you should if
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin or the whites of the eyes ( jaundice ). - bleeding that appears under the skin as red pinpoint dots and / or confusion ( see section 2 " warnings and precautions "). - swelling in the mouth . - skin disorders such as rashes , itching and blisters of theskin . these could be signs of an allergic
what zyllt contains - the active substance is clopidogrel . each film - coated tablet contains 75 mg of clopidiogrel ( as hydrogen sulphate ). - the other ingredients are : tablet core : lactose ( see section 2 under ' zyllts contains lactose '), microcrystalline cellulose , pregelatinised maize starch , macrogol 6000 and hydrogenated castor oil . tablet coating : hypromellose ( e464 ), titanium dioxide ( e171 ), red iron oxide ( e172 ), talc and propylene glycol in the film - coating . what z
lamivudine teva is an antiviral medicine that works by stopping the hepatitis b virus from multiplying in your body . it is used to treat long term ( chronic ) hepatitis b infection in adults and children aged 12 years and older . lamivudINE teva belongs to a group of medicines called nucleoside analogue reverse transcriptase inhibitors ( nrtis ). hepatitis b is a virus that infects the liver . it causes a condition known as long term (" chronic " infection , which can lead to liver damage . by blocking the ntris gene , lamivuda teva increases the liver ' s ability to
do not take lamivudine teva : - if you are allergic to lamibudine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions 28 take special care when you are taking the tablet or other similar medicines , as it may cause serious side effects . if you have liver disease ( hepatitis c . ) or are overweight , your doctor may need to perform blood tests before you start your medication . see section 4 for further information on the safety of taking lamivu teva . check with your doctor or pharmacist if you think any of these apply to you . warnings and
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take your doctor lamivudine teva is used to treat your hepatitis b infection . the duration of your infection depends on your illness . your doctor will tell you how many tablets to take . how long to take the recommended dose is one tablet once a day . take the tablet at about the same time each day . do not take more tablets than your doctor tells you to . if you have problems with your kidneys , your doctor may tell you to take a different type of lamiv
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with lamivudine teva in patients with other conditions linked to hepatitis b . if you notice any of the following serious side effects during or after therapy with ' hepatitis b ' you should contact your doctor immediately . the side effects reported during the first few weeks of lamvudine clinical trials were tiredness , respiratory tract infections , throat discomfort , headache , stomach discomfort , pain , nausea , vomiting and diarrhoea . increases in liver enzymes ( a type of enzymes that help to relax muscles ). allergic
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . lamivudine teva must not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what lamivudine teva contains - the active substance is lamvudine . each film - coated tablet contains 100 mg of lamibine . - the other ingredients are : tablet core : microcrystalline cellulose , sodium starch glycolate , magnesium stearate . tablet film - coating : hypromellose , titanium dioxide ( e171 ), macrogol , polysorbate 80 , iron oxide yellow ( e172 ) and iron oxide red ( e 172 ). tablet film coating : white to off - white , round , biconvex film - coat : 32 mm . what lamiv
nespo ( an anti - anaemic ) is used to treat your anaemia . anaemia occurs when your blood does not produce enough red blood cells . the symptoms include fatigue , weakness and shortness of breath . nespo works by blocking the effect of the natural hormone erythropoietin in your body , which helps to protect your kidneys . it also blocks the activity of your bone marrow , which produces too much of a substance called darbepoetin alfa . it is also used to prevent chronic renal failure . symptomatic anaemia is a condition that occurs when you have kidney failure .
do not take nespo : if you have high blood pressure or if you are taking other medicines . if you think you may be allergic , ask your doctor or pharmacist for advice . warnings and precautions talk to your doctor , pharmacist or nurse before taking nespos ( darbepoetin alfa ) or r - huepo . if any of the above applies to you ( or you are not sure ), tell your doctor straight away . patients with high bloodpressure who are taking medicines to treat sickle cell anaemia ( epileptic fits ( seizures ), convulsions or seizures have liver disease
your doctor will do blood tests before and during treatment with nespo to check your haemoglobin level . the usual starting dose is 10 micrograms per kilogram of body weight . your doctor may increase your dose up to a haoglobin level of 10 microg / kg per 12 hours . the pre - filled syringe should be injected directly into a vein ( intravenous ). if you have chronic renal failure , your doctor will give you a single injection under the skin ( intravenously ). the recommended dose is 0 . 45 microgram per kg body weight per day . you will also have regular blood samples taken to check
like all medicines , nespo can cause side effects , although not everybody gets them . the most commonly reported side effects are 471 to 10 in 100 patients : high blood pressure ( hypertension ) fluid retention ( oedema ) uncommonly ( may affect up to 1 in 100 people ): blood clots ( thrombosis ) pain in the area injected rash , redness and / or the skin rare (> 1 in 10 , 000 people ): serious allergic reactions sudden life - threatening allergic reactions ( anaphylaxis ) swelling of the face , lips , mouth , tongue or throat , difficulty in swallowing or breathing ( ang
keep out of the sight and reach of children . do not use nespo after the expiry date which is stated on the carton and on the syringe label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep your syringe in the outer carton in order to protect from light . after first opening , the product may be stored at room temperature ( up to 30 ) for a period of up to 7 days . keep the vial in the original package to protect it from moisture . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose
what nespo contains - the active substance is darbepoetin alfa . each pre - filled syringe contains 10 mg , 15 mg , 20 mg , 30 mg , 40 mg , 50 mg , 60 mg , 80 mg , 100 mg , 130 mg , 150 mg , 300 mg or 500 mg . - the other ingredients are sodium phosphate monobasic , sodium phosphate dibasic and sodium chloride , polysorbate 80 and water for injections . the solution is clear , colourless to slightly pearly liquid and not cloudy . each pack contains 1 , 4 or 4 pre -
macugen is a solution for the treatment of macular degeneration that contains pegaptanib . this medicine is used to prevent abnormal formation of new blood vessels in the eye . macugen is used as the treatment for adults with macular dementia . this disease causes vision loss and damage to a large part of the retina ( the macula that lines the front of the eye ). macula is a thin layer in the outer layer of your eye called the amd . abnormal blood vessels grow in the retina . macula helps to protect the retina from light . by blocking this effect , macugen helps to open up these new blood
do not use macugen : if you are allergic to pegaptanib or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active or suspected infection in your eye . warnings and precautions talk to your doctor , pharmacist or nurse before using macugen . an infection may lead to bleeding in the eye . before macugen injection , tell your doctor immediately if you experience the following symptoms : eye pain , increased discomfort , worsening eye redness , blurred or decreased vision , increased sensitivity to light , small particles in your vision . the injection may cause the injection serious allergic reactions . the symptoms are
how macugen is given macugen will be given to you by a doctor or nurse . it is given as a single injection into the back of the eye . the recommended dose is 6 to 9 injections per day . the injection will be injected into the vitreous part of your eye . your doctor will decide how much macugen you should receive . how macugen works antibiotic eye drops are used to clean the front of your eyes . some local anaesthetic (umbing medicine ) may be used to prevent any pain or discomfort after the injection . if you are allergic to antibiotic eyedrops or to any other ingredients in the eye ,
like all medicines , this medicine can cause side effects , although not everybody gets them . serious allergic reaction ( anaphylactic reaction ) angioedema of which symptoms include breathing difficulty , wheezing , swollen mouth , face , hands or feet , itching skin , fainting , rapid pulse , stomach cramps , nausea , vomiting and diarrhoea . the frequency of these side effects is not known ( cannot be estimated from the available data ). an infection in the internal portion of the eye has been reported during macugen treatment . the symptoms are listed in section 2 . if you experience any of these symptoms , contact
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label after exp . this medicine does not require any special storage conditions . store in the original package in order to protect from light . the medicine should be used immediately after preparation and should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help protect the environment .
what macugen contains - the active substance is pegaptanib . each single dose pre - filled syringe contains 0 . 3 mg of pegptanib ( equivalent to 90 mg ). - the other ingredients are : sodium chloride , monobasic sodium phosphate monohydrate , dibasicodium phosphate heptahydrate , sodium hydroxide , hydrochloric acid ( for ph adjustment ) and water for injections . see section 2 . what macugen looks like and contents of the pack macugen solution for injection in a single dose pack is supplied in a pouch . each pack contains : a ready - to
kipivance contains the active substance palifermin . it belongs to a group of substances called escherichia coli . palifermine works by blocking the growth of epithelial cells in the mouth and digestive tract , which are tissues that help to protect the skin from moisture . by blocking these cells from growing , the medicine reduces the risk of oral mucositis . this reduces soreness , dryness and inflammation of the mouth . this is the most common side effect that occurs during treatments for your blood cancer . if you have any questions about how this medicine works or why this medicine has been prescribed for you , ask
do not take kepivance - if you are allergic to palifermin , escherichia coli derived proteins or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . children and adolescents do not give this medicine to children or adolescents under 18 years of age . other medicines and kepingivance tell your doctor or pharmacist if you take , have recently taken or might take any other medicines . this includes heparin . if you think you may be pregnant or are planning to have a baby , ask your doctor
what kepivance is used for the treatment of cancer treatment in adults , the recommended dose is one 60 micrograms injection of one kilogram of body weight . this will be given as an intravenous injection into a vein . the dose will depend on how you respond to the treatment . how kepvelance is given the usual starting dose of kepervance is one microgram ( 0 . 5 milligrams ) per kilogram body weight , given once every three weeks as chemotherapy and radiotherapy . it is usually given 24 to 48 hours after the chemotherapy has finished . if you are given more kep
like all medicines , this medicine can cause side effects , although not everybody gets them . common ( may affect up to 1 in 10 people ): side effects include skin rash , itching , redness , pruritus ( erythaema ), an increase in the thickness in the mouth or tongue , change in colour of the mouth , tongue , generalised swelling ( oedema ), swelling of hands , ankles or feet , pain , fever , aching joints ( arthralgia ), altered taste , lipase levels ( amylase levels ) and digestive enzymes in the blood . treatment with kepivance may
what kepivance contains - the active substance is palifermin . each vial contains 6 . 25 mg paliferin . - the other ingredients are mannitol , sucrose , l - histidine , polysorbate 20 and diluted hydrochloric acid ( see section 2 ). what kepvelance looks like and contents of the pack kepiverance is a white powder for concentrate for solution for injection in a vial . each pack contains 6 vials .
cinacalcet accordpharma contains the active ingredient cicaglucan . it works by reducing the amount of calcium and phosphorous in the body . it is used to treat problems with organs called parathyroid glands . parathyroids are four small glands in the neck that help the thyroid gland to work properly . cinacalcitpharma is used in adults to treat secondary hyperparathyroidism ( secondary ) in adult patients with serious kidney disease who are on dialysis or who are receiving waste products that increase the level of calcium in the blood ( hypercalcaemia ). parathy
do not take cinacalcet accordpharma : - if you are allergic to the active substance of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you : - have low levels of calcium in your blood . your doctor will check your blood calcium levels regularly before and during treatment . if this applies to you , tell your doctor or pharmacist before you take this medicine . - have ever had or might now have any of the following : seizures ( fits or convulsions ) seizures - have liver problems - have heart failure . warnings and
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of cinacalcet accordpharma is one tablet a day . the tablets should be taken orally with or without food . your doctor will take regular blood samples before and during treatment to check for secondary hyperparathyroidism . the recommended starting dose for adults and children aged 3 months to 18 years is 0 . 20 mg / kg body weight per day . if you have any further questions on the use of this medicine , ask your doctor , pharmacist
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - numbness or tingling around the mouth , muscle aches , cramps or seizures . these may be signs that your calcium levels are too low ( hypocalcaemia ). - swelling of the face , lips , mouth , tongue or throat which may cause difficulty in swallowing or breathing ( angioedema ). very common ( may affect more than 1 in 10 people ): nausea . vomiting . if you notice any of these side effects ( very common ) or if they get worse ( common )
what cinacalcet accordpharma contains the active substance is cinacetalc . each film - coated tablet contains 30 mg , 60 mg or 90 mg cinacealcite . the other ingredients are : tablet core : hydrochloride , cellulose , microcrystalline - crospovidone - magnesium stearate , hypromellose , titanium dioxide ( e171 ), triacetin , indigo carmine aluminum lake ( e132 ), iron oxide yellow ( e172 ). see section 2 under " what to look like and contents of the pack cicacalcitph
jentadueto contains two active substances , linagliptin and metformin , which are medicines called dpp - 4 inhibitors . these are dipeptidyl peptidase - 4 inhibitor ( dps - 4 ) medicines that work by blocking the action of a substance called biguanides . this helps to control blood sugar levels in diabetes called ' type 2 diabetes mellitus '. this medicine works by helping your body make better use of insulin . this medicine is used in combination with certain other medicines used to treat diabetes ( such as sulphonylureas or empagliflozin ). insulin is
do not take jentadueto if you are allergic to linagliptin , metformin or any of the other ingredients of this medicine ( listed in section 6 ). if you have severely reduced kidney function or uncontrolled diabetes . if you suffer from severe hyperglycaemia ( high blood glucose ), nausea , vomiting , diarrhoea and rapid weight loss . if any of these apply to you , tell your doctor straight away . lactic acidosis is a condition that can be life - threatening and can lead to lacticacidosis ( see section " warnings and precautions "). what is ketoacidosis ? ket
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of jentadueto is currently metformin . individual tablets containing linagliptin and metformine should be taken at the same time each day . if you take more of this medicine than you should if you have accidentally taken too many tablets , contact your doctor straight away . you may experience an upset stomach . your doctor may prescribe you a lower dose of 5 mg linaglaptin and 2 , 000 mg met formin hydrochloride ( see section 2 ). if
like all medicines , this medicine can cause side effects , although not everybody gets them . some symptoms may require immediate medical attention . stop taking jentadueto and contact a doctor straight away if you experience any of the following symptoms : low blood sugar ( hypoglycaemia ) trembling , sweating , anxiety , blurred vision , tingling lips , paleness , mood change and confusion . hypocaemia is very rare ( may affect up to 1 in 10 people ). the most common side effect of jentodueto plus sulphonylurea is the combination combination of the two active substances , jentadin
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and blister after exp . the original package does not require any special storage conditions . this medicine should not be used if you notice any visible signs of tampering .
what jentadueto contains - the active substances are linagliptin and metformin hydrochloride . each jentadinueto 2 . 5 mg / 850 mg film - coated tablet contains 2. 5 mg linaglptin and 850 mg met formin hydro chloride . - the other ingredients are : tablet core : arginine , copovidone , magnesium stearate , maize starch , silica , colloidal anhydrous , hypromellose , titanium dioxide ( e171 ), talc , propylene glycol ( e1520 ). tablet coating : white to off - white
edurant contains the active substance rilpivirine . it is used to treat human immunodeficiency virus ( hiv ) infection in adults . edurant belongs to a group of hiv medicines called non - nucleoside reverse transcriptase inhibitors ( nnrtis ). it works by stopping hiv from multiplying and infecting other people who are infected with hiv . it belongs to the group of medicines called nrtis .
do not take edurant if you are allergic to rilpivirine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking the following medicines : carbamazepine or oxcarbazepine , phenobarbital , phenytoin . medicines used to treat epilepsy ( seizures ) such as rifampicin or rifapentine . medicines to treat some bacterial infections ( such as tuberculosis ). such as omeprazole , esomeprazole or lansoprazole . pantop
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one tablet once a day . children and adolescents edurant is for use in adults and adolescents aged 18 years and above . the usual dose is two tablets per day . your doctor will tell you how many tablets to take and how often to take them . the dose may need to be adjusted by your doctor . if you have rifabutin , your doctor may tell you to take one tablet twice a day , at about the same time each day
like all medicines , this medicine can cause side effects , although not everybody gets them . headache , nausea , difficulty falling asleep , insomnia and dizziness have been reported in patients taking edurant . your doctor will monitor your routine liver tests . transaminase may increase in cholesterol and pancreatic amylase in your blood . abnormal dreams , rash , stomach pain , depression , tiredness , vomiting , drowsiness , decreased appetite , sleep disorders , stomach discomfort , depressed mood , dry mouth 36 low white blood cell and / or platelet count , decrease in haemoglobin in your body , triglycerides , lipase and
what edurant contains - the active substance is rilpivirine . each tablet contains rilpaline hydrochloride . one tablet contains 25 mg / m2 of the total active substance of edurants . - the other ingredients are : the film - coated tablet core : lactose monohydrate , croscarmellose sodium , povidone k30 , polysorbate 20 , silicified microcrystalline cellulose , magnesium stearate . the film coating : lactosmonohydrate , hypromellose 2910 , titanium dioxide ( e171 ), macrogol 3000
avandamet tablets contain two different medicines called rosiglitazone and metformin . both of these two medicines are used to treat type 2 diabetes . what type of diabetes is diabetes ? your body does not make enough insulin to control blood sugar levels . your body makes too much insulin , which is not enough to control the level of sugar in your blood . when rosaiglitrazone and meetformin are used together , the insulin that your body produces does not work as well as it should . this means that your blood sugar is not controlled enough by diet and exercise or by diet alone . av
always take avandamet exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . do not take more than one tablet in the morning or two tablets in the evening . if your diabetes is not controlled , talk to your doctor straight away . if you have had a heart attack , severe angina or heart failure in the past , severe breathing difficulties , liver disease or diabetic ketoacidosis ( a complication of diabetes characterised by rapid weight loss , nausea and vomiting ). if you suffer from kidney disease ( 107 ) or if you
always take avandamet tablets exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended starting dose is 2 mg rosiglitazone ( equivalent to 1000 mg metformin ). this dose may be increased to 1 mg once a day for up to 8 days . the maximum dose should be taken every day for 4 days . your doctor will tell you how many tablets of the day to take . the recommended dose is rosaiglitrazone ( corresponding to 1000mg metformatin ). your doctor may tell you to take this dose
like all medicines , avandamet can cause side effects , although not everybody gets them . allergic reactions have been reported in patients treated with avandamanet . these include raised and itchy rash ( hives ) swelling mainly of the face or mouth ( angioedema ), which may cause difficulty in breathing collapse . if you experience any of these symptoms , stop taking the medicine and contact your doctor straightaway . if any of the above apply to you , talk to your doctor or pharmacist . lactic acidosis ( a substance present in the blood ) is a very common side effect of metformin . if
keep this medicine out of the sight and reach of children . do not use avandamet after the expiry date which is stated on the carton and the blister after exp . this medicinal product does not require any special storage conditions .
what avandamet contains - the active substances are rosiglitazone and metformin . each of the avandamanet tablets contains either 1 mg or 500 mg of rosaiglitizone ( as 500 mg ) and one 500 mg tablet ( as 1 , 000 mg ). each tablet contains 2 mg or 4 mg rosigllitazon ( as 1000 mg ). - the other ingredients are : tablet core : sodium starch glycollate , hypromellose , microcrystalline cellulose , lactose monohydrate , povidone , magnesium stearate , titanium dioxide (
clopidogrel mylan is a member of a group of medicines known as antiplatelet medicinal products . platelets are very small structures in the blood that clump together during blood clotting . by preventing this clumping and preventing the formation of blood clots ( a process known as thrombosis ) it prevents the formation and spread of these clots to other parts of the body ( known as atherothrombotic events ), which can lead to stroke , heart attack , or death . clopidiogrel melan is used to prevent the formation or spread of bloodclots . these severe
you must not be given clopidogrel mylan 31 if you are allergic to any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . warnings and precautions talk to your doctor , pharmacist or nurse before you are given the medicine . before you have been given the recommended dose , you should tell your doctor if : you have had or are going to have any of these conditions : you currently have bleeding , such as : a problem with internal bleeding such
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if you have a condition known as ' atrial fibrillation ' ( an irregular heartbeat ), your doctor may prescribe a lower dose of 75 mg of clopidogrel mylan to help control severe chest pain ( unstable angina or heart attack ). the recommended dose is 300 mg taken once a day . your doctor will tell you how many tablets to take . if your doctor tells you that you need to take one tablet a day , you should take the tablet at the same time each day .
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin or the whites of the eyes ( jaundice ). - bleeding that appears under the skin as red pinpoint dots and / or confusion ( see section 2 " warnings and precautions "). - swelling in the mouth . - skin disorders such as rashes , itching and blisters of theskin . these could be signs of an allergic
what clopidogrel mylan contains - the active substance is clopidoogrel . each film - coated tablet contains 75 mg of clopiodogrel ( as hydrochloride ). - the other ingredients are : tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 , hydrogenated castor oil ( see section 2 " clopidiogrel melan contains hydrogenated Castor oil "). tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow
doptelet belongs to a group of medicines called thrombopoietin receptor agonists . doptelet is used to treat chronic liver disease ( low platelet count ) in adults . it is used in the treatment of thromboocytopenia ( a medical procedure that reduces the risk of bleeding ). it works by reducing the number of platelets in the blood . platelets are a type of blood cells that help the blood to clot and prevent bleeding .
do not use doptelet : if you are allergic to avatrombopag or any of the other ingredients of this medicine ( listed in section 6 ). if you have ever had blood clots in your veins or arteries . warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : you are breast - feeding . you are undergoing hormone replacement therapy . you have recently had surgery or are injured . 23 you are overweight . you suffer from advanced chronic liver disease . children and adolescents do not give this medicine to children or adolescents below the age of 18 years . other medicines and this medicine tell
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose for your procedure is one 5 mg tablet once a day for 8 days . do not exceed this recommended dose . if you take more doptelet than you should if you accidentally take too many tablets , talk to a doctor or go to a hospital straight away . your doctor will tell you how many tablets to take and how often to take them . the usual starting dose for dopotelet is 20 mg twice a day . this may be increased to 40 mg once daily for up to 60
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with doptelet : very common ( may affect more than 1 in 10 people ): feeling tired common : may affect up to 1 in 100 people : low red blood cell count ( anaemia ) blood clot in the portal vein ( a blood vessel that transports blood from the liver to the intestines ) upper abdominal pain swelling bone pain muscle aches fever reporting of side effects if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this
what doptelet contains - the active substance is avatrombopag maleate . each film - coated tablet contains 20 mg / ml of the active ingredient in the tablet . - the other ingredients are : tablet core : lactose monohydrate ( see section 2 ), microcrystalline cellulose , crospovidone type b [ e110 ], silica , colloidal anhydrous , magnesium stearate . tablet coating : vinyl alcohol , talc , macrogol 3350 , titanium dioxide ( e171 ), iron oxide yellow ( e172 ). the tablet shell : pink to pale yellow , round
rapiscan belongs to a group of medicines called ' coronary vasodilators '. rapiscan is used to monitor the heart arteries ( heart rate ) and the muscles in the heart . rapiscin is used for a type of heart scan called ' myocardial perfusion imaging '. the scan contains a radioactive substance known as a ' radiopharmaceutical '. the results of theseimages are recorded using a machine called a ' readmill ' to measure the electrical activity of the heart during a scan . a small amount of radiation is injected into the body through a vein ( usually by your hand ) to obtain images of
rapiscan should not be used if you have slow heart rate , high degree heart block , sinus node disease ( a pacemaker that causes chest pain ) or unstable angina ( a condition where the heart does not work properly ). warnings and precautions talk to your doctor , pharmacist or nurse before using rapiscan if you : have low blood pressure ( hypotension ) or heart failure if you are allergic to regadenoson or any of the other ingredients of this medicine ( listed in section 6 ). if any of these apply to you , tell your doctor straight away . if you think you may be being treated with
rapiscan will be given to you by a doctor or nurse who is experienced in the use of rapiscan . the dose will depend on your heart rate and blood pressure . the recommended dose is 400 mg given as a 5 ml solution the injection may be given as 5 ml or 10 ml depending on your weight . your doctor may also give you an injection of sodium chloride 9 mg ( 0 . 9 % of your body weight ) or 5 ml of a radioactive substance ( radiopharmaceutical ). your doctor will tell you how many times you should be given the dose you need . the usual dose is one 5 ml injection
like all medicines , rapiscan can cause side effects , although not everybody gets them . some of the side effects may be serious and require immediate medical attention . stop taking rapiscin and contact your doctor immediately if you notice any of the following : - sudden stopping of the heart which may be due to damage to the heart ( heart block ). this may be a disorder of theheart ' s electrical signal . rapid heart beat low blood pressure , fainting , ministrokes , weakness of the face and inability to speak . if you have any of these , talk to your doctor or pharmacist . warnings and precautions talk
viagra contains the active substance sildenafil , which belongs to a group of medicines called phosphodiesterase type 5 ( pde5 ) inhibitors . pde 5 inhibitors relax the blood vessels in the penis , making it easier for you to get an erection . viagra is used to treat erectile dysfunction in adult men who cannot get an erect penis suitable for sexual activity .
do not take viagra if : you are allergic to sildenafil or any of the other ingredients of this medicine ( listed in section 6 ). you are taking medicines called nitrates , which can cause a dangerous fall in your blood pressure . these medicines are used to treat angina pectoris ( " chest pain "). the medicines are also known as nitric oxide donors ( such as amyl nitrite ). this can lead to adangerous fall in the blood pressure ( see section " warnings and precautions "). if any of these apply to you , talk to your doctor or pharmacist before taking viagra
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended starting dose is 50 mg once a day . you can take viagra with or without food . viagra film - coated tablets are also available as viagra orodispersible tablets . if you take more viagra than you should if you accidentally take too many viagra tablets , contact your doctor straight away . swallow the tablets whole with a glass of water . do not chew or crush them . if possible , take the tablets with a sufficient amount of saliva . if necessary , take them with
like all medicines , this medicine can cause side effects , although not everybody gets them . some of the side effects may be serious . stop taking viagra and talk to your doctor straight away if you notice any of the following side effects : - an allergic reaction ( may affect up to 1 in 100 people ). symptoms may include sudden wheeziness , difficulty in breathing , dizziness , swelling of the eyelids , face , lips or throat , chest pains and a semi - sitting position . you may need to take nitrates to relieve your chest pain . prolonged and sometimes painful erections ( may occur in 1 in 1 , 000
what viagra contains - the active substance is sildenafil . each tablet contains 25 mg of the tablet ( as the citrate salt ). - the other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , magnesium stearate . tablet coating : hypromellose , titanium dioxide ( e171 ), lactose monohydrate , triacetin , indigo carmine aluminium lake ( e132 ). what viagra looks like and contents of the pack viagra film - coated tablets have a rounded - diamond shape and are marked with
sifrol contains the active substance pramipexole . it belongs to a group of medicines called dopamine agonists . dopamine receptors in the brain are involved in transmitting signals that are important in controlling nerve impulses in thebrain . sifrol is used to treat the symptoms of primary parkinson ' s disease in adults . it is used in combination with levodopa ( a medicine that reduces the activity of dopamine receptors ). the symptoms are moderate to severe primary restless legs syndrome .
do not take sifrol - if you are allergic to pramipexole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given sifol if you have or have had any medical conditions or symptoms of kidney disease . hallucinations ( seeing , hearing or feeling things that are not there ). most hallucinations are mild to moderate . dyskinesia ( abnormal , uncontrolled movements of the limbs ). in patients with advanced parkinson ' s disease , levodopa has been shown to reduce the risk of experiencing or worsening of dys
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of sifrol for parkinson ' s disease is 3 mg once a day for the first week . your doctor will tell you how many tablets to take . the usual starting dose is 1 mg once daily . the dose may be increased to 0 . 088 mg twice a day . this will be gradually increased to the 0 . 264 mg recommended daily dose by your doctor . if your symptoms do not improve after 1 week , your doctor may prescribe a lower dose . the starting dose of
like all medicines , this medicine can cause side effects , although not everybody gets them . evaluation of these side effects is based on the following frequencies : very common ( may affect more than 1 in 10 people ): very common : may affect up to 1 in 1 , 000 people : uncommon : may affects up to one in 100 people : rare : may effect up to a maximum of 1 in 1000 people : not known ( frequency cannot be estimated from the available data ): very rare : affects less than 1 to 10 people : parkinson ' s disease other side effects include dyskinesia ( abnormal , uncontrolled movements of the limbs ),
what sifrol contains - the active substance is pramipexole . each tablet contains 0 . 088 mg ( 0 . 18 mg ), 0 . 35 mg , 0 . 7 mg pramipxole in 0 . 125 mg or 0 . 25 mg of solution . - the other ingredients are : tablet core : mannitol , maize starch , anhydrous colloidal silica , povidone k 25 , magnesium stearate . what siffrol looks like and contents of the pack sifol 0 .088 mg tablets are white to off - white , round , with " sif
emadine is a medicine used for the treatment of seasonal allergic conjunctivitis of the eye . it is used to treat allergic conditions that affect the surface of your eye . the allergic reaction to emadine may include allergic reactions to some materials ( allergens ). allergic reactions may include itching , redness and swelling on the outer layer of youreye that may make you feel worse . if you notice any of these , tell your doctor immediately .
do not use emadine : - if you are allergic to emedastine or any of the other ingredients of this medicine ( listed in section 6 . warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . children and adolescents do not give this medicine to children or adolescents below the age of 3 years because benzalkonium chloride is present in the blood . if you have any further questions on the use of this product , ask your doctor or pharmacist . if any of these apply to you ( or you are not sure ), ask the doctor or nurse at the end of this leaflet
always use emadine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is 3 drops per eye . always use this medicine exactly as described in this leaflet or as directed by your doctor , pharmacist or nurse . do not change the dose unless your doctor tells you to . check your eyes regularly . step 3 . step 1 step 2 step 3 step 4 step 5 step 6 step 7 step 8 step 9 step 10 step 12 step 8 steps 9 step 9 steps 10 step 8 use the emadrine bottle once a day . wash
like all medicines , this medicine can cause side effects , although not everybody gets them . stop using emadine and tell your doctor straight away if you notice any of the following side effects : common side effects ( may affect up to 1 in 10 people ) - eye pain - itchy eye - eye redness uncommon side effects these may be the most common ( affects up to1 in 100 people ) effects in the eye : corneal disorder ( abnormal eye sensation in the back of the eye ), increased tear production , tired eyes , eye irritation , blurred vision due to cornea staining , dry eye . general side effects
keep this medicine out of the sight and reach of children . do not use emadine after the expiry date which is stated on the carton and the blister after exp . this medicine does not require any special storage conditions . keep the blister in the outer carton in order to protect from light . store in a refrigerator ( 2 - 8 ). do not freeze . store below 25 . this will help protect you from infections .
what emadine contains - the active substance is emadastine . each ml contains 0 . 5 mg of difumarate , benzalkonium chloride , trometamol , sodium chloride , hypromellose , purified water , hydrochloric acid , sodium hydroxide , acidity levels ( ph levels ) and water for injections ( see section 2 ). what emADine looks like and contents of the pack emademine is a liquid ( a solution ) supplied in a 5 ml or 10 ml plastic ( drop - liner ) bottle with a screw cap . not all pack sizes may be marketed
levetiracetam actavis is an antiepileptic medicine . it is a medicine used to treat seizures in epilepsy in adults and adolescents aged 16 years and older with newly diagnosed epilepsy . epilepsy is a type of epilepsy characterised by repeated fits ( seizures ) that can occur at any time of the day or night . levetiraacetam actsavis is used in adults to treat the epilepsy that affects the brain on both sides of the brain . partial onset seizure ( secondary generalisation ) has been reported in patients aged 12 years or older with juvenile myoclonic epilepsy ( primary generalised tonic - clonic
do not take levetiracetam actavis : - if you are allergic to the active substance levetiraacetam ( pyrrolidone derivatives ) or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . if you have kidney problems or any slow down in the growth or puberty of your child . anti - epileptics should not be used in children . if any of these apply to you , tell your doctor or pharmacist before you take this medicine , as they may increase the risk of having thoughts of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet of levetiracetam actavis in the morning and one tablet in the evening . monotherapy dose for adults and adolescents 16 years of age and older is 1 , 000 mg twice a day . your doctor may prescribe a higher or lower dose depending on your condition and your response to treatment . the usual starting dose for children and adolescents aged 2 years and above is 1, 000 mg once a day , with or without therapy dose for adolescents aged 17 years and older .
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor or the nearest emergency department immediately if you experience : weakness , feel light - headed , dizzy or have difficulty breathing . these may be signs of a serious allergic ( anaphylactic ) reaction . swelling of the face , lips , tongue and throat ( quincke ' s oedema ). flu - like symptoms . a rash on the face with an extended rash . a high temperature . increased levels of liver enzymes seen in blood tests . a decrease in white blood cell 56 ( eosinophilia ). enlarged lymph
always take levetiracetam actavis exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet ( 250 mg ) twice a day . your doctor will tell you how many tablets to take . the usual dose is two tablets ( 500 mg ) once a day , with or without food . the daily dose is 500 mg ( one tablet ) once each day . the doctor may tell you to take one tablet of levetiraacetam at the start of the day . if you take two tablets , you may take one tablets ( 750 mg )
incruse ellipta contains the active substance oumeclidinium bromide , which belongs to a group of bronchodilators . incruse ellipta is used to treat adults with chronic obstructive pulmonary disease ( copd ). copd is a long - term condition in which the airways in your lungs become blocked , causing breathing difficulties . difficulties in breathing are due to tightening of the muscles in the lungs . this medicine works by tightening these muscles so that your breathing difficulties are easier to control . if you have copd , ellipta can help prevent a sudden attack of breathlessness and whe
do not use incruse ellipta 27 - if you are allergic to umeclidinium or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if you have asthma . if you think you may have asthma , ask your doctor for advice before you are given this medicine . if any of these apply to you , tell your doctor before you start treatment . if your asthma is not being treated , talk to a doctor or pharmacist before you begin treatment . - if your doctor has told you that you have heart problems
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of this medicine is one inhalation every 24 hours . always use incruse ellipta exactly as described in this leaflet . do not change the dose unless your doctor tells you to . if you have any further questions on the use of the product , ask your doctor , pharmacist or nurse . how much to use the recommended starting dose of incrupe ellipta is two inhalations once a day . symptoms of using this medicine are a sudden attack of breathlessness and wheez
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions are rare ( may affect up to 1 in 100 people ). if you experience any of the following symptoms while taking incruse ellipta , stop taking this medicine and contact your doctor straight away : itching skin rash , hives and redness 29 common side effects are : common cold infection of nose , throat cough , feeling of pressure , pain in the cheeks and forehead , inflammation of the sinuses ( sinusitis ), headache , constipation . uncommon side effects may be : uncommon side effect is : uncommon ( may
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the inhaler in the sealed tray in order to protect from light . after opening the seal , the inhale should be used within 6 hours . once the seal has been removed from the sealed compartment , do not put incruse ellipta back in the refrigerator . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user
what incruse ellipta contains - the active substance is umeclidinium bromide . each inhalation contains 55 mg of the active ingredient , i . e . one gram ( 23 . 5 millilitres ) of umclidinicium . one inhalation powder contains 65 mg of umaclidinnium . - the other ingredients are : tablet core : lactose monohydrate ( see section 2 under ' incrusemipta contains lactose '), magnesium stearate ( see " incrumecta contains sodium "), an inhalation solvent ( e . g . water
nucala contains the active substance mepolizumab , which is a monoclonal antibody ( a type of protein that recognises and attaches to specific receptors in the body ). it is used to treat severe asthma in adults and adolescents aged 6 years and older . severe asthma is caused by many eosinophils , a kind of white blood cell that makes up the airways in the lungs . in adults , it is more common ( less than 1 in 10 people ) than in children . in children and adolescents , the risk of asthma is not known ( frequency cannot be estimated from the available data ). asthma
do not use nucala if you are allergic to mepolizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if you have worsening asthma 58 if you experience asthma - related side effects or if your asthma has worsened after you have been treated with other medicines of this type ( monoclonal antibodies ). if you think your asthma may be getting worse , talk to a doctor or go to the nearest hospital straight away . if any of these apply to you , tell your doctor or pharmacist before using n
nucala is given under the skin ( subcutaneous injection ). the recommended dose is 12 ml ( 100 mg ) once a day . the pre - filled pen should be used within 1 hour after the injection . do not use nucala after the expiry date which is stated on the label and carton after exp . your doctor will tell you how long you should continue treatment . if you are not sure , talk to your doctor , pharmacist or nurse before you start treatment . how much to use the recommended amount is one ml ( 1 ml ) of solution for injection . the treatment may be continued for up to
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with nucala : allergic reactions allergic or allergic - like reactions may occur very commonly ( may affect up to 1 in 10 people ) after the injection . sometimes symptoms include symptoms such as chest tightness , cough , difficulty breathing fainting , dizziness , feeling lightheaded ( due to a drop in blood pressure ), swelling of eyelids , face , lips , tongue or mouth hives rash . contact your doctor immediately if you experience a reaction similar reaction to any of the other side effects listed below .
keep out of the sight and reach of children . do not use nucala after the expiry date which is stated on the carton and on the pre - filled pen after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the pen in the outer carton in order to protect from light . once removed from the refrigerator , the pen may be stored at room temperature ( up to 7 ) for a single period of no more than 7 days before use .
what nucala contains - the active substance is mepolizumab . each 1 ml ampoule contains 100 mg of mypolizumaab . - the other ingredients are sucrose , sodium phosphate dibasic heptahydrate , citric acid monohydrate , polysorbate 80 , edta disodium dihydrate and water for injections . what nukala looks like and contents of the pack nucal 1 mg ampoules are white to off - white , oval , biconvex , with a diameter of 1 mm . each pack contains a multipack containing 3 amp
what ninlaro is and what it is used for the active substance is ixazomib , which is a ' proteasome inhibitor '. what is ninlanaro used for ? ninlar is used to treat a cancer of the bone marrow called multiple myeloma . ixizomib is used in adult patients to prevent cell survival in patients with a certain type of malignant melanoma , in which a lot of proteins ( called proteasomes ) have been removed from the body . what is the cause of your condition ? what is your condition and how does it affect you ? when you have multiple
do not take ninlaro - if you are allergic to ixazomib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking the tablet . if you take more of this than you should if you accidentally take too much of the tablet , contact your doctor or pharmacist immediately . if any of these apply to you , tell your doctor straight away . do not take more than the recommended dose . if the tablet is taken with or without food , it is unlikely that you will be given more than one tablet . you should not
always take ninlaro exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if you have multiple myeloma , your doctor will tell you what dose of this medicine to take . how much to take the recommended dose is one tablet a day . you should take one tablet of lenalidomide ( a medicine that contains dexamethasone ), once a day for the first 4 weeks . your doctor may prescribe a lower dose if you take more tablets than you should . how long to take your usual dose is two tablets a day , once on the same day of
like all medicines , this medicine can cause side effects , although not everybody gets them . very common serious side effects ( may affect more than 1 in 10 people ): low platelet counts ( thrombocytopenia ), nose bleeds , easily bruise nausea , vomiting , diarrhoea , numbness , tingling or burning of the hands or feet ( peripheral neuropathy ) swelling of the legs orfeet ( peripheral oedema ) skin rash or itchy areas of the body ( rare side effects may affect up to 1 in 1 , 000 people ): severe skin rashes , red to purple bumps ( sweet
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the capsule in the outer carton in order to protect from light . after first opening , the capsule should be used immediately . this medicine does not require any special temperature storage conditions . any damage to medicine packaging should be investigated by your healthcare professional .
what ninlaro contains the active substance is ixazomib . each capsule contains 2 . 3 mg of ixezomib in 3 . 3 ml of solution . the other ingredients are : capsule contents : capsule shell : microcrystalline cellulose , magnesium stearate , talc . printing ink : the capsule shell contains gelatin , titanium dioxide ( e171 ), red iron oxide ( e172 ), shellac , propylene glycol , potassium hydroxide ( e1520 ) and black iron oxide . the capsule content : capsule shells : capsule containing 3 mg / m2 ( e132 ) 
do not use palforzia : - if you are allergic to peanuts ( arachis hypogaea ). warnings and precautions talk to your doctor , pharmacist or nurse before using palforuszia . children and adolescents from 4 to 17 years of age should not be given treatment for peanut allergy . peanut ( desensitisation ) is a substance present in the food and drink in the body that can cause allergic reactions . if you have any further questions on the use of this product , ask your doctor or pharmacist .
do not take palforzia : - if you are allergic to severe asthma or any of the other ingredients of this medicine ( listed in section 6 ). - if your asthma has a problem swallowing , or if you have long term problems with your digestive system ( e . g . a severe mast cell disorder , severe or life - threatening anaphylaxis ) which may occur within 60 days of the start of treatment . warnings and precautions talk to your doctor , pharmacist or nurse before taking palferzia . if you take more of the medicine than you should if you accidentally take too many tablets of palf
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if you have a history of allergy or allergic reactions ( anaphylaxis ), your doctor may prescribe a lower dose . the recommended dose is 3 mg once a day . treatment with palforzia will be initiated by your doctor . initial doseescalation and up - dosing steps should be initiated at the same time each day . your doctor will decide how long you should continue to take the medicine . follow the instructions of your doctor , pharmacist or nurse for further instructions on how to take
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with palforzia : severe allergic reactions : if you experience any of the following symptoms while taking the medicine , tell your doctor straight away : - trouble breathing , throat tightness , feeling offulness , trouble swallowing or speaking - changes in voice , dizziness or fainting - severe stomach cramps , pain , vomiting , diarrhoea , severe flushing or itching of the skin palfORzia may cause problems with the stomach and digestive system ( eosinophilic oes
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . store below 25 . keep this medicine in the original package in order to protect from light . any hard lumps of powder should be disposed of in accordance with local requirements .
what palforzia contains the active substances are : 0 . 5 mg , 1 mg , 10 mg or 20 mg . the other ingredients are : capsule contents : microcrystalline cellulose , colloidal anhydrous silica and magnesium stearate palforbzia 100 mg : oral powder in capsules with opening microCrystalline croulose ( e460i ), colloidal ahydrous siliconica ( e470i ) and magnesium unstearate ppalfor zia 300 mg : capsule shell : capsule shells : capsule content : oralpowder in sachet micromole ( e464 ),
the active substance of zerene is benzodiazepine . it belongs to a group of medicinal products known as hypnotic actions . it is used for the treatment of sleeping problems . treatment should be started immediately if you have problems sleeping .
you should not be given zerene : if you have hypersensitivity ( an allergy ) to zaleplon or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given the dose of zereerene sleep apnoea syndrome , which may occur for short periods . if you suffer from severe kidney or liver problems , e . g . myasthenia gravis , you may feel very weak or tired muscles , severe breathing or chest problems . children and adolescents this medicine is not recommended for use in children under 18
always take zerene exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 10 mg once a day . if you have difficulty falling asleep , do not take more than one capsule . adults 65 years of age and older if you suffer from mild to moderate liver problems your doctor will tell you how many capsules to take and how often to take them . children and adolescents from the age of 65 years to less than 5 years the recommended starting dose is one capsule twice a day ( two capsules per day ). if you develop mild tomoderate liver problems , your doctor
like all medicines , zerene can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any other changes in your health . the frequency of possible side effects listed below is defined using the following convention : 36 very common ( may affect more than 1 in 10 people ) common : may affect up to 1in 10 people 100 uncommon : may affects up to one in 10 , 000 people 1 , 000 rare : not known ( frequency cannot be estimated from the available data ) very rare : affects less than 1 to 10 people rare : cannot affect 1 in 100 people not known : frequency can affect up
what zerene contains - the active substance is zaleplon 5 mg . - the other ingredients are : capsule contents : microcrystalline cellulose , pregelatinised starch , silicon dioxide ( e171 ), sodium lauryl sulphate , magnesium stearate . capsule shell : lactose monohydrate , indigo carmine ( e132 ), gelatin , titanium dioxide , red iron oxide , yellow iron oxide ( e172 ) and black iron oxide (< e172 ). printing ink : shellac , lecithin , simethicone ( e1520 ), yellow ironoxide ( e 172 ). what z
